|
Tuesday, November 14, 2023
Print Entire 2023 Program:
 |
|
| SESSION 1 SCHEDULE | |
|
Tuesday
SESSION 1:
PROGRESS IN CORONARY ARTERY STENTING, TRANSCATHETER VALVE REPLACEMENT, AND TREATMENT OF ASCENDING AORTIC DISEASE
|
|
| x | |
| 6:45 AM - 6:50 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| CORONARY STENTS | |
| 6:50 AM - 6:55 AM | What Is New In Coronary Artery Stenting: What Is The Role For Bare Metal Stents |
| Presenter(s):Roxana Mehran, MD | |
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | What Is New With Treatment Outcomes For Left Main Coronary Artery Disease: Advantages And Limitations Of PCI And CABG: Which Has Better Long-Term Survival |
| Presenter(s):Gregg W. Stone, MD | |
| View Slides in PDF | |
| TRANSCATHETER HEART VALVES | |
| 7:02 AM - 7:07 AM | Update On The Status Of Transcatheter Mitral Valve Replacement/Repair (TMVR) |
| Presenter(s):Juan F. Granada, MD | |
| View Slides in PDF | |
| 7:08 AM - 7:13 AM | DEBATE: Update On Current State Of TAVR: A Cardiac Surgeon’s View: What Is The Role Of Surgery In Aortic Valve Disease |
| Presenter(s):Ali B. Khoynezhad, MD, PhD | |
| View Slides in PDF | |
| 7:14 AM - 7:19 AM | DEBATE: What Is New With Transcatheter Aortic Valve Replacement (TAVR): What Are Its Limitations: A Cardiologist’s View |
| Presenter(s):Torsten P. Vahl, MD | |
| View Slides in PDF | |
| THE ASCENDING AORTA | |
| 7:20 AM - 7:25 AM | Progress In Endovascular Graft Treatment Of Ascending Aortic Lesions: What New Grafts Are Being Developed: What Problems Exist: Will They Be Overcome And Will This Segment Of The Aorta Be Conquered Endovascularly |
| Presenter(s):Rodney A. White, MD | |
| View Slides in PDF | |
| 7:26 AM - 7:31 AM | Endovascular Treatment Of Type A Aortic Dissections (TAADs) In 2023: What Is Here And What Is Coming: Experience With Ascending Aortic Endografting |
| Presenter(s):Eric E. Roselli, MD | |
| View Slides in PDF | |
| 7:32 AM - 7:37 AM | Current Status Of Endo Bentall Procedures In Patients: Review Of Early Clinical Experiences: How Can It Be Done Without Left Ventricular Access |
| Presenter(s):Yazan Duwayri, MD MBA / Brad Leshnower, MD | |
| View Slides in PDF | |
| 7:38 AM - 7:43 AM | Current And Future Status Of Ascending Aortic Endograft Repairs: Devices And Experience With Endo-Wheat And Endo-Bentall Procedures |
| Presenter(s):Nimesh Desai, MD, PhD | |
| View Slides in PDF | |
| 7:44 AM - 7:50 AM | Panel Discussion |
| END OF SESSION 1 | |
| SESSION 2 SCHEDULE | |
|
Tuesday
SESSION 2:
PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
|
|
| x | |
| 7:50 AM - 7:55 AM | Current Status Of Open Aortic Arch Repair: What Is The Benchmark That Endo And Hybrid Techniques Must Compete With |
| Presenter(s):Anthony L. Estrera, MD | |
| View Slides in PDF | |
| 7:56 AM - 8:01 AM Power Point Presentation with Synched Audio |
Update On Hybrid Repair Of Aortic Arch And Thoracic Aortic Aneurysms Using ThoraFlex (Hybrid) And Relay Devices For Frozen Elephant Trunk (FET) And TEVAR: Indications And Results |
| Presenter(s):Joseph S. Coselli, MD / Ourania Preventza, MD | |
| View Slides in PDF | |
| 8:02 AM - 8:07 AM | Update On Endovascular Arch Repair With Cook 2- Or 3-Branched Device For Lesions Involving The Entire Aortic Arch: Retrograde Versus Antegrade Insertion Of Arch Branches: Advantages Of A Fully Percutaneous Approach |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 8:08 AM - 8:13 AM | Long-Term Results With 2-Branched Endograft (Relay – Terumo Aortic) And Single Branched Device (Nexus – Endospan) For Treatment Of Zone 0 Arch Lesions |
| Presenter(s):Toru Kuratani, MD, PhD | |
| View Slides in PDF | |
| 8:14 AM - 8:19 AM | Update On The Terumo Relay Branched Endograft Device For Aortic Arch Lesion Repairs: Advantages, Limitations And Results |
| Presenter(s):Vicente Riambau, MD, PhD / Ciro Ferrer, MD, PhD / Martin Czerny, MD | |
| View Slides in PDF | |
| 8:20 AM - 8:25 AM | A New Device For Endovascular Repair Of Aortic Arch Aneurysms: Advantages And Early Clinical Experience |
| Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
| View Slides in PDF | |
| 8:26 AM - 8:31 AM | Update On Total And Partial Aortic Arch Lesion Repairs With The Gore TAG Single Branch Endograft: An Off-The-Shelf (OTS) Device For Revascularizing Arch Branches: Experience To Date, Advantages And Limitations |
| Presenter(s):Michael D. Dake, MD / Himanshu Patel, MD / Joseph E. Bavaria, MD | |
| View Slides in PDF | |
| 8:32 AM - 8:37 AM | How Best To Treat TBADs Extending Into The Arch Or Ascending Aorta; When Open, When Endo, When Hybrid |
| Presenter(s):I-Hui Wu, MD, PhD | |
| View Slides in PDF | |
| 8:38 AM - 8:43 AM | A New Device For Endovascular Aortic Arch Reconstruction: Characteristics, Advantages And Early Clinical Results |
| Presenter(s):Chang Shu, MD | |
| View Slides in PDF | |
| 8:44 AM - 8:49 AM | How Best To Treat Aortic Arch Lesions: Customized Versus Off-The-Shelf (Chimney) Versus Physician Modified Endografts: Is Open Repair Ever Necessary |
| Presenter(s):Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 8:50 AM - 8:55 AM | Value Of Ascending Aortic Banding As Primary Or Adjunctive Treatment For Aortic Arch Lesions |
| Presenter(s):Chun Che Shih, MD, PhD | |
| View Slides in PDF | |
| 8:56 AM - 9:02 AM | Panel Discussion |
| END OF SESSION 2 | |
| SESSION 3 SCHEDULE | |
|
Tuesday
SESSION 3:
PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: REPORTING STANDARDS, CLASSIFICATION SYSTEMS, STABILISE, AND MORE
|
|
| x | |
| 9:02 AM - 9:07 AM | Guideline Update On The SVS-STS Aortic Dissection Reporting Standards And Classification System: How Do They Help In Precisely Determining High Risk TBAD Patients |
| Presenter(s):Joseph V. Lombardi, MD, MBA | |
| View Slides in PDF | |
| 9:08 AM - 9:13 AM | Important Bullet Points Regarding Aortic Dissections From The European Association For Cardiothoracic Surgery: What Is New About Them |
| Presenter(s):Martin Czerny, MD | |
| View Slides in PDF | |
| 9:14 AM - 9:19 AM | Imperfect TEVAR Stent-Graft Performance As A Cause Of Aortic Remodeling: How It Can Be Prevented And Treated With The Chinese Fabulous® Thoracic Aortic Stent-Graft Designed Specifically For Aortic Dissections |
| Presenter(s):Weiguo Fu, MD | |
| View Slides in PDF | |
| 9:20 AM - 9:25 AM | New Findings Regarding The STABILISE Concept For Treating Acute And Chronic TBADs By Disrupting The Intimal Flap By Overdilating The Distal Bare Stent: How It Works, Precautions, And Should It Be The Treatment Of Choice |
| Presenter(s):Jean-Marc Alsac, MD, PhD | |
| View Slides in PDF | |
| 9:26 AM - 9:31 AM | Updated Experience With The STABILISE Technique For Acute And Subacute TBADs: Indications, Technical Tips, Precautions And Results |
| Presenter(s):Andrea Kahlberg, MD / Germano C.G. Melissano, MD / Roberto L.V. Chiesa, MD | |
| View Slides in PDF | |
| 9:32 AM - 9:37 AM | Dual Lumen Interventions To Promote False Lumen Thrombosis In Chronic Aortic Dissections: The FLIRT Procedure: What Is It; When Is It Useful; How To Do It |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| View Slides in PDF | |
| 9:38 AM - 9:43 AM | There Will Always Be A Need For Open Repair For Post-Dissection TAAAs: In What Circumstances |
| Presenter(s):Hazim J. Safi, MD | |
| View Slides in PDF | |
| 9:44 AM - 9:49 AM | Distal Stent-Graft Induced New Entry Tears (SINEs) With TEVAR Treatment Of TBADs: Prevention By Avoiding Oversizing And Ballooning And Using Tapered Endografts |
| Presenter(s):Ludovic Canaud, MD, PhD | |
| View Slides in PDF | |
| 9:50 AM - 9:55 AM | The Impact Of Distal Stent-Graft Induced New Entry Tears (SINEs) On Aortic Remodeling Of Chronic TBADs: How To Prevent And Treat Them |
| Presenter(s):Chun Che Shih, MD, PhD | |
| View Slides in PDF | |
| 9:56 AM - 10:01 AM | Highlights From The New SVS, AATS, AHA, ACC, ACR, STS, SVM, SCAI, SCA Aortic Disease Guidelines: What Are The Key Differences |
| Presenter(s):James H. Black, III, MD | |
| View Slides in PDF | |
| 10:02 AM - 10:07 AM Power Point Presentation with Synched Audio |
International Experience With Endovascular Treatment Of Complex Aortic Diseases In Patients With Connective Tissue Disease (CTD) Including Loeys-Dietz And Ehlers-Danlos Syndromes: What Is Its Role |
| Presenter(s):Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| 10:08 AM - 10:14 AM | Panel Discussion |
| 10:14 AM - 10:24 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 3 | |
| SESSION 4 SCHEDULE | |
|
Tuesday
SESSION 4:
MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
|
|
| x | |
| 10:24 AM - 10:29 AM | When Should Fully Open Repair Be First Line Treatment For TAAAs And When Should A Hybrid (Endograft Proximal + Open Distal) Be The Preferred Treatment: How To Do The Latter |
| Presenter(s):Margaret Tracci, MD, JD | |
| View Slides in PDF | |
| 10:30 AM - 10:35 AM | New Strategies And Indications For Open TAAA Repair Including Failed EVAR And F/B/EVAR: Technical Tips And Results |
| Presenter(s):Andrea Kahlberg, MD / Germano C.G. Melissano, MD / Roberto L.V. Chiesa, MD | |
| View Slides in PDF | |
| 10:36 AM - 10:41 AM | Update On Aortic Arch Repairs With Frozen Elephant Trunk (FET) Followed By Open Or Endo Extensions For TAAA Repairs: Techniques And Outcomes; Importance Of Staging |
| Presenter(s):Michael J. Jacobs, MD / Barend M.E. Mees, MD, PhD, FEBVS / Geert Willem H. Schurink, MD, PhD | |
| View Slides in PDF | |
| 10:42 AM - 10:47 AM | New Findings From The STABLE I And II Trials: What Are The Short And Long-Term Benefits And Limitations Of A Distal Bare Stent Combined With A Proximal Covered Stent (The Petticoat Procedure): Update On Aortic Remodeling |
| Presenter(s):Joseph V. Lombardi, MD, MBA | |
| View Slides in PDF | |
| 10:48 AM - 10:53 AM | 25 Years Of Data From The IRAD Registry (International Registry of Acute Aortic Dissection): How Has Treatment Evolved; What Lessons Have Been Learned: What Key Questions Remain |
| Presenter(s):Santi Trimarchi, MD, PhD | |
| View Slides in PDF | |
| 10:54 AM - 10:59 AM | F/B/EVAR For TAAAs Degenerative And Post TBAD: The Good, Bad And Ugly: Complications And How To Prevent Them: Value Of The BeBack Catheter To Cross The Dissection Flap |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD | |
| View Slides in PDF | |
| 11:00 AM - 11:05 AM Power Point Presentation with Synched Audio |
Experience With Inner And Outer Branched Endografts And The t-Branch OTS Device (Cook) To Treat TAAAs After TBADs: Technical Tips And Results |
| Presenter(s):Marcelo Ferreira, MD | |
| View Slides in PDF | |
| 11:06 AM - 11:12 AM | Panel Discussion |
| 11:12 AM - 11:17 AM | Update On The Endovascular Treatment Of Ascending Aortic Disease With The Gore Ascending Aortic Endograft: Advantages, Limitations And Results From The ARISE Trial |
| Presenter(s):Ali Azizzadeh, MD | |
| View Slides in PDF | |
| 11:18 AM - 11:23 AM Power Point Presentation with Synched Audio |
Unitary Manifold Endograft System For Complex Type 4 TAAAs, Aneurysms With Chronic TBADs, Ruptured Complex AAAs And Failed Prior EVAR Repairs: How Does It Work And Up To 10-Year Results |
| Presenter(s):Patrick W. Kelly, MD | |
| View Slides in PDF | |
| 11:24 AM - 11:29 AM Power Point Presentation with Synched Audio |
With Acute Type A Aortic Dissection (TAAD) And End-Organ Ischemia, Which Should Come First – Aortic Repair Or Restoration Of Branch Perfusion: How To Accomplish The Latter |
| Presenter(s):David M. Williams, MD | |
| View Slides in PDF | |
| 11:30 AM - 11:35 AM | Improved Aortic Remodeling With TEVAR And A Distal Bare Metal Stent In Acute Complicated TBAD |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| View Slides in PDF | |
| 11:36 AM - 11:41 AM | Endovascular Thermal Septotomy Of The Dissection Flap With An Electrocautery Activated Guidewire To Eliminate And Prevent Enlargement Of The False Lumen To Treat Chronic TBADs: Is There A Downside |
| Presenter(s):Carlos H. Timaran, MD | |
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | Current Status Of A Catheter Aortic Septotomy Device For Treating Aortic Dissections By Cutting The Septum From Below: Yes, There Is A Downside To Other Septotomies That Cut The Septum From Above |
| Presenter(s):Ramon Berguer, MD, PhD | |
| View Slides in PDF | |
| 11:48 AM - 11:53 AM | With Acute Type B Aortic Intramural Hematomas (IMHs): When Is TEVAR Indicated: How Long Should Treatment Be Delayed For Optimal Outcomes: Earlier TEVAR Has More Adverse Events |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break - Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 4 | |
| SESSION 5 SCHEDULE | |
|
Tuesday
SESSION 5:
NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY AND TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING
|
|
| x | |
| 1:00 PM - 1:05 PM | Failing EVARs Are An Enlarging Epidemic: Etiology And How Best To Prevent And Treat The Problem: Can Cloud Based Fusion Help |
| Presenter(s):Murray L. Shames, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | What Evidence Really Matters In Evaluating EVAR Results: What Is The Best Type Of Evidence To Compare EVAR With Open Repair: RCTs May Not Reflect Reality As Well As Other Methods: The NICE Guidelines Prove It |
| Presenter(s):Matt M. Thompson, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Are There Registry Differences In Neck Behavior And AAA Sac Shrinkage After Excluder And Endurant Endografts: Why We Need A Head-To-Head Randomized Comparison After EVAR With The 2 Endografts: The ADVANCE RCT |
| Presenter(s):Marc L. Schermerhorn, MD / Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Observation Of Small AAAs (<5.0 cm) Is Safe, Predictable And Does Not Reduce EVAR Options: Are There Exceptions And Does AAA Volume Matter |
| Presenter(s):Jon S. Matsumura, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Update On A Novel New Endovascular Technology (Nectero) To Slow AAA Growth; How Does It Work And 3-Year Clinical Results: Status Of The STAAABLE RCT And Recent Approval Of FDA Fast Track Designation |
| Presenter(s):Venkatesh G. Ramaiah, MD / Daniel G. Clair, MD / Andrew Holden, MBChB | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Why And When EVAR Is NOT The Best Treatment For All AAAs Even With Favorable EVAR Anatomy: When Open And When No Treatment Is Better |
| Presenter(s):Fabio Verzini, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 1:36 PM - 1:42 PM | Panel Discussion |
| 1:42 PM - 2:47 PM | A Note Of Caution Regarding Nellix Endografts And EVAS From The European Society for Vascular Surgery (ESVS) Guidelines Committee |
| Presenter(s):Jonathan R. Boyle, MD, MA (Cantab), FRCS / Nikolaos Tsilimparis, MD, PhD / Isabelle Van Herzeele, MD, PhD / Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Short And Long-Term Results For Endovascular Therapy For Infected Aortic Aneurysms At Various Levels: A 17-Year, 163-Case Experience: EVAR Can Work |
| Presenter(s):Boonprasit Kritpracha, MD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | Sac Dynamics After EVAR Influence Long-Term Survival: What Can Be Done To Improve AAA Sac Shrinkage: Filling The Sac With Polymer Plugs From Shape Memory Medical Promotes Sac Shrinkage: Update On The AAA-SHAPE Study |
| Presenter(s):Michel M.P. Reijnen, MD, PhD / Andrew Holden, MBChB | |
| View Slides in PDF | |
| 2:00 PM - 2:05 PM | Update On Long-Term Results From The DREAM RCT Comparing EVAR With Open Repair For AAAs Suitable For Both: Adverse Neck Anatomy (Short, Wide, Angulated) Was Associated With Increased Reintervention And Mortality Rates Equally After Open And Endo Repairs: How Should This Influence Treatment |
| Presenter(s):Jan D. Blankensteijn, MD | |
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | Management Of The Internal Iliac Artery With Extensive Aortoiliac Aneurysms In The Era Of Iliac Branched Devices: Is There Any Role For Open Surgery |
| Presenter(s):Heron E. Rodriguez, MD | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Danger Of Performing EVAR In Patients With Visceral Artery (SMA) Occlusive Disease: What Can Happen And How Should It Be Avoided |
| Presenter(s):Karan Garg, MD / Neal S. Cayne, MD / Carlos H. Timaran, MD / Frank J. Veith, MD | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | Which AAA Patients Should Get Open Repair (OR) In 2023: Young Healthy Patients With Large AAAs Do Better With OR: But EVAR Outcomes Are Improving While OR Outcomes Are Not |
| Presenter(s):Marc L. Schermerhorn, MD | |
| View Slides in PDF | |
| 2:24 PM - 2:30 PM | Panel Discussion |
| 2:30 PM - 2:40 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 5 | |
| SESSION 6 SCHEDULE | |
|
Tuesday
SESSION 6:
MORE ABOUT AAAs AND EVAR, STANDARD AND COMPLEX: UPDATES ON THE UK NICE AAA GUIDELINES AND OTHER AORTIC PATHOLOGY
|
|
| x | |
| 2:40 PM - 2:45 PM | The Safe-AAA Study Emphasizes The Importance Of Ongoing Surveillance And Continuing EVAR Device Risk: Some EVAR Endografts Have Been Found To Have More Late Risks Than Others |
| Presenter(s):Philip P. Goodney, MD, MS / Eric A. Secemsky, MD, MSc | |
| View Slides in PDF | |
| 2:46 PM - 2:51 PM | Review Of All Recent AAA Guidelines: Do They Support Or Refute The NICE AAA Guidelines |
| Presenter(s):Andrew W. Bradbury, MD, FRCSEd | |
| View Slides in PDF | |
| 2:52 PM - 2:57 PM | How Have The NICE AAA Guidelines Influenced The Performance Of EVAR In The UK: Are The Guidelines Wrong And Can They Be Fixed |
| Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
| View Slides in PDF | |
| 2:58 PM - 3:03 PM | Why The NICE AAA Guidelines Are The Way They Are: Bias Has Played A Role As It Does In Many Things: Randomized Controlled Trials (RCTs) Can Be Misleading |
| Presenter(s):Frans L. Moll, MD, PhD | |
| TOPICS RELATED TO INFRARENAL AORTIC LESIONS AND AAAs | |
| 3:04 PM - 3:09 PM | Spontaneous Infrarenal Acute Aortic Syndrome: What Is It And Why Is It Best Treated With A Unibody Stent-Graft |
| Presenter(s):Felice Pecoraro, MD | |
| View Slides in PDF | |
| 3:10 PM - 3:15 PM | Diabetes Versus COVID-19: How Should Both Modify AAA Treatment Or Its Planning |
| Presenter(s):Ronald L. Dalman, MD | |
| View Slides in PDF | |
| 3:16 PM - 3:21 PM | How Does Metformin Work To Slow AAA Growth: Is It The Reason For Decreased AAA Incidence In Diabetes |
| Presenter(s):Kak Khee Yeung, MD, PhD | |
| View Slides in PDF | |
| 3:22 PM - 3:27 PM Power Point Presentation with Synched Audio |
The Metformin For AAA Growth Inhibition (MAAGI) Multicenter Trial: Design And Preliminary Results: Will The Drug Help In The Treatment Of Small AAAs |
| Presenter(s):Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| TOPICS RELATED TO COMPLEX AORTIC PATHOLOGY | |
| 3:28 PM - 3:33 PM | Value Of IVUS In Treating Complex Aortic Pathology |
| Presenter(s):Andres Schanzer, MD | |
| View Slides in PDF | |
| 3:34 PM - 3:39 PM | Early Experience With Off-The-Shelf Inner Branch Stent Grafting For Suprarenal AAAs And TAAAs |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | With Failed EVAR, When Is F/EVAR The Best Treatment: Tips And Tricks For Performing It Successfully |
| Presenter(s):Andres Schanzer, MD | |
| View Slides in PDF | |
| 3:46 PM - 3:56 PM | Panel Discussion |
| END OF SESSION 6 | |
| SESSION 7 SCHEDULE | |
|
Tuesday
SESSION 7:
MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC THORACIC PATHOLOGY; STROKE PREVENTION WITH TEVAR
|
|
| x | |
| 3:56 PM - 4:01 PM | How To Predict Failed Proximal EVAR Fixation With Short Necked AAAs So Initial Treatment Should Be With F/EVAR Or Ch/EVAR |
| Presenter(s):Martin R. Back, MD | |
| View Slides in PDF | |
| 4:02 PM - 4:07 PM | Update On Prevention Of Gas Emboli And Stroke With TEVAR: How Important Is CO2 Flushing And Other Measures |
| Presenter(s):Tilo Koelbel, MD, PhD / Stephan Haulon, MD | |
| View Slides in PDF | |
| 4:08 PM - 4:13 PM | High Risk Features In Uncomplicated TBAD Patients: How Do We Know They Justify Elective TEVAR |
| Presenter(s):Joseph V. Lombardi, MD, MBA / Jeffrey P. Carpenter, MD | |
| View Slides in PDF | |
| 4:14 PM - 4:19 PM | Current Role Of Physician Modified Endografts (PMEGs) For Total Endovascular Aortic Arch Repair |
| Presenter(s):Carlos H. Timaran, MD | |
| View Slides in PDF | |
| 4:20 PM - 4:25 PM | How To Prevent Bird Beaking And Type I Endoleaks With TEVAR In The Aortic Arch: How To Size TEVAR Grafts Optimally And Does It Matter |
| Presenter(s):Thomas L. Forbes, MD | |
| View Slides in PDF | |
| 4:26 PM - 4:31 PM | How Best To Treat TBADs Extending Into The Aortic Arch Or Ascending Aorta: When Open, When Endo, When Hybrid: Technical Tips |
| Presenter(s):I-Hui Wu, MD, PhD | |
| View Slides in PDF | |
| 4:32 PM - 4:37 PM | Endovascular Aortic Arch Interventions: Hybrid Options Versus Total Endovascular Repair |
| Presenter(s):Cherrie Z. Abraham, MD | |
| View Slides in PDF | |
| 4:38 PM - 4:43 PM | Long-Term (>5 Years) Good Results Of The Medtronic Valiant Captiva Endografts For TEVAR In TBAD Patients: Advantages And Disadvantages |
| Presenter(s):Nimesh Desai, MD, PhD / Joseph E. Bavaria, MD | |
| View Slides in PDF | |
| 4:44 PM - 4:49 PM | How To Treat Aortic Dissections With An Entry Tear In The Aortic Arch: Can Ancillary Techniques Help |
| Presenter(s):Santi Trimarchi, MD, PhD | |
| View Slides in PDF | |
| 4:50 PM - 4:56 PM | Panel Discussion |
| END OF SESSION 7 | |
| SESSION 8 SCHEDULE | |
|
Tuesday
SESSION 8:
MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NATURAL HISTORY; NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TBADs
|
|
| x | |
| 4:56 PM - 5:01 PM | Celiac Artery Orifice Coverage During TEVAR Is Not Always Benign: It Is Often Associated With Visceral Ischemia And Other Poor Outcomes |
| Presenter(s):Richard G.J. Gibbs, FRCS | |
| View Slides in PDF | |
| 5:02 PM - 5:07 PM | What Does Endovascular Aortic Repair Do To Cardiac And Coronary Artery Function: Does The Position Of The Graft Make A Difference: Do We Need A Compliant Endograft |
| Presenter(s):Rachel E. Clough, PhD, FRCS | |
| View Slides in PDF | |
| DEBATE ON TREATMENT OF ACUTE UNCOMPLICATED TBADs | |
| 5:08 PM - 5:13 PM | DEBATE: With Uncomplicated Acute TBADs, The Case For Waiting 2-6 Weeks From Onset For TEVAR And Then Limiting Aortic Coverage |
| Presenter(s):Mark A. Farber, MD | |
| View Slides in PDF | |
| 5:14 PM - 5:19 PM | DEBATE: With Uncomplicated TBADs, The Case For Early TEVAR With Extensive Aortic Coverage In Most Patients |
| Presenter(s):William D. Jordan Jr., MD / Brad Leshnower, MD | |
| View Slides in PDF | |
| 5:20 PM - 5:25 PM | How To Prevent Abdominal Extension Of The False Lumen And TAAAs With TBADs: Does Early TEVAR Help: What Other Techniques Show Promise |
| Presenter(s):Rodney A. White, MD | |
| View Slides in PDF | |
| 5:26 PM - 5:31 PM | The Indication For TEVAR Is More Important Than Its Timing In Predicting Outcomes With Acute Uncomplicated TBAD Patients: When Is Medical Treatment Alone Indicated |
| Presenter(s):Ali Azizzadeh, MD | |
| View Slides in PDF | |
| 5:32 PM - 5:37 PM Power Point Presentation with Synched Audio |
With TBADs, Is True Lumen Compression Ever So Severe That It Negatively Influences TEVAR Deployment Or Performance: How Can It Be Managed |
| Presenter(s):Sara L. Zettervall, MD / Benjamin W. Starnes, MD | |
| View Slides in PDF | |
| 5:38 PM - 5:43 PM | With TBADs, Distal Fenestrations Are Important: How Should They Be Treated |
| Presenter(s):Frank R. Arko, MD | |
| View Slides in PDF | |
| 5:44 PM - 5:49 PM | Hybrid Surgical And Endovascular Staged Approaches For The Treatment Of Complex Aneurysmal Lesions Involving The Thoracic Aorta |
| Presenter(s):Francesco Setacci, MD | |
| View Slides in PDF | |
| 5:50 PM - 5:55 PM | Re-Entry Specific Endovascular Therapy (RESET), i.e. TEVAR Plus Dealing With Re-Entry Tears: It Promotes False Lumen Thrombosis, Aortic Remodeling And Improves Outcomes: How To Do It |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| 5:56 PM - 6:02 PM | Panel Discussion End of Program A |
| END OF SESSION 8 | |
| SESSION 9 SCHEDULE | |
|
Tuesday
SESSION 9:
PROGRESS IN VASCULAR ROBOTICS, LAPAROSCOPY, GUIDANCE SYSTEMS AND SIMULATION
Moderators:Willem Wisselink, MD / Barry T. Katzen, MD
|
|
| x | |
| 6:47 AM - 6:50 AM | Opening Remarks |
| Presenter(s):Enrico Ascher, MD | |
| 6:50 AM - 6:55 AM | How Can Ex Vivo Training With Simulators Decrease Vascular Complications And Improve Outcomes |
| Presenter(s):Michael E. Barfield, MD | |
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | Laparoscopic Aortic Surgery: How I Did It Routinely And Why I Stopped After More Than 150 Cases |
| Presenter(s):Laurent Chiche, MD, FEBVS | |
| View Slides in PDF | |
| 7:02 AM - 7:07 AM | 25 Years Of Robotic Vascular Surgery: If It Is So good, Why Isn’t It Mainstream Now |
| Presenter(s):Willem Wisselink, MD | |
| View Slides in PDF | |
| 7:08 AM - 7:13 AM Power Point Presentation with Synched Audio |
Focus On Radiation Protection During Simulation-Based Training Improves Both Correct Behavior And Procedural Performance: Proven By A Randomized Comparison |
| Presenter(s):Lars B. Lonn, MD, PhD | |
| View Slides in PDF | |
| 7:14 AM - 7:19 AM | Inside Out: Next Generation Technology That Transmits Physical Intelligence And Parameters Continuously From Within The Patient: How Will It Help In Vascular Treatment |
| Presenter(s):Barry T. Katzen, MD | |
| View Slides in PDF | |
| RADIATION REDUCING IMAGING GUIDANCE TECHNIQUES | |
| 7:20 AM - 7:25 AM | True Radiation Reduction Strategies For Complex Endovascular Procedures: FORS, Digital Zooming, IVUS, And Live Fusion Guidance |
| Presenter(s):Carlos H. Timaran, MD | |
| View Slides in PDF | |
| 7:26 AM - 7:31 AM | Updated Experience With The Fiberoptic 3D Endovascular Guidance With The Fiberoptic RealShape (FORS) System (From Philips): Advantages And Limitations |
| Presenter(s):Joost van Herwaarden, MD, PhD | |
| View Slides in PDF | |
| 7:32 AM - 7:37 AM | Update On The 3D Radiation Free Electromagnetic Intraoperative Positioning System (IOPS) From Centerline For Endovascular Guidance: Advantages And Limitations |
| Presenter(s):Francis Caputo, MD / Matthew J. Eagleton, MD | |
| View Slides in PDF | |
| 7:38 AM - 7:43 AM | New Findings Related To The Incidence Of Cancer After EVAR: What Causes It And How Can It Be Reduced |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 7:44 AM - 7:50 AM | Panel Discussion |
| END OF SESSION 9 | |
| SESSION 10 SCHEDULE | |
|
Tuesday
SESSION 10:
NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
Moderators:Ali F. AbuRahma, MD / Bruce A. Perler, MD, MBA
|
|
| x | |
| 7:50 AM - 7:55 AM | Update On International Variations In Carotid Stenosis Treatment Within Countries And Between Countries Is Huge Despite All The RCTs On Which They Are Based Being The Same: What Are The Implications |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 7:56 AM - 8:01 AM | Current Optimal Treatment For Carotid Artery Dissection: When Best Medical Therapy (BMT), When Open Surgery, When Carotid Stenting (CAS) With Proximal Embolic Protection |
| Presenter(s):Felice Pecoraro, MD | |
| View Slides in PDF | |
| 8:02 AM - 8:07 AM | Intracranial Imaging For Strokes With A Newly Developed Imaging Platform Using Artificial Intelligence To Integrate All Forms Of Imaging To Facilitate Patient Care: The VIZ.ai System |
| Presenter(s):Allan L. Brook, MD | |
| View Slides in PDF | |
| 8:08 AM - 8:13 AM | Value Of Advanced Imaging In The Diagnosis And Treatment Of Near Total Occlusions And String Signs Of The Internal Carotid Artery (ICA): How Are They Best Treated: When Conservatively; When Invasively By CEA; By CAS |
| Presenter(s):Christos D. Liapis, MD | |
| View Slides in PDF | |
| 8:14 AM - 8:19 AM | What Is Carotid Near Occlusion: When And How Is It Best Treated Currently: Conservatively, CEA, CAS In Symptomatic Patients: In Asymptomatic Patients |
| Presenter(s):Weiguo Fu, MD | |
| View Slides in PDF | |
| 8:20 AM - 8:26 AM | Panel Discussion |
| 8:26 AM - 8:31 AM | DEBATE: ALL Asymptomatic Carotid Stenosis (ACS) Patients Are Best Treated Medically: Invasive Treatment Causes More Harm Than Good And Should Not Be Reimbursed |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| View Slides in PDF | |
| 8:32 AM - 8:37 AM | DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated And Reimbursed Accordingly |
| Presenter(s):Bruce A. Perler, MD, MBA | |
| View Slides in PDF | |
| 8:38 AM - 8:43 AM | DEBATE: Both Views Are Wrong: Severe Carotid Stenosis Has Declined As A Cause Of Ischemic Stroke To <1% Per Year: So <5% Of ACS Patients Should Be Treated Invasively |
| Presenter(s):Robert W. Chang, MD | |
| View Slides in PDF | |
| DIFFERING VIEWS ON CAROTID SCREENING | |
| 8:44 AM - 8:49 AM | A Tribute To George S. Lavenson, MD (1932-2023) And His Case For Widespread Carotid Screening |
| Presenter(s):Benjamin W. Starnes, MD | |
| View Slides in PDF | |
| 8:50 AM - 8:55 AM | The Case Against Carotid Screening: It Leads To Unneeded And Possibly Harmful Treatment |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| View Slides in PDF | |
| 8:56 AM - 9:01 AM | Screening For ACS And Common Femoral Artery Disease: How Can It Guide Lipid Treatment: How Low Should LDL-Cholesterol (LDL-C) Be Pushed And What Will It Do To Carotid Plaques |
| Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS | |
| View Slides in PDF | |
| 9:02 AM - 9:07 AM | What Are The Effects Of A Minor Stroke With Apparent Full Recovery: Minor Strokes Are By No Means Minor: Why Is This Important In Evaluating The Conclusions Of RCTs |
| Presenter(s):Emmanuel M. Houdart, MD | |
| View Slides in PDF | |
| 9:08 AM - 9:15 AM | Panel Discussion |
| 9:15 AM - 9:30 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 10 | |
| SESSION 11 SCHEDULE | |
|
Tuesday
SESSION 11:
MORE ABOUT CAROTID AND VERTEBRAL DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
Moderators:Klaus D. Mathias, MD / Allan L. Brook, MD
|
|
| x | |
| 9:30 AM - 9:35 AM | Carotid Artery Aneurysms: What Etiologies Cause Them; When Is Endovascular Treatment Best And Technical Tips For Doing So Successfully |
| Presenter(s):Peter L. Faries, MD, FACS | |
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | When After An Acute Stroke With Thrombolysis Treatment, Or Without, Should Carotid Endarterectomy (CEA) Be Performed: Delay Has Consequences: But CEA Within 48 Hours Of Symptom Onset Has A Higher Complication Rate |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 9:42 AM - 9:47 AM | After Thrombolysis And/Or Mechanical Thrombectomy For An Acute Stroke In Patients With Carotid Stenosis, Which Invasive Treatment (CEA Or CAS) Is Best And When Should It Be Performed |
| Presenter(s):Laura Capoccia, MD, PhD | |
| View Slides in PDF | |
| 9:48 AM - 9:53 AM | With Acute Strokes, What Is New With Endovascular Intracranial Techniques For Arterial Clot Removal: How Can Artificial Intelligence (AI) And Intraarterial Thrombolysis With Alteplase (Genentech) Help – What Is Happening With The CHOICE RCT |
| Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD | |
| View Slides in PDF | |
| 9:54 AM - 9:59 AM | How Does Temporal Access And A Through And Through Femoral Wire Facilitate CAS With A Difficult Aortic Arch: Technical Tips And Results |
| Presenter(s):Piotr Myrcha, MD | |
| View Slides in PDF | |
| 10:00 AM - 10:05 AM | Update On Acute Stroke Interventions: Challenging Cases And Tips For Treating Them Successfully |
| Presenter(s):Kolja Sievert, MD / Horst Sievert, MD | |
| View Slides in PDF | |
| 10:06 AM - 10:11 AM | How Best To Treat An ICA Occlusion With Distal Embolization: Sequence And Timing Of Treatment: Site Of Treatment (OR Versus Angio Suite Versus Hybrid Room): Technical Tips |
| Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD | |
| View Slides in PDF | |
| 10:12 AM - 10:17 AM | Outcomes Of Carotid Interventions (CEA And CAS) In Women And Younger Patients: How And Why Do They Differ From Those In Men And Older Patients |
| Presenter(s):Caron B. Rockman, MD | |
| View Slides in PDF | |
| 10:18 AM - 10:23 AM | Update On Endovascular Interventions In The Vertebrobasilar System For Acute Strokes: A New Horizon, What Is Involved And Results |
| Presenter(s):Ivo Petrov, MD, PhD | |
| View Slides in PDF | |
| 10:24 AM - 10:30 AM | Panel Discussion |
| END OF SESSION 11 | |
| SESSION 12 SCHEDULE | |
|
Tuesday
SESSION 12:
PROGRESS IN THE TREATMENT OF AORTIC AND AORTO-ILIAC OCCLUSIVE DISEASE
|
|
| x | |
| 10:30 AM - 10:35 AM | Life Altering Events After Endovascular Aortic Repairs Include Death, Dialysis, Paralysis Or Stroke: The Incidence Of These Events Varies Markedly Depending On The Level Of Repair |
| Presenter(s):Marc L. Schermerhorn, MD | |
| View Slides in PDF | |
| 10:36 AM - 10:41 AM Power Point Presentation with Synched Audio |
Hidden Tricks For Diagnosing Iliac Endofibrosis In Professional Cyclists: Diagnosis Can Be Challenging And Require Unusual Techniques |
| Presenter(s):Gabriel Szendro, MD | |
| View Slides in PDF | |
| 10:42 AM - 10:47 AM | 5-Year Update On The Value Of VBX Balloon Expandable Covered Stents In Treating Complex Aorto-Iliac Occlusive Disease: Advantages And Limitations: When And How Does Shockwave Lithotripsy Help |
| Presenter(s):Andrew Holden, MBChB | |
| View Slides in PDF | |
| 10:48 AM - 10:53 AM | Value And Limitations Of The iCast Balloon Expandable Covered Stent (From Getinge) Recently FDA Approved For Treating Iliac Artery Lesions |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| COVERED ENDOVASCULAR RECONSTRUCTION OF THE AORTIC BIFURCATION (CERAB) PROCEDURE | |
| 10:54 AM - 10:59 AM | Long-Term Outcomes Of The CERAB Procedure With Covered Stents For Complex Aorto-Iliac Occlusive Disease: Why It Is Better Than Kissing Bare Stents: Which Stent Should We Use |
| Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
| View Slides in PDF | |
| 11:00 AM - 11:05 AM | The CERAB Technique: From A Niche Procedure To A Better General Solution For Complex Aorto-Iliac Occlusive Disease Based On The 2-Year Results Of The Multicenter BeGlory Registry |
| Presenter(s):Maria A. Ruffino, MD, EBIR, FCIRSE | |
| View Slides in PDF | |
| 11:06 AM - 11:11 AM | Value Of Shockwave Intravascular Lithotripsy (IVL) For Calcified Aorto-Iliac Occlusive Disease Treatment And For Facilitating Large Bore Access With Narrowed Calcified Iliac Arteries |
| Presenter(s):Daniel G. Clair, MD | |
| View Slides in PDF | |
| 11:12 AM - 11:17 AM | Panel Discussion |
| 11:18 AM - 11:23 AM | Impact Of Female Gender On Outcomes Of Endovascular Treatment Of Aorto-Iliac Occlusive Disease: When Is Open Repair Indicated |
| Presenter(s):Franco Grego | |
| View Slides in PDF | |
| 11:24 AM - 11:29 AM | Treatment Of Infrarenal And Pararenal Aortic Stenosis: When Stents; When Stent-Grafts; When Open Bypass: Why Results Are Worse In Women |
| Presenter(s):Sigrid Nikol, MD | |
| View Slides in PDF | |
| 11:30 AM - 11:35 AM | Endovascular Treatment Of Aorto-Iliac Occlusions With Impotence (Leriche Syndrome): Long-Term Results: Is Open Repair Ever Needed |
| Presenter(s):Sonia Ronchey, MD, PhD | |
| View Slides in PDF | |
| 11:36 AM - 11:41 AM | DEBATE: How To Treat Chronic Flush Juxtarenal Aortic Occlusions Endovascularly With Safety: Endo Is The Way To Go |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | DEBATE: Not So: Open Or Hybrid Repairs Are Best For Complex Juxtarenal Aorto-Iliac Occlusive Disease: Technical Tips |
| Presenter(s):Yamume Tshomba, MD | |
| View Slides in PDF | |
| 11:48 AM - 11:53 AM | What Is New In The Treatment Of External Iliac Artery Endofibrosis In Committed Cyclists: Is There A Role For Endovascular Treatment |
| Presenter(s):Margaret Tracci, MD, JD / Kenneth J. Cherry, MD | |
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 12 | |
| SESSION 13 SCHEDULE | |
|
Tuesday
SESSION 13:
NEW CONCEPTS, MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI) (See Also Session 87)
Moderators:Barry T. Katzen, MD / Kak Khee Yeung, MD, PhD
|
|
| x | |
| 1:00 PM - 1:05 PM | What Is Big Data In Vascular Surgery: How Can It Be Used With Artificial Intelligence (AI) In Evidence Based Medicine: How Can It Replace Randomized Controlled Trials (RCTs) |
| Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Will Big Data Enhance Vascular Care |
| Presenter(s):Michael R. Jaff, DO | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Enhancing Clinical Decision Making In AAA Diagnosis And Treatment With AI: How Can It Help With Prediction Of AAA Growth, Endoleaks And Spinal Cord Ischemia |
| Presenter(s):Kak Khee Yeung, MD, PhD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Update On How Vascular Treatment Will Intersect With Other New Technologies: Wearable Trackers, AI, And Using CT Scans To Predict Plaque Histology (ElucidVivo) |
| Presenter(s):David H. Deaton, MD, FACS | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | How Does An AI Based Prediction Of Rupture Risk Compare With Size Based Predictions |
| Presenter(s):Jes S. Lindholt, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Is Image Fusion Guidance For Complex And Simple Aortic Procedures Really Worthwhile And Cost Effective: Why Is It A Question And Do We Need A Trial |
| Presenter(s):Rachel E. Clough, PhD, FRCS | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | How Can AI Facilitate Assessment After EVAR And F/B/EVAR: Are Volume Measurements Before And After Endo Repairs Necessary |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | High Fidelity Computational Modeling To Help With Decision Making In Carotid Stenosis |
| Presenter(s):Santi Trimarchi, MD, PhD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Update On Siemens I-Flow: A New Intelligent Technology To Improve The Endo Treatment Of Lower Extremity Occlusive Disease |
| Presenter(s):Ravi K. Veeraswamy, MD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | For The Novice, How In Simple Terms Do The FORS, IOPS And Cydar Guidance Systems Work To Improve Endovascular Procedures And Reduce Radiation Exposure |
| Presenter(s):Mark A. Adelman, MD | |
| View Slides in PDF | |
| 2:00 PM - 2:05 PM Power Point Presentation with Synched Audio |
How Can AI Help In The Treatment Of Aorto-Iliac Occlusive Disease |
| Presenter(s):Peter C.J. Goverde, MD | |
| View Slides in PDF | |
| 2:06 PM - 2:12 PM | Panel Discussion |
| END OF SESSION 13 | |
| SESSION 14 SCHEDULE | |
|
Tuesday
SESSION 14:
PART 1: VASCULAR SURGERY’S NUMBERS AND IDENTITY AND HOW TO MEET THE SPECIALTY’S NEEDS FOR ITS SERVICES; THE IMPORTANCE OF MENTORSHIP IN VASCULAR SURGERY
PART 2: LATE BREAKING DEVELOPMENTS IN COVID RELATED VASCULAR DISEASE ISSUES |
|
| x | |
| PART 1 – Vascular Surgery’s Numbers And Identity And How To Meet The Specialty’s Needs For Its Services; The Importance Of Mentorship In Vascular Surgery | |
| 2:12 PM - 2:17 PM | What Makes Vascular Surgery Different, Are There Insufficient Numbers Of Vascular Trainees And Surgeons: How To Improve Our Identity And Recognition And Expand Our Numbers |
| Presenter(s):Evan C. Lipsitz, MD, MBA | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | Update On Applicants For 0+5 And 5+2 Vascular Surgery Training Programs: The Number Of Applicants Is Up: What About Their Quality: Do We Need More Programs |
| Presenter(s):Peter L. Faries, MD, FACS / Dawn M. Coleman, MD, FACS | |
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | Increased Diversity In Vascular Surgery And Will It Improve The Shortage Of Vascular Surgeons |
| Presenter(s):Dawn M. Coleman, MD, FACS | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | How To Improve Vascular Surgery Stature And Well-Being Within An Institution By Transforming It Into Its Own Freestanding Department: What Benefits Accrue |
| Presenter(s):Jeffrey H. Hsu, MD | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | Progress Made By The American Board Of Vascular Surgery (ABVS) In The Last Several Years: Do We Still Need An Independent Board And How Should We Achieve It |
| Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | The Importance Of Mentorship In Vascular Surgery: How Best To Achieve It |
| Presenter(s):Malachi Sheahan, MD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | Panel Discussion |
| PART 2 – Late Breaking Developments In COVID Related Vascular Disease Issues | |
| 2:54 PM - 2:59 PM | Current Developments In COVID-19 Prevention And Treatment: How Effective Are Current Vaccines, Boosters And Antiviral Therapies: Status Of Intranasal Vaccines And Antivirals: What Is New And What Is In The Pipeline |
| Presenter(s):Clayton J. Brinster, MD | |
| View Slides in PDF | |
| 3:00 PM - 3:05 PM | Timing Of A Major Operative Intervention After A Positive COVID-19 Test Affects Postoperative Mortality: When To Retest And When Best To Intervene |
| Presenter(s):Panos Kougias, MD, MSc | |
| View Slides in PDF | |
| 3:06 PM - 3:11 PM | COVID-19 Associated Arterial Events Are Worse In Non-Vaccinated Individuals: What Is The Role And Effectiveness Of Endovascular Therapy |
| Presenter(s):Michel Makaroun, MD | |
| View Slides in PDF | |
| 3:12 PM - 3:17 PM | Is The COVID-19 Pandemic Behind Us: What We Know About Herd Immunity And The Lasting Effects Of Long COVID |
| Presenter(s):Clayton J. Brinster, MD | |
| View Slides in PDF | |
| 3:18 PM - 3:23 PM | Panel Discussion |
| 3:24 PM - 3:36 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 14 | |
| SESSION 15 SCHEDULE | |
|
Tuesday
SESSION 15:
PROGRESS IN THE TREATMENT OF VISCERAL AND RENAL ARTERY DISEASE
Moderators:James C. Stanley, MD / Michael C. Dalsing, MD
|
|
| x | |
| 3:36 PM - 3:41 PM | DEBATE: All Visceral And Renal Artery Aneurysms Can Be Treated Endovascularly: Bare Stent Flow Diverters Are The New Frontier In Their Treatment |
| Presenter(s):Maria A. Ruffino, MD, EBIR, FCIRSE | |
| View Slides in PDF | |
| 3:42 PM - 3:47 PM | DEBATE: Open Treatment Of Visceral And Renal Artery Aneurysms Is Sometimes Best: When Is This So |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 3:48 PM - 3:53 PM | Optimal Current Treatment Of Renal Artery Aneurysms: When Endo; When Open; Technical Tips |
| Presenter(s):Fred A. Weaver, MD, MMM | |
| View Slides in PDF | |
| 3:54 PM - 3:59 PM | The Vascular Low Frequency Consortium: What Is It And What Management Changing Information Does It Tell Us About The Size When Renal Artery Aneurysms Become Dangerous: It Is >3 cm In Diameter |
| Presenter(s):Peter F. Lawrence, MD | |
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | Best Endovascular Techniques To Exclude Large Renal And Visceral Aneurysms |
| Presenter(s):Jacques Busquet, MD | |
| View Slides in PDF | |
| 4:06 PM - 4:11 PM | Update On The New SVS Practice Guidelines For Treating Visceral Artery Aneurysms; When Endo; When Open |
| Presenter(s):Rabih A. Chaer, MD | |
| View Slides in PDF | |
| 4:12 PM - 4:17 PM | Retrograde Open Mesenteric Stenting (ROMS): It Is Indicated With Peritoneal Signs And When Prograde Stenting Is Not Possible: Tips To Gain Retrograde Access To The SMA |
| Presenter(s):Richard J. Powell, MD | |
| View Slides in PDF | |
| 4:18 PM - 4:23 PM | With Acute Mesenteric Ischemia With Necrotic Bowel, Open Treatment With SMA Bypass Using A Deep Vein Conduit Is An Option |
| Presenter(s):Patrick A. Stone, MD | |
| View Slides in PDF | |
| 4:24 PM - 4:29 PM | Technical Tips For Recanalizing Long Complex Visceral Artery (SMA) Occlusions |
| Presenter(s):Armando Mansilha, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 4:30 PM - 4:36 PM | Panel Discussion |
| END OF SESSION 15 | |
| SESSION 16 SCHEDULE | |
|
Tuesday
SESSION 16:
UPDATE ON OPEN VASCULAR SURGICAL AND HYBRID PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS
Moderators:Linda M. Harris, MD / Keith D. Calligaro, MD
|
|
| x | |
| 4:36 PM - 4:41 PM | Open Conversion For Failing Suprarenal And Thoracic Endovascular Repairs: When Is Endo Rescue Not Possible And Open Conversion Necessary: Technical Tips |
| Presenter(s):Francis Caputo, MD | |
| View Slides in PDF | |
| 4:42 PM - 4:47 PM | When Is Open Treatment Of Complex Aorto-Iliac Occlusive Disease Best: Tips And Tricks For Doing It Safely In The Endovascular Era |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 4:48 PM - 4:53 PM | Technical Tips For Open Retroperitoneal Exposure Of The Aorta And All Its Abdominal Branches; How To Do A Retroperitoneal Aorto- Bifemoral Bypass |
| Presenter(s):Kamphol Laohapensang, MD | |
| View Slides in PDF | |
| 4:54 PM - 4:59 PM | Use Of Minimal Incisions For Retroperitoneal Aorto-Bifemoral Bypass And Other Procedures: Technical Tips And Limitations |
| Presenter(s):Robert M. Proczka, MD, PhD | |
| 5:00 PM - 5:05 PM | Duplex Surveillance Should Be Used After All Open Aorto-Bifemoral Bypasses: How Does It Improve Outcomes |
| Presenter(s):Keith D. Calligaro, MD | |
| View Slides in PDF | |
| 5:06 PM - 5:11 PM | Open Treatment Of Infected Aortic Grafts And Endografts By Replacing Them With Rifampkin Soaked Dacron Or Cryopreserved Aortic Conduits: When Is Which Treatment Appropriate, And Results |
| Presenter(s):Manju Kalra, MBBS | |
| View Slides in PDF | |
| 5:12 PM - 5:17 PM | Update On Renal Consequences Of Left Renal Vein Division During Open AAA Repair: It Is Not Always Benign |
| Presenter(s):Kimihiro Komori, MD, PhD | |
| View Slides in PDF | |
| 5:18 PM - 5:23 PM | Open And Endovascular Treatment Of Intestinal, Renal, And Lumbar Artery Aneurysms In Children |
| Presenter(s):James C. Stanley, MD | |
| View Slides in PDF | |
| 5:24 PM - 5:30 PM | Panel Discussion |
| UPDATE ON COARCTATION TREATMENT | |
| 5:30 PM - 5:35 PM | Endovascular Repair Of Aortic Coarctation: Balloon Angioplasty Versus Bare Stents Versus Covered Stents And When Is Open Repair Necessary |
| Presenter(s):Tilo Koelbel, MD, PhD | |
| View Slides in PDF | |
| 5:36 PM - 5:41 PM Power Point Presentation with Synched Audio |
Update On The Experience With BeGrafts (From Bentley), A Balloon Expandable Covered Stent For Treating Aortic Coarctations: Advantages And Limitations |
| Presenter(s):Elchanan Bruckheimer, MBBS | |
| View Slides in PDF | |
| 5:42 PM - 5:47 PM | Axillo-Unifemoral And Axillo-Bifemoral Bypasses Have Equal Patency For More Than A Year: Why The Bilateral Procedure Should Only Be Used When Bilateral Ischemia Exists |
| Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS | |
| View Slides in PDF | |
| 5:48 PM - 5:53 PM | Positive Remodeling In The Ascending Aorta As Well As Distally After TEVAR Treatment Of Aortic Coarctations |
| Presenter(s):Frank R. Arko, MD | |
| View Slides in PDF | |
| 5:54 PM - 5:59 PM | Panel Discussion End of Program B |
| END OF SESSION 16 | |
| SESSION 17 SCHEDULE | |
|
Tuesday
SESSION 17:
MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH – PART 1
Moderators:Michael R. Jaff, DO
|
|
| x | |
| 7:00 AM - 7:05 AM | Introduction To The Symposium |
| Presenter(s):Frank J. Veith, MD | |
| 7:05 AM - 7:15 AM | Welcome And Introduction |
| Presenter(s):Michael R. Jaff, DO | |
| View Slides in PDF | |
| 7:15 AM - 7:25 AM | The Basics Of Pulmonary Embolism Diagnosis: What Is The Role Of The History, Exam, Biomarkers |
| Presenter(s):Ido Weinberg, MD, MSc | |
| View Slides in PDF | |
| 7:25 AM - 7:35 AM | Do We Need An Echocardiogram To Manage Acute Submassive PE |
| Presenter(s):David M. Dudzinski, MD | |
| View Slides in PDF | |
| 7:35 AM - 7:45 AM | Advanced Imaging For PE: How To Interpret The CT PE On The Run |
| Presenter(s):Brian B. Ghoshhajra, MD, MBA | |
| View Slides in PDF | |
| 7:45 AM - 7:55 AM | Testing For Cancer And Other Hypercoagulable States In PE: Why, When, And What Tests |
| Presenter(s):Rachel Rosovsky, MD, MPH | |
| View Slides in PDF | |
| 7:55 AM - 8:10 AM | Medical Treatment Of PE: When, Why, For How Long, And How Can I Remember |
| Presenter(s):Luis H. Eraso, MD | |
| 8:10 AM - 8:20 AM | Intravenous Thrombolytic Therapy For PE: Does This Replace Catheter-Based Therapies |
| Presenter(s):Jay Giri, MD, MPH | |
| View Slides in PDF | |
| 8:20 AM - 8:35 AM | An Overview Of Technologies For Management Of High-Risk PE |
| Presenter(s):Eric A. Secemsky, MD, MSc | |
| View Slides in PDF | |
| 8:35 AM - 8:45 AM | Ultrasound-Assisted Pharmacomechanical Thrombectomy: Does This Really Work |
| Presenter(s):Kush R. Desai, MD | |
| View Slides in PDF | |
| 8:45 AM - 8:55 AM | Percutaneous Mechanical Thrombectomy Without Lytics: The Indigo System |
| Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA | |
| View Slides in PDF | |
| 8:55 AM - 9:05 AM | Percutaneous Mechanical Thrombectomy Without Lytics: The Flowtriever System |
| Presenter(s):Mitchell D. Weinberg, MD | |
| View Slides in PDF | |
| 9:05 AM - 9:15 AM | Large Bore Aspiration Thrombectomy: Tips, Tricks And Pearls |
| Presenter(s):Ripal T. Gandhi, MD, FSVM, FSIR | |
| View Slides in PDF | |
| 9:15 AM - 9:25 AM | The Big Trials In PE: What’s Running, What’s Starting, What Will They Tell Us |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| 9:25 AM - 9:40 AM | Panel Discussion |
| Panelist(s): Gary M. Ansel, MD / Kush R. Desai, MD / Luis H. Eraso, MD / Brian B. Ghoshhajra, MD, MBA / Jay Giri, MD, MPH / Raghu Kolluri, MD / Robert A. Lookstein, MD, MHCDL, FSIR, FAHA / Rachel Rosovsky, MD, MPH / Eric A. Secemsky, MD, MSc / Ido Weinberg, MD, MSc / Mitchell D. Weinberg, MD | |
| 9:40 AM - 10:10 AM | Break - Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 17 | |
| SESSION 18 SCHEDULE | |
|
Tuesday
SESSION 18:
MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH – PART 2
Moderators:Michael R. Jaff, DO
|
|
| x | |
| 10:10 AM - 10:20 AM | Contemporary Endovascular Strategies For Treatment Of Massive PE |
| Presenter(s):Christopher J. Kwolek, MD, MBA | |
| View Slides in PDF | |
| 10:20 AM - 10:30 AM | ECMO-Assisted Pulmonary Embolectomy In Massive PE: Can It Replace Open Surgical Thrombolectomy |
| Presenter(s):Animesh Rathore, MD | |
| View Slides in PDF | |
| 10:30 AM - 10:40 AM | Is There Anything New In Vena Cava Filters In PE Treatment |
| Presenter(s):John A. Kaufman, MD, MS | |
| View Slides in PDF | |
| 10:40 AM - 10:55 AM | Your Referring Docs Think Heparin Is All They Need To Offer For PE – How To Tell The Intervention Story |
| Presenter(s):Patrick Troy, MD | |
| View Slides in PDF | |
| 10:55 AM - 11:10 AM | Pulmonary Denervation: A New Frontier In The Treatment Of Pulmonary Hypertension |
| Presenter(s):Mark G. Davies, MD | |
| View Slides in PDF | |
| 11:10 AM - 11:25 AM | Balloon Pulmonary Angioplasty For Chronic Thromboembolic Pulmonary Hypertension: Has This Become Mainstream |
| Presenter(s):Kenneth Rosenfield, MD | |
| View Slides in PDF | |
| 11:25 AM - 11:35 AM | The Team Approach To PE Management: The National PERT Consortium |
| Presenter(s):William B. Keeling, MD | |
| View Slides in PDF | |
| 11:35 AM - 12:00 PM | Challenging The Experts: Interactive Q&A |
| Panelist(s): Mark G. Davies, MD / Kush R. Desai, MD / Jay Giri, MD, MPH / Robert A. Lookstein, MD, MHCDL, FSIR, FAHA / John A. Kaufman, MD, MS / William B. Keeling, MD / Christopher J. Kwolek, MD, MBA / Animesh Rathore, MD / Kenneth Rosenfield, MD / Eric A. Secemsky, MD, MSc / Patrick Troy, MD / Ido Weinberg, MD, MSc | |
| View Slides in PDF | |
| 12:00 PM - 1:00 PM | Lunch Break - Visit Exhibits And Pavilions (2nd and 3rd Floors) End of Program C-1 |
| END OF SESSION 18 | |
| SESSION 19 SCHEDULE | |
|
Tuesday
SESSION 19:
HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS
Moderators:Cynthia K. Shortell, MD / Joseph L. Mills, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Key Points From The SVS Appropriate Use Criteria For Management Of Intermittent Claudication: Are Invasive Treatments Being Overused And Will These Criteria Help |
| Presenter(s):Jessica P. Simons, MD, MPH / Karen Woo, MD, PhD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | What Are The Dangers Of Working In An Office Based Lab (OBL): Why I Chose Not To Work There |
| Presenter(s):Dipankar Mukherjee, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Real Five-Year Single Center Results With Atherectomy For De Novo Lower Extremity Lesions And In Stent Restenosis: How Good Or Bad Are They |
| Presenter(s):Russell H. Samson, MD, DFSVS, RVT, FACS | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Intravascular Lithotripsy (From Shockwave) For Peripheral Arterial Occlusive Lesions: What Are The New Systems (L6 And M5+) For Delivering And What Are The Advantages |
| Presenter(s):Andrew Holden, MBChB | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | How Do SoundBite Wires (From SoundBite Medical) Help To Cross Calcified Lesions, Especially BTK: Updated Experience |
| Presenter(s):Marianne Brodmann, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Alternate Anatomic Approaches To Lower Extremity Arteries When Standard Approaches Are Prevented By Scarring Or Infection |
| Presenter(s):Neal S. Cayne, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Updated Status And Prospects For Sirolimus Coated Devices And Bioresorbable Stents ATK And BTK |
| Presenter(s):Marianne Brodmann, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Advances In Deep Venous Arterialization Techniques: Better Access, Procedure Maintenance And Wound Care Matter For Limb Salvage In No Option CLTI Patients |
| Presenter(s):Anahita Dua, MD, MS, MBA | |
| View Slides in PDF | |
| 1:48 PM - 2:04 PM | Panel Discussion |
| END OF SESSION 19 | |
| SESSION 20 SCHEDULE | |
|
Tuesday
SESSION 20:
MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT
Moderators:Vincent L. Rowe, MD / Marianne Brodmann, MD
|
|
| x | |
| 2:04 PM - 2:09 PM | How To Train Vascular Surgeons In Distal Bypass Procedures In 2023: How Many Cases Are Needed To Achieve Competence |
| Presenter(s):Francesco Spinelli, MD | |
| View Slides in PDF | |
| 2:10 PM - 2:15 PM | Novel Uses Of Selective Superficial Venous Arterialization To Achieve Lower Limb Salvage: Techniques, Indications, Precautions And Results |
| Presenter(s):John M. Felder, MD / Patrick J... Geraghty, MD | |
| View Slides in PDF | |
| 2:16 PM - 2:21 PM | Coagulation Testing To Allow Optimal Thromboprophylaxis And Decrease Thrombosis Rates In Lower Extremity Grafts And Stents |
| Presenter(s):Anahita Dua, MD, MS, MBA | |
| View Slides in PDF | |
| 2:22 PM - 2:27 PM | Fractional Flow Reserve (FFR) In Claudicants And CLTI Patients: The Value Of Physiology Over Anatomy In The Fempop Segment |
| Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
| View Slides in PDF | |
| 2:28 PM - 2:33 PM | Pedal Acceleration Time (PAT): What Is It And Its Feasibility And Utility As An Assessment Tool For Limb Ischemia And Adequacy Of Revascularization Procedures |
| Presenter(s):Vincent L. Rowe, MD | |
| View Slides in PDF | |
| 2:34 PM - 2:39 PM | What Are The Best Ways To Evaluate CLTI Treatment Outcomes: Physiology (ABIs And PVRs), Wound Healing, Anatomy (Angiography Or Ultrasound), MACE Or MALE: Why It Matters |
| Presenter(s):Ido Weinberg, MD, MSc / Mitchell D. Weinberg, MD | |
| View Slides in PDF | |
| 2:40 PM - 2:45 PM | For Intermittent Claudication, What Endovascular Revascularization Strategies Are Currently Justified For Aortoiliac And Femoropopliteal Artery Disease: From A Meta-Analysis |
| Presenter(s):Iris Baumgartner, MD | |
| View Slides in PDF | |
| 2:46 PM - 2:52 PM | Panel Discussion |
| 2:52 PM - 3:00 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 20 | |
| SESSION 21 SCHEDULE | |
|
Tuesday
SESSION 21:
HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE
Moderators:Neal S. Cayne, MD / Gary M. Ansel, MD
|
|
| x | |
| 3:00 PM - 3:05 PM | Pillars For Success With Radial Artery Access For Remote Visceral, Renal Or Lower Extremity Lesion Treatment |
| Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR | |
| View Slides in PDF | |
| 3:06 PM - 3:11 PM | Value And Technical Tips To Make The Supera Stent Work In Tortuous And Angulated Non-SFA Lesion Locations |
| Presenter(s):Rajiv Parakh, MBBS, MS, FRCS | |
| View Slides in PDF | |
| 3:12 PM - 3:17 PM | Non-Aspiration Based Mechanical Thrombo-Embolectomy With The Pounce (From Surmodics) Or Rotarex (From BD) Devices: How Do They Work And What Will Their Role Be In Treating Acute Limb Ischemia |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| 3:18 PM - 3:23 PM | Pedal Bypass As A Bail Out After Failed Or Compromised Retrograde Access: Rescuing A Threatened Limb After Bridges Burned |
| Presenter(s):Palma M. Shaw, MD, MBA, FACS, RPVI, DFSVS | |
| View Slides in PDF | |
| 3:24 PM - 3:29 PM | Technical Tips For A Successful BTK Intervention In Patients With CLTI Including How To Perform An Antegrade Femoral Artery Puncture And Pass The Guidewire Into The SFA |
| Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
| View Slides in PDF | |
| 3:30 PM - 3:35 PM | Tips And Tricks To Make Distal Bypasses Work In The Endo Era: When If Ever Might In Situ Techniques Be Worth The Effort |
| Presenter(s):Kellie R. Brown, MD | |
| View Slides in PDF | |
| 3:36 PM - 3:41 PM | Local Anesthetic Injection Into Lesion Site Facilitates PTA And Stent Placement: How To Do It (Video Presentation) |
| Presenter(s):Andrej Schmidt, MD | |
| View Slides in PDF | |
| 3:42 PM - 3:47 PM | Panel Discussion |
| 3:47 PM - 3:52 PM | Does Atherectomy Still Have Value After Shockwave Lithotripsy Treatment Of A Calcified Occlusive Lesion |
| Presenter(s):Lawrence A. Garcia, MD | |
| View Slides in PDF | |
| 3:53 PM - 3:58 PM | When Should Common Femoral Occlusive Disease Be Treated Endovascularly Based On The CONFESS Trial |
| Presenter(s):Hany M. Zayed, MD | |
| View Slides in PDF | |
| 3:59 PM - 4:04 PM | The Deeper Limus Trial Using A Limus Coated Temporary Spur Balloon (From Reflow Medical): How Does The Device Work And Preliminary Results |
| Presenter(s):Marianne Brodmann, MD | |
| View Slides in PDF | |
| 4:05 PM - 4:10 PM | Heel Ulceration And Ischemic Gangrene Involving The Achilles Tendon Should Not Be An Indication For A BTK Amputation: Revascularization And Appropriate Local Treatment Can Save Such A Limb |
| Presenter(s):Mark G. Davies, MD | |
| View Slides in PDF | |
| 4:11 PM - 4:16 PM | Popliteal Artery-To-Distal Bypass For Limb Salvage; Status In 2023: Technical Tips And Value: When Is It Better Than Endovascular Treatments |
| Presenter(s):Francesco Spinelli, MD | |
| View Slides in PDF | |
| 4:17 PM - 4:23 PM | Panel Discussion |
| END OF SESSION 21 | |
| SESSION 22 SCHEDULE | |
|
Tuesday
SESSION 22:
MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI)
Moderators:Brian G. DeRubertis, MD / Caitlin W. Hicks, MD, MS
|
|
| x | |
| 4:24 PM - 4:29 PM | CLTI Is A Global Epidemic; How Can A CLTI Program Decrease Its Morbidity |
| Presenter(s):Barry T. Katzen, MD | |
| View Slides in PDF | |
| 4:30 PM - 4:35 PM | Open And Endo Revascularization In Young Patients With PAD: What Works, What Doesn’t, What Factors Impact Outcomes And How Should Treatment Be Modified |
| Presenter(s):William P. Robinson, MD | |
| View Slides in PDF | |
| 4:36 PM - 4:41 PM | Is BEST-CLI Best For CLTI Patients And Interventional Treatments |
| Presenter(s):Lawrence A. Garcia, MD | |
| View Slides in PDF | |
| 4:42 PM - 4:47 PM | Intravascular Lithotripsy And DCB Versus DCB Alone In The Treatment Of Infrapopliteal Lesions In Diabetics: Rationale And Design Of The DEBATE-BTK SHOCK RCT And Early Results |
| Presenter(s):Francesco Liistro, MD | |
| View Slides in PDF | |
| 4:48 PM - 4:53 PM | How To Size Lower Extremity Target Arteries For Endo Treatments Accurately Using Intravascular Ultrasound (IVUS): How Does It Help |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| View Slides in PDF | |
| 4:54 PM - 4:59 PM | Lower Extremity Interventions (PTA, Stents, Atherectomy) Under IVUS Guidance: Its Costs, Advantages And Limitations |
| Presenter(s):Ignacio Escotto, MD | |
| View Slides in PDF | |
| 5:00 PM - 5:06 PM | Panel Discussion |
| 5:06 PM - 5:11 PM | Overuse, Misuse, And Just Plain Inappropriate Use Of Lower Extremity And Other Endovascular Procedures: How Should The Vascular Community Police Itself To Prevent Such Procedures |
| Presenter(s):Michael S. Conte, MD | |
| View Slides in PDF | |
| 5:12 PM - 5:17 PM | Experience With >1500 Retrograde Recanalization For Chronic Total Occlusions (CTOs); What Predicts Technical Success And What Predicts Periprocedural Complications: Are Reentry Devices Ever Helpful |
| Presenter(s):Erwin Blessing, MD | |
| View Slides in PDF | |
| 5:18 PM - 5:23 PM | How To Avoid Or Manage Unexpected Catastrophes When Treating CLTI In The Operating Room Or Angio Suite |
| Presenter(s):Robert B. McLafferty, MD, MBA | |
| View Slides in PDF | |
| 5:24 PM - 5:29 PM | Tibial Interventions For Intermittent Claudication: An Ethical And Professional Challenge For All Vascular Specialists And The Vascular Community |
| Presenter(s):Michael S. Conte, MD | |
| View Slides in PDF | |
| 5:30 PM - 5:35 PM | A New Technology (From AOTI) Combining Local Oxygen Therapy With Cycled Compression And Humidification Enhances Healing Of Diabetic Wounds And Ischemic Ulcers After Revascularization |
| Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD | |
| View Slides in PDF | |
| 5:36 PM - 5:41 PM | Contemporary Comparative Results Of BTK Open Bypass Revascularization: Heparin Bonded PTFE Grafts Versus In Situ Or Reversed Vein Grafts: When Are PTFE Grafts To Tibial/Peroneal Arteries Worthwhile |
| Presenter(s):Giovanni Pratesi, MD / Carlo Pratesi, MD | |
| View Slides in PDF | |
| 5:42 PM - 5:47 PM | Nerve Block Without General Anesthesia Allows Safer Bypass Surgery For CLTI Even With High Risk Patients |
| Presenter(s):Nobuyoshi Azuma, MD | |
| View Slides in PDF | |
| 5:48 PM - 5:53 PM | Techniques For Overcoming Problems With Subintimal Angioplasty For Chronic Total Occlusions (CTOs): Like Inability To Re-Enter The True Lumen: Fancy Gadgets (Outback, Pioneer, Enteer, OffRoad) Are Almost Never Needed |
| Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
| View Slides in PDF | |
| 5:54 PM - 5:59 PM | How To Do Bypass Surgery To Heavily Non-Compressible Calcified Target Arteries |
| Presenter(s):Enrico Ascher, MD / Frank J. Veith, MD | |
| View Slides in PDF | |
| 6:00 PM - 6:06 PM | Panel Discussion End of Program C-2 |
| END OF SESSION 22 | |
|
Wednesday, November 15, 2023
Print Entire 2023 Program:
|
|
| SESSION 23 SCHEDULE | |
|
Wednesday
SESSION 23:
GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
Moderators:Enrico Ascher, MD / Andrej Schmidt, MD
|
|
| x | |
| 6:40 AM - 6:45 AM | How Do Prior Endovascular Interventions Affect Future Lower Extremity Bypass Outcomes For CLTI: Why Do The Results Of The BEST-CLI Trial Make This More Important |
| Presenter(s):Matthew T. Menard, MD | |
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | Do Diabetic Patients With CLTI And Extensive Foot Necrosis Have Time For An Endovascular First Strategy: Primary Open Bypass Is Better Treatment In This Setting |
| Presenter(s):Katariina M. Noronen, MD, PhD | |
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Presenting Symptoms Of Lower Extremity Occlusive Disease And Intermittent Claudication Are Different In Women Than In Men: Why Is This Important |
| Presenter(s):Linda M. Harris, MD | |
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | Selective Coronary Revascularization Based On Preop CT Fractional Flow Reserve (FFRCT) Improves Long-Term Survival Of CLTI Patients After Lower Extremity Revascularization: When Should Coronary Revascularization Be Performed – Before Or After The Lower Extremity Procedure |
| Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD | |
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | Why Does Medial Artery Calcification (MAC) Lead To Small Artery Disease (SAD): A Computational Based Analysis Of Lower Limb Blood Flow Reveals That Increasing Vascular Stiffness May Be Causative: Can Anything Be Done About It |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| OPTIMAL TECHNIQUES FOR VESSEL PREP FOR ENDOVASCULAR TREATMENTS | |
| 7:10 AM - 7:15 AM | Optimal Different Techniques Of Vessel Prep For Plain Old Balloon Angioplasty (POBA), Drug Coated Balloon (DCB) Treatment And Drug Eluting Stent (DES) Treatment |
| Presenter(s):Fabrizio Fanelli, MD, EBIR | |
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | Technical Tips For Vessel Prep For DCBs And DESs: It Is Different And Not Simple: Is Vessel Prep Currently Overrated |
| Presenter(s):Erwin Blessing, MD | |
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | New Devices And A New Paradigm For Treating Lower Extremity Arterial Lesions Via A Radial Approach: Can Lesions Below The Knee Be Treated |
| Presenter(s):Craig M. Walker, MD | |
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | What Are The Downsides To Trans-Radial Or Pedal Access |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| TECHNICAL TIPS ON GUIDEWIRE CHOICE AND USAGE | |
| 7:34 AM - 7:39 AM | Tips For Treating Difficult BTK/BTA Lesions: How To Get A Guidewire Across A Long Calcified Occlusion, Getting A Resistant Balloon To Go Over The Wire And Tips For Retrograde Access |
| Presenter(s):Marco G. Manzi, MD | |
| View Slides in PDF | |
| 7:40 AM - 7:45 AM | Guidewire Tips For Treating Lesions Below The Ankle (BTA): Sliding, Piercing, Dissecting, Retrograde Maneuvers |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 7:46 AM - 7:53 AM | Panel Discussion |
| END OF SESSION 23 | |
| SESSION 24 SCHEDULE | |
|
Wednesday
SESSION 24:
NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
Moderators:Craig M. Walker, MD / Iris Baumgartner, MD
|
|
| x | |
| PROGRESS IN ATHERECTOMY | |
| 7:53 AM - 7:58 AM Power Point Presentation with Synched Audio |
New Developments In Laser Atherectomy And Lithotripsy: What Progress Has Been Made And Are Their Benefits Proven |
| Presenter(s):George L. Adams, MD | |
| View Slides in PDF | |
| 7:59 AM - 8:04 AM | Which Vascular Specialists Are Performing Tibial Atherectomies And Angioplasties For Intermittent Claudication And Are There Suboptimal Outcomes |
| Presenter(s):Caitlin W. Hicks, MD, MS | |
| View Slides in PDF | |
| 8:05 AM - 8:10 AM | Update On Optical Coherence Tomography (OCT) Guided Intraluminal Crossing Catheters (Avinger) For SFA Occlusions: Intraluminal Patency Superiority And New Data On The TigerEye Catheter |
| Presenter(s):Todd R. Vogel, MD, MPH | |
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | 2-Year Experience With The Rotarex Atherectomy And Thrombectomy System (From BD) For Arterial Occlusive Disease And In Stent Restenosis (ISR): How Does It Work And Advantages |
| Presenter(s):Michael K.W. Lichtenberg, MD | |
| View Slides in PDF | |
| UPDATE ON THE SUPERA STENT | |
| 8:17 AM - 8:23 AM Power Point Presentation with Synched Audio |
Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First |
| Presenter(s):Peter C.J. Goverde, MD | |
| 8:24 AM - 8:29 AM | Update On The Supera Interwoven Stent: When Is It The Best Treatment And How To Optimally Deploy This Unique Stent |
| Presenter(s):D. Christopher Metzger, MD / Craig M. Walker, MD | |
| View Slides in PDF | |
| DRUG ELUTING STENTS (DESs) FOR BTK LESIONS | |
| 8:30 AM - 8:35 AM | Updated Experience With Everolimus And Other Nonabsorbable DESs To Treat Infrapopliteal BTK Lesions – Long And Short - Causing CLTI: What Are The Stents And How Are They Doing |
| Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA | |
| View Slides in PDF | |
| 8:36 AM - 8:41 AM | Update On Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5 Years: From The DISAPEAR Registry And A Meta-Analysis Of Other Bioresorbable BTK Stent Results |
| Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) | |
| View Slides in PDF | |
| 8:42 AM - 8:47 AM | Progress In And 1-Year Results Of The LIFE-BTK Randomized Controlled Comparison Of Abbott’s Esprit Drug-Eluting Resorbable Stent With Plain Balloon Angioplasty (POBA) |
| Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 8:48 AM - 8:53 AM | Updated Results With A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: From The STAND RCT And The HEAL Registry |
| Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI / Marco G. Manzi, MD | |
| View Slides in PDF | |
| 8:54 AM - 9:00 AM | Panel Discussion |
| END OF SESSION 24 | |
| SESSION 25 SCHEDULE | |
|
Wednesday
SESSION 25:
LOWER EXTREMITY TOPICS RELATED TO DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs)
Moderators:Kenneth Ouriel, MD, MBA / Sahil A. Parikh, MD
|
|
| x | |
| 9:00 AM - 9:05 AM | Older And More Recent Meta-Analyses Reveal Increased Mortality And Amputation Rates In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: Are These Increased Rates Still Valid In View Of The Many Recent Studies That Do Not Confirm Them |
| Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
| View Slides in PDF | |
| 9:06 AM - 9:11 AM | Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices |
| Presenter(s):Christian A. Behrendt, MD | |
| View Slides in PDF | |
| 9:12 AM - 9:17 AM | The Final Word On The Safety Of Paclitaxel Coated Balloons And Stents: Putting Together Observation, Randomized Trial And Meta-Analysis Derived Data |
| Presenter(s):Eric A. Secemsky, MD, MSc / Peter A. Schneider, MD | |
| View Slides in PDF | |
| 9:18 AM - 9:23 AM | 2-Year Results With The Sundance DCB (Surmodics) To Treat BTK Occlusive Lesions: From The SWING Trial |
| Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) | |
| View Slides in PDF | |
| 9:24 AM - 9:29 AM | Update On DCBs For BTK Angioplasty: RCT Comparing A Paclitaxel DCB (Litos From Acotec) Versus A Sirolimus DCB (Magic Touch From Concept Medical): Rationale Of The Studies, Update On Enrollment And Interesting Cases In The DEBATE BTK DUELL RCT |
| Presenter(s):Francesco Liistro, MD / Edward T. Choke, MD | |
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | Progress With A Sustained Release Sirolimus DCB: Results With The Magic Touch DCB Compared To A Paclitaxel DCB: From The SIRONA Study |
| Presenter(s):Thomas Zeller, MD / Andrej Schmidt, MD / Dierk Scheinert, MD / Marianne Brodmann, MD | |
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | Adventitial Drug Delivery With The BullFrog Device (From Mercator Medical) And The Spur Device (From Reflow): How Do They Work And How Will We Know They Improve Results |
| Presenter(s):William A. Gray, MD | |
| View Slides in PDF | |
| 9:42 AM - 9:47 AM | The Light And Darkness Of Fluoropolymer-Based Limus DESs In The Treatment Of Femoropopliteal Lesions |
| Presenter(s):Osamu Iida, MD, PhD | |
| View Slides in PDF | |
| 9:48 AM - 9:53 AM | Lower Extremity Endovascular Treatments: Who Is Performing Most Of Them And Where: Are They Overutilized And Why: How To Fix The Problem |
| Presenter(s):Russell H. Samson, MD, DFSVS, RVT, FACS | |
| View Slides in PDF | |
| 9:54 AM - 9:59 AM | Are DESs Ever Associated With Aneurysmal Degeneration: Is It Related To The Drug (Paclitaxel Or Limus) Or To The Fluoropolymer Excipient To Which The Drug Is Attached |
| Presenter(s):Osamu Iida, MD, PhD | |
| View Slides in PDF | |
| 10:00 AM - 10:08 AM | Panel Discussion |
| 10:08 AM - 10:18 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 25 | |
| SESSION 26 SCHEDULE | |
|
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
Moderators:Joseph L. Mills, MD / John R. Laird, MD
|
|
| x | |
| NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs | |
| 10:18 AM - 10:23 AM | DCB Treatment Of Femoropopliteal Lesions Causing CLTI (From Boston Scientific) Is Cost Effective: Based On A 5-Year Study Of Patients In Mexico Treated With Ranger DCBs |
| Presenter(s):Ignacio Escotto, MD | |
| View Slides in PDF | |
| 10:24 AM - 10:29 AM | Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With De Novo Or Recurrent Fempop Lesions At 5 Years In The ILLUMENATE US And European RCTs |
| Presenter(s):Sean P. Lyden, MD / Marianne Brodmann, MD / Sahil A. Parikh, MD / William A. Gray, MD | |
| View Slides in PDF | |
| 10:30 AM - 10:35 AM | 3-Year Results Of A RCT Comparing SurVeil DCBs (Surmodics) With In.Pact DCBs (Medtronic) For Treating Fempop Lesions: From the TRANSCEND Trial |
| Presenter(s):Peter A. Schneider, MD | |
| View Slides in PDF | |
| 10:36 AM - 10:41 AM | New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 5-Year Results With TASC A/B Lesions Versus TASC C/D Lesions |
| Presenter(s):Francesco Liistro, MD | |
| View Slides in PDF | |
| 10:42 AM - 10:47 AM | Value Of In.Pact DCBs (Medtronic) For Long Complex SFA-Pop Lesions Including ISR And CTOs: Technical Tips And Contraindications: From The Global Registry: What Is The Best Endo Treatment For These Lesions |
| Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD | |
| View Slides in PDF | |
| 10:48 AM - 10:53 AM | Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 3- And 4-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages |
| Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD | |
| View Slides in PDF | |
| 10:54 AM - 10:59 AM | Below The Ankle Endo Interventions In 2023: Techniques, Devices And Should Balloons Be Drug Coated Or Not |
| Presenter(s):Marianne Brodmann, MD | |
| View Slides in PDF | |
| 11:00 AM - 11:05 AM | New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On An Updated Meta-Analysis And Global Data: When Is It The Best DES; When Is It The Best Treatment: Is Distal Microembolization A Concern |
| Presenter(s):Peter A. Schneider, MD / William A. Gray, MD / Sahil A. Parikh, MD / Michael D. Dake, MD | |
| View Slides in PDF | |
| 11:06 AM - 11:11 AM | Updated 5-Year Results Of The IMPERIAL RCT Head To Head Comparison Of The Eluvia DES (Boston Scientific) With The Zilver PTX DES (Cook): Both Are Safe And Effective: What Are The Differences |
| Presenter(s):Stefan Mueller-Huelsbeck, MD / William A. Gray, MD / Thomas Zeller, MD | |
| View Slides in PDF | |
| 11:12 AM - 11:18 AM | Panel Discussion |
| NEW INFORMATION ON BTK DCBs AND DESs | |
| 11:18 AM - 11:23 AM | Advances In BTK Drug Delivery Technology And DCBs: What Have We Learned From The In.Pact Deep BTK DCB Trial And New Challenges With Treating CLTI Patients |
| Presenter(s):Thomas Zeller, MD | |
| View Slides in PDF | |
| 11:24 AM - 11:29 AM Power Point Presentation with Synched Audio |
5-Year Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency Versus POBA To Treat BTK Lesions |
| Presenter(s):Wei Guo, MD / Francesco Liistro, MD | |
| View Slides in PDF | |
| 11:30 AM - 11:35 AM | Orbital Atherectomy Vessel Preparation To Maximize DCB Efficacy In Calcified BTK Lesions: OPTIMIZE BTK RCT 2-Year Results |
| Presenter(s):Thomas Zeller, MD | |
| View Slides in PDF | |
| 11:36 AM - 11:41 AM | The Sirolimus DCB BTK Era Begins: The SELUTION DCB (From MedAlliance And Cordis): Why The FDA Considered It A Breakthrough Device: Results From Singapore And Europe Are Promising And Justified The Ongoing SELUTION4BTK IDE Trial: Preliminary Results |
| Presenter(s):Patrick J... Geraghty, MD / George L. Adams, MD / Michael K.W. Lichtenberg, MD | |
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | Why Some BTK DCB Trials Have Not Shown Uniformly Better Results: Technical And Balloon Factors Matter |
| Presenter(s):Francesco Liistro, MD | |
| View Slides in PDF | |
| 11:48 AM - 11:53 AM | Three-Year Results For The BioMimics 3D Swirling Flow Stent Show Why It Is The Most Cost-Effective Stent Of Choice For CLTI Patients |
| Presenter(s):Michael K.W. Lichtenberg, MD / Bret Wiechmann, MD / Amy Yip, PhD / Peter Gaines, MD | |
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| View Slides in PDF | |
| 12:00 PM - 1:35 PM | Celebratory Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 26 | |
| SESSION 27 SCHEDULE | |
|
Wednesday
SESSION 27:
PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
Moderators:Michael S. Conte, MD / Marco G. Manzi, MD
|
|
| x | |
| 1:35 PM - 1:40 PM | DEBATE: IVUS Is Useful In The Majority Of Lower Extremity Interventional Treatments |
| Presenter(s):Eric A. Secemsky, MD, MSc | |
| View Slides in PDF | |
| 1:41 PM - 1:46 PM | DEBATE: Not So: Peri-Procedural Duplex Scanning May Be Better And Cheaper Than IVUS For Improved Imaging In Most Lower Extremity Intervention |
| Presenter(s):Enrico Ascher, MD / Natalie A. Marks, MD, RPVI, RVT, FSVM | |
| View Slides in PDF | |
| 1:47 PM - 1:52 PM | No Option CLTI: Why Is It A Misnomer: Hybrid And Other Actual Options For Treatment And Limb Salvage |
| Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
| View Slides in PDF | |
| VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES | |
| 1:53 PM - 1:58 PM | What Are The Best Options For Limb Salvage When A Single Autologous Vein Is Inadequate: Does The BEST-CLI RCT Help |
| Presenter(s):Joseph L. Mills, MD | |
| View Slides in PDF | |
| 1:59 PM - 2:04 PM | PTFE Bypasses To Infrapopliteal Target Arteries Can Save Limbs In Patients Facing Imminent Amputation With No Other Therapeutic Option: They Can Have Worthwhile Long-Term Patency And Limb Salvage Rates: A Multicenter Experience |
| Presenter(s):Hasan H. Dosluoglu, MD | |
| View Slides in PDF | |
| 2:05 PM - 2:10 PM | For Patients Facing Amputation With No Endo Options Or Useable Vein, PTFE Tibial Bypasses Are A Worthwhile Option That Yields Acceptable Mid-Term Patency And Long-Term Limb Salvage Rates |
| Presenter(s):R. Clement Darling III, MD | |
| View Slides in PDF | |
| 2:11 PM - 2:16 PM | Current Outcomes With PTFE Bypasses To Infrapopliteal (Tibial) Targets: Why Is There Variability Between Surgeons And Institutions: How Does The BEST-CLI Trial Help |
| Presenter(s):Matthew T. Menard, MD | |
| View Slides in PDF | |
| UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI | |
| 2:17 PM - 2:22 PM | Long-Term View Of The Role And Value Of Vein Arterialization: Best Way To Do It And Late Results: From The First To Make It Work |
| Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
| View Slides in PDF | |
| 2:23 PM - 2:28 PM | Endovascular And Surgical Venous Arterialization For REAL No Option Patients Facing Amputation From CLTI: Does Neo-Angiogenesis Occur |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 2:29 PM - 2:34 PM | Pivotal US Trial (PROMISE II), US Feasibility Study (PROMISE I) And European 2-Year Registry Results With Deep Vein Arterialization Using The LimFlow Device For CLTI With Gangrene Shows Reasonable Limb Salvage And Wound Healing |
| Presenter(s):Daniel G. Clair, MD / Andrej Schmidt, MD / Daniela Branzan, MD | |
| View Slides in PDF | |
| 2:35 PM - 2:40 PM | What’s New In Gene And Stem Cell Therapy For No Option CLTI In 2023 |
| Presenter(s):Richard J. Powell, MD | |
| View Slides in PDF | |
| 2:41 PM - 2:46 PM | Importance Of Open Surgical Procedures In A Limb Preservation Practice: What Are They And When Should They Be Used: It Is No longer About In Situ Vein Bypasses |
| Presenter(s):Richard F. Neville, MD | |
| View Slides in PDF | |
| 2:47 PM - 2:53 PM | Panel Discussion |
| END OF SESSION 27 | |
| SESSION 28 SCHEDULE | |
|
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
|
|
| x | |
| 2:53 PM - 2:58 PM | Value Of Heparin Bonded PTFE Grafts For Femoral To Below-The-Knee Bypasses: A Systematic Review And Meta-Analysis: Are There Advantages To Propaten Grafts: Value To Crural Targets |
| Presenter(s):Yann Gouëffic, MD, PhD | |
| View Slides in PDF | |
| 2:59 PM - 3:04 PM | Improved Method For Restoring Patency To Occluded PTFE Bypasses Using A Fluoroscopically Guided Adherent Clot Remover (From Edwards): It’s Less Invasive And More Effective |
| Presenter(s):Neal S. Cayne, MD / Frank J. Veith, MD | |
| View Slides in PDF | |
| PERCUTANEOUS BYPASSES | |
| 3:05 PM - 3:10 PM | Percutaneous (PQ) Transvenous Fempop PTFE Bypasses With The Torus 2 Device (Now From Endologix): How It Works And Updated Status Of The DETOUR And TORUS Trials In The US With 2-Year Results |
| Presenter(s):Sean P. Lyden, MD / Daniel G. Clair, MD / Peter A. Schneider, MD | |
| View Slides in PDF | |
| 3:11 PM - 3:16 PM | Updated Late European Results Of The Detour PQ Fempop Arterial Bypass Routed Through The Femoral Vein From The DETOUR 1 Trial: Which Open Bypasses Will Be Made Obsolete |
| Presenter(s):Dainis K. Krievins, MD / Peter A. Schneider, MD | |
| View Slides in PDF | |
| 3:17 PM - 3:22 PM | A Novel Technique For Percutaneous Extravascular Fempop Bypass - Routing A PTFE Graft Through The Soft Tissue Of The Thigh: It Is A Transcatheter Technique That Is Clampless, Sutureless, And Without External Exposure: How Is It Done; Advantages And Results |
| Presenter(s):Pierre G. Sarradon, Docteur / Jean Pierre Becquemin, MD, FRCS | |
| View Slides in PDF | |
| 3:23 PM - 3:28 PM | Panel Discussion |
| NEW INFORMATION ON STENT-GRAFTS | |
| 3:28 PM - 3:33 PM | Can Viabahn Stent-Grafts Be Used Safely And Effectively In The SFA For CLTI: From Pooled Multicenter Data: What Are The Limitations Of These Devices |
| Presenter(s):Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| 3:34 PM - 3:39 PM | Performance Of A New Generation Balloon Expandable Stent-Graft (VBX From Gore) For Peripheral Aneurysmal And Occlusive Disease As Well As Bridging Stent For F/B/EVAR |
| Presenter(s):Rocco Giudice, MD / Ciro Ferrer, MD, PhD | |
| View Slides in PDF | |
| TREATMENT OF IN STENT RESTENOSIS (ISR) | |
| 3:40 PM - 3:45 PM | Update On The Excimer Laser For Treating ISR: It Has A Role In Crossing And Debulking Difficult Lesions: Technical Tips |
| Presenter(s):Craig M. Walker, MD | |
| View Slides in PDF | |
| 3:46 PM - 3:51 PM | How Best To Treat Long Difficult Complex SFA Lesions Including Those From ISR |
| Presenter(s):Sonia Ronchey, MD, PhD | |
| View Slides in PDF | |
| 3:52 PM - 4:03 PM | Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors) |
| END OF SESSION 28 | |
| SESSION 29 SCHEDULE | |
|
Wednesday
SESSION 29:
LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
|
|
| x | |
| 4:03 PM - 4:08 PM | The Japanese SPINACH Registry Confirms That Open Bypasses Are Superior To Endovascular Treatments In CLTI Patients When Ischemia And Infection Are Advanced |
| Presenter(s):Nobuyoshi Azuma, MD | |
| View Slides in PDF | |
| 4:09 PM - 4:14 PM | The Global Vascular Guidelines And WIfI Staging For CLTI Are Better Than Obsolete TASC Guidelines Because Treatment Recommendations, Revascularization Strategies And Needs For The Future Are Not Solely Based On Lesion Anatomy But Are Nuanced By Other Factors: What Are They |
| Presenter(s):Michael S. Conte, MD | |
| View Slides in PDF | |
| 4:15 PM - 4:20 PM | Ancillary Outcomes Of The BEST-CLI RCT Comparing Endovascular And Open Treatment For CLTI When Both Treatments Are Feasible; What Are The Deficiencies In BEST-CLI And Why Might Interventionalists Claim It Is Misleading |
| Presenter(s):Alik Farber, MD, MBA / Matthew T. Menard, MD / Kenneth Rosenfield, MD | |
| View Slides in PDF | |
| 4:21 PM - 4:26 PM | Why Many Interventionalists Believe The Conclusions Of Best-CLI (Which Involved Mostly Fempop Treatments) Are Misleading |
| Presenter(s):Sahil A. Parikh, MD | |
| View Slides in PDF | |
| 4:27 PM - 4:32 PM | Key Findings From The Just Completed BASIL 2 RCT Comparing Open And Endovascular Treatments For Severe Leg Ischemia From Mostly BTK Disease: How Do They Mesh With BEST-CLI Results |
| Presenter(s):Andrew W. Bradbury, MD, FRCSEd | |
| View Slides in PDF | |
| 4:33 PM - 4:38 PM | Panel Discussion |
| METHODS FOR EVALUATING FOOT PERFUSION | |
| 4:39 PM - 4:44 PM | How And Why To Measure Foot Perfusion During And After Endo Treatments: Hyperspectral Imaging, O2 Sensors, Etc: When Is The Angiosome Concept Helpful; When Not |
| Presenter(s):Marianne Brodmann, MD | |
| View Slides in PDF | |
| 4:45 PM - 4:50 PM | New Methods For Evaluating The Significance Of Lower Extremity Arterial Lesions And Foot Perfusion Using Fractional Flow Reserve (FFR) And MRI; How They Work And Their Value In Assessing Therapeutic Success |
| Presenter(s):Bijan Modarai, PhD, FRCS | |
| View Slides in PDF | |
| 4:51 PM - 4:56 PM | What Are The Best Methods For Measuring Foot Perfusion: They Are Invaluable In CLTI For Assessing Treatment Success And Predicting Healing |
| Presenter(s):Werner Lang, MD | |
| View Slides in PDF | |
| 4:57 PM - 5:02 PM | Panel Discussion |
| END OF SESSION 29 | |
| SESSION 30 SCHEDULE | |
|
Wednesday
SESSION 30:
NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
Moderators:Matthew T. Menard, MD / Marianne Brodmann, MD
|
|
| x | |
| INTERMITTENT CLAUDICATION (IC) | |
| 5:02 PM - 5:07 PM Power Point Presentation with Synched Audio |
An RCT After 2 Years Showed That Stent Treatment For Intermittent Claudication (IC) Improves Quality Of Life More Than Medical Treatment And Exercise: Do The Long-Term Results Refute Or Negate The 2-Year Results |
| Presenter(s):Hans Lindgren, MD, PhD | |
| View Slides in PDF | |
| 5:08 PM - 5:13 PM | At 2 Years After Endovascular Interventions For IC, Only 32% Of Patients Were Free From Recurrent IC: From A VQI Multicenter Study: What Are The Implications |
| Presenter(s):Peter F. Lawrence, MD / Karen Woo, MD, PhD | |
| View Slides in PDF | |
| 5:14 PM - 5:19 PM | When Are Invasive Vascular Treatments Justified For IC And When Are They Not: What Is The Evidence |
| Presenter(s):Caitlin W. Hicks, MD, MS / James H. Black, III, MD | |
| View Slides in PDF | |
| 5:20 PM - 5:25 PM | With Critical ALI, Catheter Based Aspiration Techniques Should Be Considered First-Line Therapy: When Should Other Treatments Be Used |
| Presenter(s):Mathew D. Wooster, MD, MBA | |
| View Slides in PDF | |
| 5:26 PM - 5:31 PM | Panel Discussion |
| ACUTE LIMB ISCHEMIA (ALI) (See Also Session 63) | |
| 5:31 PM - 5:36 PM | Key Points In The Diagnosis And Treatment Of ALI In The Lower Limbs: When To Use Endovascular Treatments And When To Use Open Treatments With Thrombectomy Or A Bypass Because Such ALI Is Always Associated With Chronic Occlusive Disease |
| Presenter(s):Martin Björck, MD, PhD | |
| View Slides in PDF | |
| 5:37 PM - 5:42 PM | The PROMOTE-ALI Study Shows That Open Surgery Is Still Number One In The Treatment Of ALI |
| Presenter(s):Katariina M. Noronen, MD, PhD | |
| View Slides in PDF | |
| 5:43 PM - 5:48 PM | Endovascular Mechanical Thrombectomy Is Obviating The Need For Thrombolytics In ALI: Which Device Is Best – When And Why |
| Presenter(s):Patrick E. Muck, MD, FACS | |
| View Slides in PDF | |
| 5:49 PM - 5:54 PM | Percutaneous Vacuum Thrombectomy For ALI: Devices And Techniques: In 2023 When Is There A Role For Thrombolytics, Angioplasty, Open Balloon Catheter Thrombectomy Or A Bypass |
| Presenter(s):Scott L. Stevens, MD | |
| View Slides in PDF | |
| 5:55 PM - 6:00 PM | What Is New With Penumbra Indigo Clot Aspiration Systems: What Makes Them Different: Indications And Contraindications |
| Presenter(s):James F. Benenati, MD | |
| View Slides in PDF | |
| 6:01 PM - 6:06 PM | Update On How To Treat ALI Under Duplex Ultrasound Guidance: Advantages And Limitations |
| Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD | |
| View Slides in PDF | |
| 6:07 PM - 6:12 PM | The STRIDE Multicenter Trial Showed That Mechanical Suction Thrombectomy With The Indigo Aspiration System (Penumbra) For Lower Limb ALI Had A Low Complication Rate And Excellent Limb Salvage: When Was Angioplasty, Stenting Or A Bypass Necessary |
| Presenter(s):Thomas S. Maldonado, MD | |
| View Slides in PDF | |
| 6:13 PM - 6:20 PM | Panel Discussion End of Program D |
| END OF SESSION 30 | |
| SESSION 31 SCHEDULE | |
|
Wednesday
SESSION 31:
ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
Moderators:Peter Henke, MD / Ido Weinberg, MD, MSc
|
|
| x | |
| 6:40 AM - 6:45 AM | When, Why And How To Lower High Triglyceride Levels: Value Of Vascepa To Decrease Cardiac Risk In Vascular Patients: Based On The REDUCE-IT RCT |
| Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | New Strategies On How To Avoid And Treat Periprocedural Myocardial Infarctions (MIs) In Open Endo Vascular Surgery Patients |
| Presenter(s):Peter Henke, MD | |
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | DEBATE: LDL Cholesterol (LDL-C) Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful: What Does The Latest Evidence Show |
| Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS | |
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | DEBATE: Not So: Update On LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death |
| Presenter(s):Ron Waksman, MD | |
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | Update On LDL-C Lowering During A Lifetime: How Low To Strive For With Intensive Drug Therapy: How Young To Start If High; How Old To Continue Statins: Why And How Often Should LDL-C Levels Be Measured |
| Presenter(s):J. David Spence, MD | |
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | LDL-C Lowering Should Be Maximized With High Dose Statins And Ezetimibe (Zetia) To Minimize Risks From Atherosclerotic Lesions: The LDL-C Level Cannot Be Too Low And Side Effects Are Minor: LDL-C Levels Must Be Monitored And Treated To A Target Level |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | New Findings From The VOYAGER PAD And COMPASS Trials With Low Dose Rivaroxaban (Xarelto From Janssen And J&J) And Aspirin: How Do These Drugs Lower Major Adverse Limb And Cardiac Event Rates After Lower Extremity Revascularization (Endo And Open) For PAD |
| Presenter(s):Marianne Brodmann, MD / Sebastian E. Debus, MD, PhD | |
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimibe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For: The CLEAR RCT Show That Bempedoic Acid Really Works |
| Presenter(s):Richard Bulbulia, MA, MD, FRCS | |
| View Slides in PDF | |
| 7:34 AM - 7:42 AM | Panel Discussion |
| END OF SESSION 31 | |
| SESSION 32 SCHEDULE | |
|
Wednesday
SESSION 32:
CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS
Moderators:Ron Waksman, MD / Michael R. Jaff, DO
|
|
| x | |
| UPDATE ON RENAL DENERVATION FOR HYPERTENSION | |
| 7:42 AM - 7:47 AM | Update On The Status Of Renal Denervation For Hypertension: It Is Here To Stay: Where Is It Going: Status Of The Radiofrequency Denervation SPYRAL HTN-OFF MED RCT (vs Sham) And Other Catheter-Based Ablative And Ultrasound Methods (The RADIANCE II RCT Findings) |
| Presenter(s):Eric A. Secemsky, MD, MSc | |
| View Slides in PDF | |
| 7:48 AM - 7:53 AM | Multiorgan Denervation For Treatment Of Hypertension, Diabetes And Metabolic Syndrome: How To Do It |
| Presenter(s):Kolja Sievert, MD / Horst Sievert, MD | |
| View Slides in PDF | |
| 7:54 AM - 7:59 AM | A Precision Medicine Approach To Managing Pediatric Renovascular Hypertension: How Can Medical And Open Surgical Treatment Control It |
| Presenter(s):Dawn M. Coleman, MD, FACS | |
| View Slides in PDF | |
| OTHER TOPICS RELATED TO VASCULAR DISEASE AND ITS TREATMENT | |
| 8:00 AM - 8:05 AM | How Does The Female Sex Impact The Occurrence Of Lower Extremity Atherosclerosis, Its Treatment And Results Of Treatment |
| Presenter(s):Katherine A. Gallagher, MD | |
| View Slides in PDF | |
| 8:06 AM - 8:11 AM | How And Why Do Thoracic Endografts For TEVAR Negatively Affect The Blood Pressure And The Heart: Can A Compliant Endograft Prevent The Problem |
| Presenter(s):Frans L. Moll, MD, PhD | |
| View Slides in PDF | |
| 8:12 AM - 8:17 AM | When Should Smoking Be Stopped Before AAA Repair; Before Lower Extremity Bypass: At Least 4 Weeks: Why Does The Duration Of Cessation Matters |
| Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS | |
| View Slides in PDF | |
| 8:18 AM - 8:23 AM | Update On Limiting Transfusion And Permitting Anemia After Major Vascular Operations Increases Mortality And Serious Adverse Events Especially In Patients With Cardiac Co-Morbidities |
| Presenter(s):Panos Kougias, MD, MSc | |
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | How To Quantitate Late Mortality Risk In Asymptomatic Carotid Stenosis (ACS) Patients: Why It’s Important In Deciding To Treat ACS Patients Non-Invasively |
| Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS | |
| View Slides in PDF | |
| 8:30 AM - 8:35 AM Power Point Presentation with Synched Audio |
Secondary Prevention Of Vascular Disease And Its Complication With PCSK9 Inhibitors; When They Should Be Used And When Not: How Well Does The New Oral PCSK9 (Inhibitor MK-01616 Work) |
| Presenter(s):Roxana Mehran, MD | |
| View Slides in PDF | |
| 8:36 AM - 8:41 AM | How Important Is Inflammation As Determined By C-Reactive Protein (CRP) Levels In Predicting Adverse Cardiac Events: What Drugs Can Lower This Risk |
| Presenter(s):Ron Waksman, MD | |
| View Slides in PDF | |
| 8:42 AM - 8:50 AM | Panel Discussion |
| 8:50 AM - 9:06 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 32 | |
| SESSION 33 SCHEDULE | |
|
Wednesday
SESSION 33:
PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
Moderators:Timur P. Sarac, MD / Peter L. Faries, MD, FACS
|
|
| x | |
| TO TREAT OR NOT TO TREAT TYPE 2 ENDOLEAKS | |
| 9:06 AM - 9:11 AM | Active AAA Sac Management With Polymers: This Is The Missing Link To Improve Outcomes After EVAR: Technique And Results From The SHAPE AAA-Trial |
| Presenter(s):Michel M.P. Reijnen, MD, PhD / Andrew Holden, MBChB | |
| View Slides in PDF | |
| 9:12 AM - 9:17 AM | Fibrin Glue Sac Filling Technique During EVAR To Prevent All Endoleaks: It Should Be Routine And Is A Game Changer Based On A Multicenter Trial: How To Do It |
| Presenter(s):Qingsheng Lu, MD | |
| View Slides in PDF | |
| TREATING TYPE 1 ENDOLEAKS | |
| 9:18 AM - 9:23 AM | Post EVAR Type 1A Endoleaks Are Predictable And Preventable: Strategies To Prevent Them Or Treat Them |
| Presenter(s):Michael J. Singh, MD | |
| View Slides in PDF | |
| 9:24 AM - 9:29 AM | Embolization Of Type 1 Endoleaks Post EVAR: Longer Term Outcomes; Who To Select For The Procedure And Tips And Tricks For Doing It |
| Presenter(s):Robert A. Morgan, MD | |
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | When And How To Use Embolization Coils To Treat Type 1A Endoleaks Successfully: When Won’t Coils Work: How To Diagnose Type 1A Endoleaks Accurately |
| Presenter(s):Sigrid Nikol, MD | |
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): How Does A Standard Protocol Help; How To Treat Them When They Occur |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 9:42 AM - 9:48 AM | Panel Discussion |
| 9:49 AM - 9:54 AM | A RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: The Next Generation Of EVAR Endografts Must Prevent Endoleaks: How Can It Be Done |
| Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD | |
| View Slides in PDF | |
| 9:55 AM - 10:00 AM | Preventing Threatening Type 2 Endoleaks By IMA Embolization When AAA Sac And IMA Are Large: Indications And Technical Tips And Evidence |
| Presenter(s):Toru Kuratani, MD, PhD | |
| View Slides in PDF | |
| 10:01 AM - 10:06 AM | With A Large IMA (> 3mm), When Should It Be Embolized; Or When Should It Be Revascularized: How And Why |
| Presenter(s):Piotr M. Kasprzak, MD | |
| View Slides in PDF | |
| 10:07 AM - 10:12 AM | Reduction Of Type 2 Endoleaks By Pre-Emptive Coiling Of Aortic Side Branches >3 mm: How Do We Know Based On A Mid-Term Analysis |
| Presenter(s):Götz M. Richter, MD, PhD | |
| View Slides in PDF | |
| 10:13 AM - 10:19 AM | Panel Discussion |
| TREATMENT OF TYPE 2 ENDOLEAKS AND ENDOTENSION AFTER EVAR | |
| 10:20 AM - 10:25 AM | Transcaval Approach To Treat Type 2 Endoleaks After EVAR: Indications: Technique; Precautions And Results |
| Presenter(s):Ross Milner, MD | |
| View Slides in PDF | |
| 10:26 AM - 10:31 AM | Glue Embolization Is Effective Treatment For Most Threatening Type 2 Endoleaks: When And How Best To Do It: Limitations |
| Presenter(s):Neal S. Cayne, MD | |
| View Slides in PDF | |
| 10:32 AM - 10:37 AM | New Concepts In Post EVAR Endoleaks And Endotension: The Role Of Fabric Fatigue, Concealed Or Positional Endoleaks And AAA Sac Hygromas: How Can These Be Detected And Best Treated |
| Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS | |
| View Slides in PDF | |
| 10:38 AM - 10:43 AM | How To Use 3D Fusion Software (GE) To Get Into The Nidus And Treat Type 2 Endoleaks: Best Embolic Agent And Alternate Approaches (Transgraft Or Transcaval) For Access: How To Seal The Graft Puncture Site |
| Presenter(s):Mark W. Mewissen, MD, RVT | |
| View Slides in PDF | |
| 10:44 AM - 10:49 AM | Laser Assisted Transgraft Onyx Embolization Of Type 2 Endoleaks: Indications, Equipment And Technique: How Is The Graft Puncture Site Revealed |
| Presenter(s):Zvonimir Krajcer, MD, FACC | |
| View Slides in PDF | |
| 10:50 AM - 10:55 AM | Most Type 2 Endoleaks After EVAR Should Be Left Alone Because Treatments Have Poor Results, Have Complications And Do Not Improve Outcomes: Are There Exceptions |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 10:56 AM - 11:01 AM | With Type 2 Endoleaks And Sac Expansion, Open Sacotomy And Branch Ligation Is Often The Best Treatment: What Precautions Are Needed In Case There Is An Occult Type 1 Leak |
| Presenter(s):Zachary M. Arthurs, MD | |
| View Slides in PDF | |
| 11:02 AM - 11:11 AM | Panel Discussion |
| END OF SESSION 33 | |
| SESSION 34 SCHEDULE | |
|
Wednesday
SESSION 34:
TCT AND PLINIO ROSSI RECORDED LIVE COMPLEX AND CHALLENGING ENDOVASCULAR CASES
Moderators:Juan F. Granada, MD / Sahil A. Parikh, MD
|
|
| x | |
| Moderator(s): D. Christopher Metzger, MD / Sahil A. Parikh, MD | |
| 11:12 AM - 11:36 AM | Complex Subclavian Pseudoaneurysm After Impella Explant |
| PLINIO ROSSI’S RECORDED LIVE COMPLEX AND CHALLENGING ENDO CASES | |
| Moderator(s): Fabrizio Fanelli, MD, EBIR / Andrew Holden, MBChB / Carlo Setacci, MD | |
| 11:36 AM - 11:43 PM | Renal Bridging Stent Rescue After EVAR |
| Presenter(s):Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 11:43 AM - 11:48 AM | Discussion |
| 11:48 AM - 11:55 AM | BTK Angioplasty In A CLTI Patient: Never Give Up |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 11:55 AM - 12:00 PM | Discussion |
| 12:00 PM - 1:35 PM | Celebratory Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 34 | |
| SESSION 35 SCHEDULE | |
|
Wednesday
SESSION 35:
RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE LINC GROUP
|
|
| x | |
| 1:35 PM - 1:46 PM | Presentation: Calcium In BTK: What Are The Options |
| Presenter(s):Andrej Schmidt, MD | |
| View Slides in PDF | |
| 1:46 PM - 1:57 PM | Recorded Case: Long Segment BTK Revascularization With Orbital Atherectomy And DCB |
| 1:57 PM - 2:07 PM | Recorded Case: Reconstruction Of The Tibioperoneal Trifurcation With DES |
| END OF SESSION 35 | |
| SESSION 36 SCHEDULE | |
|
Wednesday
SESSION 36:
ISSUES IMPORTANT IN VASCULAR SURGERY: PRACTICE PATTERNS, HISTORY, EFFICIENCY, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR
Moderators:Dawn M. Coleman, MD, FACS / Kim J. Hodgson, MD
|
|
| x | |
| 2:08 PM - 2:13 PM | Care Fragmentation In Vascular Treatment: What Is It; What Are Its Causes And What Is Its Impact On Outcomes After Vascular Procedures |
| Presenter(s):Olamide Alabi, MD / William D. Jordan Jr., MD | |
| View Slides in PDF | |
| 2:14 PM - 2:19 PM | History Of Women In Surgery And Vascular Surgery: What Does The Future Hold Within The Next 10 Years |
| Presenter(s):Cynthia K. Shortell, MD | |
| View Slides in PDF | |
| 2:20 PM - 2:25 PM | How To Improve Operating Room Efficiency For Vascular Surgical Operations: Why Is Inefficiency In This Setting So Widespread And Hard To Fix |
| Presenter(s):Panos Kougias, MD, MSc | |
| View Slides in PDF | |
| 2:26 PM - 2:31 PM | Why Non-Compete Clauses In Contracts Should be Eliminated By Law: The SVS Position In Favor Of Such Law Contrasts With The AHA Position Against |
| Presenter(s):Margaret Tracci, MD, JD | |
| View Slides in PDF | |
| 2:32 PM - 2:37 PM | Why Systematic Reviews, Meta-Analyses And RCTs Can Be Misleading: What To Do About It: Does Current Wisdom Help |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 2:38 PM - 2:43 PM | Why Endovascular Treatments Are Overutilized: Who Is Responsible: How Can The Problem Be Remedied |
| Presenter(s):Kim J. Hodgson, MD | |
| View Slides in PDF | |
| 2:44 PM - 2:49 PM | Lifeline Proprietary Carotid Screening: Who Profits: Is It A Good Thing Or A Hoax; What Can It Tell Us About The Prevalence Of Asymptomatic Carotid Stenosis |
| Presenter(s):William A. Gray, MD | |
| View Slides in PDF | |
| ISSUES IN VASCULAR TRAINING | |
| 2:50 PM - 2:55 PM | Optimal New Training Paradigm For Vascular Surgeons: 0+5 Vascular Surgery Residency Followed By 2 Years Of Cardiac Surgery Residency Training: Why Is It Better Than 2 Extra Years Of Laboratory Research |
| Presenter(s):Alan B. Lumsden, MD, FACS | |
| View Slides in PDF | |
| 2:56 PM - 3:01 PM | Integrated (0+5) Vascular Residency Plus CT Surgery Fellowship – How Many Are There; Are They Over Trained And Underutilized: How Has It Helped Me |
| Presenter(s):Jennifer L. Perri, MD, MBA | |
| View Slides in PDF | |
| 3:02 PM - 3:07 PM | Is Vascular Surgery Facing A Looming Decline Because Of Inadequate Numbers Of Both 5+2 And 0+5 Training Programs: What Should And Can Be Done About It: What Are The Impediments |
| Presenter(s):Michael B. Silva, Jr., MD | |
| View Slides in PDF | |
| 3:08 PM - 3:13 PM | How To Remedy The Deficiency Vascular Fellows And Residents Have In Their Numbers Of Open Vascular Surgical Operations: When Should They Get Additional Subspecialty Training In Another Institution |
| Presenter(s):Malachi Sheahan, MD | |
| View Slides in PDF | |
| 3:14 PM - 3:19 PM | How Human Behavior – Even With Vascular Specialists – Is Controlled By Biases And Rationalizations: How To Overcome These And Perform Better |
| Presenter(s):Scott L. Stevens, MD | |
| View Slides in PDF | |
| 3:20 PM - 3:33 PM | Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors) |
| END OF SESSION 36 | |
| SESSION 37 SCHEDULE | |
|
Wednesday
SESSION 37:
MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs)
Moderators:Sean P. Roddy, MD / Krishna Jain, MD
|
|
| x | |
| 3:33 PM - 3:38 PM | How COVID And Changes In The Economy Have Caused Hospitals To Run Out Of Money; What Is The Resulting Impact On Vascular Care And Vascular Doctors; What Can Be Done About It |
| Presenter(s):Samuel R. Money, MD, MBA | |
| View Slides in PDF | |
| 3:39 PM - 3:44 PM | DEBATE: How Heart And Vascular Centers Are Attracting Private Equity Investment Leading To Benefits For All Concerned Including Vascular Surgeons And Their Patients |
| Presenter(s):Jean Bismuth, MD | |
| View Slides in PDF | |
| 3:45 PM - 3:50 PM | DEBATE: Heart And Vascular Centers Are Artificial Entities That Disadvantage Vascular Surgeons And Don’t Improve Patient Care |
| Presenter(s):Malachi Sheahan, MD | |
| View Slides in PDF | |
| 3:51 PM - 3:56 PM | Vascular Spinoff Revenue In Tertiary Healthcare Systems: Substantially More Downstream Benefits From Vascular Surgeons: How To Make Hospital Administrators Appreciate The Value Of Vascular Surgeons And Reward Them Appropriately |
| Presenter(s):Joseph V. Lombardi, MD, MBA | |
| View Slides in PDF | |
| ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs | |
| 3:57 PM - 4:02 PM | The Ever Changing Reimbursement For Lower Extremity Endovascular Therapies In Hospitals And OBLs: Why It’s Happening And Where Is It Going |
| Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD | |
| View Slides in PDF | |
| 4:03 PM - 4:08 PM | Strategies To Succeed In An OBL Despite Continuing Cuts In CMS Reimbursement |
| Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
| View Slides in PDF | |
| 4:09 PM - 4:14 PM | Panel Discussion |
| MORE ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs | |
| 4:15 PM - 4:20 PM | DEBATE: OBLs Are Bad: Why I Choose Not To Work In An OBL |
| Presenter(s):Dipankar Mukherjee, MD | |
| View Slides in PDF | |
| 4:21 PM - 4:26 PM | DEBATE: Not True! How Can OBLs Provide Good Vascular Care With Excellent Results, Be Profitable And Still Allow Vascular Surgeons To Only Work From 8 AM To 5 PM |
| Presenter(s):Mark A. Mattos, MD | |
| View Slides in PDF | |
| 4:27 PM - 4:32 PM | How To Make Out-Patient Vascular Treatment Facilities (OBLs, ASCs) Safe, Effective And Profitable Without Doing Unjustified Procedures |
| Presenter(s):Christopher J. Kwolek, MD, MBA | |
| View Slides in PDF | |
| 4:33 PM - 4:38 PM | Comparison of Arterial Closure Devices In An OBL Setting: Which Is Best Based On An Experience With 19,000 Cases |
| Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
| View Slides in PDF | |
| 4:39 PM - 4:44 PM | Tips For Performing High-Risk Lower Extremity Endovascular Procedures Including Redos Safely And Effectively In An OBL |
| Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD | |
| View Slides in PDF | |
| 4:45 PM - 4:50 PM | OBL Audits: What Are They Looking For And How To Avoid Civil And Criminal Penalties: Do Practice Guidelines Help Or Harm |
| Presenter(s):O. William Brown, MD, JD | |
| View Slides in PDF | |
| 4:51 PM - 4:56 PM | Panel Discussion |
| END OF SESSION 37 | |
| SESSION 38 SCHEDULE | |
|
Wednesday
SESSION 38:
UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES AND RCTs: THE FDA: STATISTICS; EVIDENCE BASED MEDICINE; MISCELLANEOUS
Moderators:Jack L. Cronenwett, MD / Sean P. Roddy, MD
|
|
| x | |
| 4:57 PM - 5:02 PM | What Obstacles And Blows Are Vascular Surgeons And Other Vascular Specialists Facing In 2023: Will Planned Increased Reimbursement For Office And Hospital Visits Cause More Decreases In Procedural Reimbursements |
| Presenter(s):Sean P. Roddy, MD | |
| View Slides in PDF | |
| 5:03 PM - 5:08 PM | VQI Collaboration With The International Consortium of Vascular Registries (ICVR): How Can It Better Evaluate Aortic Endograft Performance |
| Presenter(s):Adam Beck, MD | |
| View Slides in PDF | |
| 5:09 PM - 5:14 PM Power Point Presentation with Synched Audio |
The Role And Value Of Guidelines And RCTs In Vascular Practice; Why Guidelines And RCTs Can Be Misleading: What To Do About The Problem |
| Presenter(s):Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| REGULATORY AND FDA ISSUES | |
| 5:15 PM - 5:20 PM | How Can A Device Qualify With The FDA For BREAKTHROUGH Status And How Does It Differ From SAFER Status |
| Presenter(s):Valerie M. Merkle, PhD | |
| View Slides in PDF | |
| 5:21 PM - 5:26 PM | Past, Present And Future Collaboration Between Industry, Clinicians And The FDA To Address Unmet Clinical Needs: We Should Not Be Adversaries |
| Presenter(s):Dorothy B. Abel, BSBME | |
| View Slides in PDF | |
| EVIDENCE-BASED MEDICINE ISSUES | |
| 5:27 PM - 5:32 PM | Improved And Simplified Clinical Trial Statistics For Dummies: Why p Values Are Decreasing In Importance And Bayesian Statistics Are Increasing In Importance: What Is The Latter |
| Presenter(s):Charles C. Miller, PhD | |
| View Slides in PDF | |
| 5:33 PM - 5:38 PM | Registry Based RCTs (RBRCTs): What Are They, How Do They Work And Why Are They Better Than Other Evidence-Based Techniques |
| Presenter(s):Jens Eldrup-Jorgensen, MD / Jack L. Cronenwett, MD | |
| View Slides in PDF | |
| 5:39 PM - 5:44 PM | Panel Discussion |
| MISCELLANEOUS | |
| 5:45 PM - 5:50 PM | Managing Various Specialties And Generations Of Specialists In A Multi-Specialty Vascular Institute Or Center: How To Satisfy Everyone And Optimize Patient Outcomes |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| 5:51 PM - 5:56 PM | Despite What The New York Times And Others Say, Close Relationships Of Vascular Surgeons With Industry Are Mostly Ethical And Beneficial To Patients And Society: Pitfalls To Avoid |
| Presenter(s):Bruce A. Perler, MD, MBA | |
| View Slides in PDF | |
| 5:57 PM - 6:02 PM | Innovation In Vascular Surgery: Ideas, Funding, Partners And Intellectual Property: How To Turn Fantasy Into Reality |
| Presenter(s):Jeffrey H. Lawson, MD, PhD | |
| View Slides in PDF | |
| 6:03 PM - 6:08 PM | Current Quality Analysis For Vascular Surgeons And Vascular Specialists Does Not Reflect Quality Of Care: Why And What Can Be Done About It |
| Presenter(s):Richard F. Neville, MD | |
| View Slides in PDF | |
| 6:09 PM - 6:14 PM | Editorial Update On The JVS And All Its Progeny: Its Status And How It Will Be Improved |
| Presenter(s):Ronald L. Dalman, MD / Thomas L. Forbes, MD | |
| View Slides in PDF | |
| 6:15 PM - 6:20 PM | Effects Of The Affordable Care Act (ACA) On Vascular Surgical Outcomes: Does The Medicaid Expansion Of The ACA Improve Outcomes Or Not |
| Presenter(s):Mohammad H. Eslami, MD, MPH | |
| View Slides in PDF | |
| 6:21 PM - 6:30 PM | Panel Discussion End of Program E |
| END OF SESSION 38 | |
| SESSION 39 SCHEDULE | |
|
Wednesday
SESSION 39:
MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs), INFLAMMATORY ANEURYSMS AND THEIR TREATMENT
Moderators:Ramon Berguer, MD, PhD / Paulo E. Ocke Reis, MD, PhD
|
|
| x | |
| 6:50 AM - 6:55 AM | What Is Best Medical Treatment For TBAD Patients: How Best To Control Blood Pressure And To Get Patients To Comply: They Don’t |
| Presenter(s):Colin D. Bicknell, MD, FRCS | |
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | Requirement For Adjunctive Branch Stents After TEVAR For Complicated TBADs Is An Indicator Of Poor Prognosis: What Can Be Done To Offset It |
| Presenter(s):Mark K. Eskandari, MD | |
| View Slides in PDF | |
| 7:02 AM - 7:07 AM | Current Optimal Management Of Intramural Hematomas (IMHs): Which Ones Should Be Treated With TEVAR And What Is The Best Extent Of Aortic Coverage |
| Presenter(s):Frank J. Criado, MD | |
| View Slides in PDF | |
| 7:08 AM - 7:13 AM | Outer/ Inner/Upward Branches Or Fenestrations: Strategies For Complex Aortic Repair For Patients With Chronic TBADs: What Are The Unmet Needs |
| Presenter(s):Bijan Modarai, PhD, FRCS | |
| View Slides in PDF | |
| 7:14 AM - 7:19 AM | Current Advances In The Treatment For Inflammatory Aneurysms: How Effective Are EVAR And TEVAR |
| Presenter(s):Furuzan Numan, MD | |
| View Slides in PDF | |
| 7:20 AM - 7:25 AM | Panel Discussion |
| 7:25 AM - 7:30 AM | DEBATE: The STABILISE Technique Will Lead To Paradigm Shift In The Treatment Of TBADs And Will Replace Most False Lumen Occlusion Devices And F/B/EVAR Treatments: It Relaminates The Aorta And Eliminates The False Lumen: How To Do It And Precautions |
| Presenter(s):Igor A. Laskowski, MD, PhD / Josh B. Goldberg, MD / Heepeel Chang, MD | |
| View Slides in PDF | |
| 7:31 AM - 7:36 AM | DEBATE: Not So Fast! A Multimodular Approach To Treating Chronic TBADs With TAAAs: Who Needs A F/B/EVAR; Who Needs A Candy-Plug Or Other Occlusion Technique |
| Presenter(s):Tilo Koelbel, MD, PhD / Fiona Rohlffs, MD | |
| View Slides in PDF | |
| 7:37 AM - 7:42 AM | When Are Thoracic Endografts Valuable Treatments For Genetic Aortopathies |
| Presenter(s):Cherrie Z. Abraham, MD | |
| View Slides in PDF | |
| 7:43 AM - 7:48 AM | What Are The Knowledge Gaps In The Treatment Of TBADs: How Can And Will They Be Resolved |
| Presenter(s):Colin D. Bicknell, MD, FRCS | |
| View Slides in PDF | |
| 7:49 AM - 7:54 AM | A Recently Funded Multicenter NIH Grant (IMPROVE-AD) To Evaluate Unknowns In The Treatment Of Acute And Subacute TBADs: What Will It Tell Us And Why Was It So Hard To Get It Approved: Are There Other Similar RCTs Outside The US |
| Presenter(s):Gustavo S. Oderich, MD, FACS | |
| View Slides in PDF | |
| 7:55 AM - 8:00 AM | Panel Discussion |
| END OF SESSION 39 | |
| SESSION 40 SCHEDULE | |
|
Wednesday
SESSION 40:
MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
Moderators:Rodney A. White, MD / Thomas S. Maldonado, MD
|
|
| x | |
| 8:00 AM - 8:05 AM | When In Addition To TEVAR And F/BEVAR Are False Lumen (FL) Occlusion Procedures Needed To Reduce FL Pressure And Promote Aortic Remodeling |
| Presenter(s):Götz M. Richter, MD, PhD | |
| View Slides in PDF | |
| 8:06 AM - 8:11 AM | With TAAD When And How Should The Distal Aorta Be Treated By TEVAR Before Repairing The Ascending Aorta |
| Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD | |
| View Slides in PDF | |
| 8:12 AM - 8:17 AM | Fenestrated TEVAR Devices For The Treatment Of Post Dissection Aortic Arch False Lumen Aneurysms: What Devices Are Available, How Do They Work And Results |
| Presenter(s):Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 8:18 AM - 8:23 AM Power Point Presentation with Synched Audio |
With Chronic TBADs Laser Assisted Resection Of The Dissection Membrane Creates A Single Lumen TEVAR Landing Zone: How Is The Technique Performed And Early Results |
| Presenter(s):Nuno V. Dias, MD, PhD / Bjõrn Sonesson, MD, PhD | |
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | Continuing Experience For Precise TEVAR Placement In Or Near The Arch By Valsalva And PEEP (Munich Valsalva Maneuver): It Is Safe And Effective And Better Than Adenosine, Rapid Pacing And Caval Occlusion: How To Do It And Results |
| Presenter(s):Nikolaos Tsilimparis, MD, PhD | |
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | Panel Discussion |
| 8:35 AM - 8:40 AM | Single, Double Or 3-Branched Endograft Devices For Arch Lesion Repairs: When Is Each Best And Why: How To Do It From A Totally Femoral Approach |
| Presenter(s):Gustavo S. Oderich, MD, FACS | |
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | An Off-The-Shelf Combined Valve+Fenestrated Endograft For Treating Acute TAADs – An Endo Bentall: Device Description, Indications And Clinical Status |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 8:47 AM - 8:52 AM | Percutaneous Endovascular Arch Repair Is Feasible With The Use Of Adjuncts: The “Innominate Approach” Avoids The Need To Get Open Exposure Of The Carotid Arteries For Access: How Is It Done |
| Presenter(s):Timothy A. Resch, MD, PhD | |
| View Slides in PDF | |
| 8:53 AM - 8:58 AM | Physician Modified Double Fenestrated Stent-Grafts (PMEGs) For Total Aortic Arch Repair: Technique, Precautions And Results In 150 Cases |
| Presenter(s):Ludovic Canaud, MD, PhD | |
| View Slides in PDF | |
| 8:59 AM - 9:04 AM | Zone 0 Aortic Arch Branched Endograft Repair Is Feasible With A Mechanical Aortic Valve: Tips And Tricks For Performing It Without Impairing Valve Function |
| Presenter(s):Nikolaos Tsilimparis, MD, PhD | |
| View Slides in PDF | |
| 9:05 AM - 9:11 AM | Panel Discussion |
| 9:11 AM - 9:24 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 40 | |
| SESSION 41 SCHEDULE | |
|
Wednesday
SESSION 41:
OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
Moderators:Christopher J. Kwolek, MD, MBA / Gilbert R. Upchurch, MD
|
|
| x | |
| COMPLEX AAAs AND TAAAs | |
| 9:24 AM - 9:29 AM | Aortic Neck Dilatation And AAA Sac Shrinkage After F/EVAR Is Better Than After Standard EVAR |
| Presenter(s):Thomas S. Maldonado, MD | |
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | Recent Progress In Prevention Of Spinal Cord Ischemia (SCI) Especially Paraplegia After Complex AAA And TAAA Endovascular Repairs |
| Presenter(s):Adam Beck, MD / Matthew J. Eagleton, MD | |
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | Complete Aortic Endovascular Repairs (Zones 0-10) Using Parallel Endografts With A Docking Station: How And Why To Make Them Work Effectively Despite Doubts About Parallel Grafts |
| Presenter(s):Manish Mehta, MD, MPH | |
| View Slides in PDF | |
| 9:42 AM - 9:47 AM | Value Of Ch/EVAR For Juxtarenal AAAs: They Are As Safe And Effective As Any Other Procedure And Simpler: Based On A Meta-Analysis Of Mid-Term Outcomes |
| Presenter(s):Joost van Herwaarden, MD, PhD | |
| View Slides in PDF | |
| 9:48 AM - 9:53 AM | Key Findings From The UK-Complex Aneurysm Study (UK-COMPASS) Comparing Outcomes Of Off-Label EVAR, Open Repair And F/EVAR For Short Necked AAAs |
| Presenter(s):S. Rao Vallabhaneni, MD, FRCS / Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
| View Slides in PDF | |
| 9:54 AM - 9:59 AM | Comparison Of Endo And Open Repair Of Post Dissection TAAAs: Which Procedure Is Best And When |
| Presenter(s):Fabio Verzini, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 10:00 AM - 10:05 AM | What Is A Hybrid Repair Of A TAAA (Proximal Endograft + Distal Open Repair - The Upchurch Procedure): When Is It Indicated; What Are The Advantages And Results |
| Presenter(s):Gilbert R. Upchurch, MD / Sal Scali, MD / Dean Arnaoutakis, MD | |
| View Slides in PDF | |
| 10:06 AM - 10:12 AM | Panel Discussion |
| TOPICS RELATED TO INTERESTING NEW DEVICES | |
| 10:12 AM - 10:17 AM | Update On The Incraft Endograft (From Cordis) For Standard Infrarenal EVAR: Is Its Low Profile An Advantage Or Limitation |
| Presenter(s):Giovanni B. Torsello, MD / Matteo Orrico, MD / Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 10:18 AM - 10:23 AM | How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur |
| Presenter(s):Manju Kalra, MBBS | |
| View Slides in PDF | |
| 10:24 AM - 10:29 AM | Can EVAR And F/EVAR Be Done Under Local Anesthesia: Can They Become Outpatient Procedures Or Office Based Lab Procedures: What Are The Contraindications |
| Presenter(s):Michael C. Stoner, MD | |
| View Slides in PDF | |
| 10:30 AM - 10:35 AM Power Point Presentation with Synched Audio |
WeFlow Device For Juxtarenal AAA, TAAA And Arch Repairs: A New Inner Branch And Outer Branch Approach: How Does It Work And Promising Results |
| Presenter(s):Wei Guo, MD | |
| View Slides in PDF | |
| 10:36 AM - 10:40 AM | Panel Discussion |
| END OF SESSION 41 | |
| SESSION 42 SCHEDULE | |
|
Wednesday
SESSION 42:
PROGRESS IN TREATING ILIAC LESIONS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
Moderators:Thomas S. Maldonado, MD / Rodney A. White, MD
|
|
| x | |
| TREATMENT OF ILIAC ANEURYSMS AND IBDs | |
| 10:40 AM - 10:45 AM | Surprisingly Occlusion Of 1 Or Both Hypogastric Arteries During EVAR Does NOT Result In Serious Adverse Events: From A Large VQI Study |
| Presenter(s):Heepeel Chang, MD | |
| View Slides in PDF | |
| 10:46 AM - 10:51 AM | Update On The Gore IBE Excluder For Treating Iliac Aneurysms And Preserving Hypogastric Artery Flow: Why It Should Be Preserved Whenever Possible: When Can It Not Be |
| Presenter(s):Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| 10:52 AM - 10:57 AM | Updated Experience With Cook IBD For The Treatment Of Common Iliac Aneurysms: Including After Previous EVAR |
| Presenter(s):Giovanni B. Torsello, MD / Carlos H. Timaran, MD / Andres Schanzer, MD | |
| View Slides in PDF | |
| 10:58 AM - 11:03 AM | Long-Term Comparison Of The Cook Zenith And Gore Excluder IBDs: Advantages And Limitations Of Both: What Is Currently The Best Bridging Stent |
| Presenter(s):Giovanni Pratesi, MD | |
| View Slides in PDF | |
| 11:04 AM - 11:09 AM | An Iliac Customized Fenestrated Device (From Terumo Aortic): When And How Can It Work In Anatomies Unsuitable For Branched Endografts: Advantages And Limitations |
| Presenter(s):Afshin Assadian, MD / Fadi Taher, MD | |
| View Slides in PDF | |
| 11:10 AM - 11:15 AM | Update On The Advantages Of The Artivion (Formerly CryoLife/Jotec) IBD Device For Treating Common And Internal Iliac Artery Aneurysms: When Bell Bottom Technique; When IBD: From The PLIANT II Study |
| Presenter(s):Lee Bouwman, MD, PhD | |
| View Slides in PDF | |
| 11:16 AM - 11:21 AM | Covered Endovascular Reconstruction Of The Iliac Bifurcation (CERIB) For Preservation Of Pelvic Flow During Treatment Of Aortoiliac Occlusive Disease: How And When To Do It |
| Presenter(s):Joshua D. Adams, MD | |
| View Slides in PDF | |
| 11:22 AM - 11:30 AM | Panel Discussion |
| UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS | |
| 11:30 AM - 11:35 AM | Is There A Role For Bare Stents (Allay From Intressa, Formerly Cardiatis) In The Treatment Of Type A Aortic Dissections (TAADs) |
| Presenter(s):Rodney A. White, MD | |
| View Slides in PDF | |
| 11:36 AM - 11:41 AM | 8-Year Clinical Experience With Bare Stent And Chimney Treatment Of TAADs |
| Presenter(s):Ivo Petrov, MD, PhD / Victor S. Costache, MD, PhD | |
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | 3-Year Experience With Bare Stents (Allay From Intressa, Formerly Cardiatis) For The Treatment Of TAADs |
| Presenter(s):Claude D. Vaislic, MD | |
| View Slides in PDF | |
| 11:48 AM - 11:53 AM | Role Of Bare Metal AMDS Stents From Artivion (Formerly CryoLife/Jotec) For Repair Of Acute Type A Dissections: Indications And Results |
| Presenter(s):Wilson Y. Szeto, MD / Grayson H. Wheatley, MD | |
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:35 PM | Celebratory Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 42 | |
| SESSION 43 SCHEDULE | |
|
Wednesday
SESSION 43:
MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
Moderators:Michael L. Marin, MD / Fred A. Weaver, MD, MMM
|
|
| x | |
| 1:35 PM - 1:40 PM | Should Saccular AAAs Be Repaired At A Smaller Diameter Than Fusiform AAAs: How To Measure Saccular AAA Diameter: Should It Include The Normal Aorta Or Not |
| Presenter(s):Frans L. Moll, MD, PhD | |
| View Slides in PDF | |
| 1:41 PM - 1:46 PM | Decreasing Frequency Of Elective And Ruptured AAA Repairs Is Due To Epidemiology Rather Than Other Factors Like Screening |
| Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD | |
| View Slides in PDF | |
| AAA NECK BEHAVIOR AFTER EVAR | |
| 1:47 PM - 1:52 PM | Optimal Stent Design And Optimal Degree Of Oversizing To Avoid Neck Dilatation And Why It Matters |
| Presenter(s):Carlos F. Bechara, MD | |
| View Slides in PDF | |
| 1:53 PM - 1:58 PM | Major Aortic Neck Dilatation Occurs Equally After EVAR And Open Repair: From The DREAM RCT: This ONLY Occurs After EVAR With Self-Expanding Endografts |
| Presenter(s):Jan D. Blankensteijn, MD | |
| View Slides in PDF | |
| 1:59 PM - 2:04 PM | What Should Be The Role Of Physician Modified Endografts (PMEGs) For the Treatment Of Short Or No Neck AAAs When Industry Made F/EVAR Devices Are Available: Why PMEGs Are Only Good In Some Centers: New Computer 3D Modeling Adjuncts (From Terumo) To Make PMEGs Better And Simpler |
| Presenter(s):Benjamin W. Starnes, MD | |
| View Slides in PDF | |
| 2:05 PM - 2:10 PM | DEBATE: Low Profile Devices For EVAR Are Failing: Their Future Is Questionable Based On Results Of Other Devices Like The Endurant Endograft At 10 Years (From The ENGAGE OUS Registry) |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 2:11 PM - 2:16 PM | DEBATE: Not So: Ovation Stent-Grafts (From Endologix) Have Good 5-Year Results With No Neck Dilatation Or Migration Even With Challenging Neck Anatomy: Based On A Multicenter International Study Of A Low Profile Endograft |
| Presenter(s):Mahmoud B. Malas, MD, MHS | |
| View Slides in PDF | |
| 2:17 PM - 2:22 PM | Is AAA Thrombus More Dangerous In Women Than In Men: What Are The Dangers Of Such Thrombus |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 2:23 PM - 2:28 PM | How Well Does Non-Fluoroscopic Guidance Using The IOPS System From Centerline Work For Performance Of Standard EVAR: Findings From The MOTION Trial |
| Presenter(s):Francis Caputo, MD | |
| View Slides in PDF | |
| 2:29 PM - 2:34 PM | Despite Great Advances With AAA Management, Little Progress Has Been Made In 2 Important Areas: Improving Indications For Treatment And Precision Of Measurement: AAAs ≤6.0 cm Rarely Rupture |
| Presenter(s):Frank J. Criado, MD | |
| View Slides in PDF | |
| 2:35 PM - 2:41 PM | Panel Discussion |
| END OF SESSION 43 | |
| SESSION 44 SCHEDULE | |
|
Wednesday
SESSION 44:
MORE NEW DEVELOPMENTS IN AAAs: HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
Moderators:Evan C. Lipsitz, MD, MBA / Janet T. Powell, MD, PhD
|
|
| x | |
| AAA SAC THROMBUS LOAD | |
| 2:41 PM - 2:46 PM | Impact Of Thrombus In AAA Sac And Neck On AAA Behavior And EVAR Outcomes: How To Quantitate Thrombus Load And Distribution |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| View Slides in PDF | |
| 2:47 PM - 2:52 PM | DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity Without Rupture And With Rupture: By What Mechanisms Is Thrombus Harmful And How Can Thrombus Load Be Quantitated |
| Presenter(s):David H. Deaton, MD, FACS | |
| View Slides in PDF | |
| 2:53 PM - 2:58 PM | DEBATE: Large Flow Luminal Space In An AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| OTHER AAA RELATED TOPICS | |
| 2:59 PM - 3:04 PM | Graft Infolding: A Unique EVAR Complication: How To Prevent It And How To Treat It |
| Presenter(s):Ashraf Mansour, MD | |
| View Slides in PDF | |
| 3:05 PM - 3:10 PM | With Aneurysmal Disease What Causes The Aorta To Rotate: What Is The Impact Of Counterclockwise Rotation Of The Aneurysmal Aorta |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| View Slides in PDF | |
| 3:11 PM - 3:16 PM | Observation For Small AAAs (<5.0 cm) Is Safe And Does Not Impair Future EVAR Options |
| Presenter(s):Jon S. Matsumura, MD | |
| View Slides in PDF | |
| 3:17 PM - 3:22 PM | Update On Median Arcuate Ligament Syndrome (MALS): Current Status Of Its Etiological Concepts And Optimal Diagnosis And Treatment |
| Presenter(s):Prof. Dr. Med Wilhelm Sandmann, MD | |
| View Slides in PDF | |
| 3:23 PM - 3:28 PM | Update On Technical Tips To Perform SAFE Large Sheath Percutaneous Femoral Access And Closure For Complex AAA EVAR In Obese Or Scarred Groins – Even With Calcified Arteries: It Is Almost Always Possible |
| Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 3:29 PM - 3:34 PM | Increased Inflammatory Biomarkers And Increased 18F FDG Uptake On PET CT In AAA Patients Are Associated With Rapid Growth And Worse Long-Term Survival: Should These Markers Be Tested Routinely And How Should AAA Treatment Be Modified If They Are Elevated |
| Presenter(s):Natzi Sakalihasan, MD, PhD | |
| View Slides in PDF | |
| 3:35 PM - 3:41 PM | Panel Discussion |
| 3:41 PM - 3:50 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 44 | |
| SESSION 45 SCHEDULE | |
| x | |
| 3:50 PM - 3:55 PM | Aorto-Enteric Fistulas Associated With Infected EVARs Or Open Prosthetic Grafts; What Are The Differences Between Them And What Are the Implications For Treatment |
| Presenter(s):Sal Scali, MD | |
| View Slides in PDF | |
| 3:56 PM - 4:01 PM | International Experience With 1,000 Physician Modified Endografts For Complex Aortic Aneurysms: When Is The Procedure A Good Thing And When Is It A Bad Thing |
| Presenter(s):Nikolaos Tsilimparis, MD, PhD | |
| View Slides in PDF | |
| 4:02 PM - 4:07 PM | Impact Of COVID, The NICE Guidelines And Changing Disease Patterns On AAA Practice In The UK: Which Is Most Important |
| Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD | |
| View Slides in PDF | |
| 4:08 PM - 4:13 PM | TEVAR For Acute Complicated TBAD: Improved Outcomes When The Endograft Is Extended To Zone 2 Versus Zone 3: Why Is This So And What To Do About The Subclavian Artery |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| 4:14 PM - 4:19 PM | Safe Anticoagulation In F/B/EVAR Patients Requiring Spinal Fluid Drainage |
| Presenter(s):Afshin Assadian, MD | |
| View Slides in PDF | |
| 4:20 PM - 4:25 PM | Panel Discussion |
| 4:25 PM - 4:30 PM | Are We Overtreating AAAs: The Current Diameter Threshold For AAA Repair Is No Longer Relevant: Based On New Scrutiny Of Old Trials And A Meta-Analysis Of AAA Rupture Risk |
| Presenter(s):Timothy A. Resch, MD, PhD | |
| View Slides in PDF | |
| 4:31 PM - 4:36 PM | What Is “Failure To Rescue” After Endovascular TAAA Repairs: What Factors Are Responsible And Why Is It Important |
| Presenter(s):Jade S. Hiramoto, MD | |
| View Slides in PDF | |
| 4:37 PM - 4:42 PM | Laser In Situ F/EVAR As An Off-The-Shelf Option For Ruptured Complex Or Short Necked AAAs And Failed EVAR: Experience And Technical Tips |
| Presenter(s):Timothy A. Resch, MD, PhD | |
| View Slides in PDF | |
| 4:43 PM - 4:48 PM Power Point Presentation with Synched Audio |
10-Year Experience Shows The Safety And Effectiveness Of Endoanchors For F/EVAR: They Support A Shortened Main Endograft Length And A Reduced Procedural Complexity |
| Presenter(s):Jörg Tessarek, MD | |
| View Slides in PDF | |
| 4:49 PM - 4:54 PM | Risk Factors And Late Clinical Consequences Of AAA Neck Dilatation After EVAR With Self-Expanding Endografts: What Are The Differences In Neck Behavior After Excluder And Endurant Endografts: Based On 10-Year Results From The ENGAGE Registry |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 4:55 PM - 5:00 PM | Panel Discussion |
| END OF SESSION 45 | |
| SESSION 46 SCHEDULE | |
|
Wednesday
SESSION 46:
MORE SHORT HOT NEW TOPICS RELATED TO AORTO-ILIAC AND CAROTID DISEASE AND THEIR TREATMENTS; ANTI-ATHEROSCLEROSIS VACCINE
Moderators:Andres Schanzer, MD / Peter F. Lawrence, MD
|
|
| x | |
| 5:01 PM - 5:06 PM | Are Low Profile Devices For EVAR And TEVAR Improving Or Worsening Outcomes |
| Presenter(s):Naoki Fujimura, MD, PhD | |
| View Slides in PDF | |
| 5:07 PM - 5:12 PM | Why Is It Important To Avoid “Lost To Follow Up” In AAA Studies: What Measures Can Do So |
| Presenter(s):Matthew W. Mell, MD, MS | |
| View Slides in PDF | |
| 5:13 PM - 5:18 PM | Single Access Retrograde Iliac Branch Endograft Device (IBD) Implantation: Technique, Advantages And Limitations |
| Presenter(s):Mario L. Lachat, MD | |
| View Slides in PDF | |
| 5:19 PM - 5:24 PM | Treo Endograft From Terumo Aortic For EVAR: Advantages And 5-Year Results From The US IDE Trial |
| Presenter(s):Michael C. Stoner, MD / Matthew J. Eagleton, MD | |
| View Slides in PDF | |
| 5:25 PM - 5:30 PM | Isolated Iliac Artery Aneurysms Do NOT Rupture And Need To Be Treated Until They Are At Least 4 Centimeters In Diameter |
| Presenter(s):Christopher J. Smolock, MD | |
| View Slides in PDF | |
| 5:31 PM - 5:36 PM | How To Safely Stent The Large Fenestration Of A ZFEN Endograft When It Is Crossed By Struts: Indications For Doing So And Late Results |
| Presenter(s):Luis A. Sanchez, MD | |
| View Slides in PDF | |
| 5:37 PM - 5:42 PM | The Mega-Aortic Syndrome: What Is It: When And How Should It Be Treated |
| Presenter(s):Martin Czerny, MD | |
| View Slides in PDF | |
| 5:43 PM - 5:49 PM | Panel Discussion |
| CAROTID RELATED TOPICS | |
| 5:49 PM - 5:54 PM | Transcarotid Artery Revascularization (TCAR) Versus Carotid Endarterectomy (CEA): In A Single Center Experienced In Both, Which Is Best And When |
| Presenter(s):Zach AbuRahma, DO / Ali F. AbuRahma, MD | |
| View Slides in PDF | |
| 5:55 PM - 6:00 PM | Intracranial Angiography During TCAR: Technique And Value |
| Presenter(s):Peter L. Faries, MD, FACS / Michael L. Marin, MD | |
| View Slides in PDF | |
| MORE AORTA RELATED TOPICS | |
| 6:01 PM - 6:06 PM | Improved Survival After Implementation Of A Large Scale Dedicated Network For Aortic Emergencies: Why The French SOS Aorta System Works |
| Presenter(s):Jean-Marc Alsac, MD, PhD | |
| View Slides in PDF | |
| 6:07 PM - 6:12 PM | How Can The Gore Recapturable C3 Excluder Endograft Be Modified As A PMEG For F/EVAR And TAAA Repair: Technique And Results |
| Presenter(s):Wayne W. Zhang, MD | |
| View Slides in PDF | |
| 6:13 PM - 6:18 PM | The Sandwich-Periscope Technique For Left Subclavian Revascularization With Zone 2 TEVAR: It May Be The Best Way And How To Do It: Technique |
| Presenter(s):Sukgu Han, MD | |
| View Slides in PDF | |
| ANTI-ATHEROSCLEROSIS VACCINE | |
| 6:19 PM - 6:24 PM | An Interesting New Anti-Atherosclerosis Vaccine (AntheroVax): How It Works And Current Status |
| Presenter(s):Nicholas Kipshidze, MD, PhD, DSc | |
| View Slides in PDF | |
| 6:25 PM - 6:30 PM | Panel Discussion End of Program F |
| END OF SESSION 46 | |
|
Thursday, November 16, 2023
Print Entire 2023 Program:
|
|
| SESSION 47 SCHEDULE | |
|
Thursday
SESSION 47:
EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS, TRIBUTE TO ROGER M. GREENHALGH
|
|
| x | |
| 6:50 AM - 6:55 AM | Combating Bias In Medical And Vascular Studies And Therapeutic Decision Making: Why It Is Such A Big Deal And What To Do About It |
| Presenter(s):Matthew T. Menard, MD | |
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | Update On Remote Monitoring Of Vascular Graft Function And Other Parameters: Where Is It At And Where Is It Going |
| Presenter(s):Richard F. Neville, MD | |
| View Slides in PDF | |
| 7:02 AM - 7:07 AM | New Wearable Technologies For Telemonitoring Vascular Diseases And Their Treatments: What Are The Current UK Research Priorities: How Will They Improve Patient Care |
| Presenter(s):Celia Riga, MD, FRCS | |
| View Slides in PDF | |
| 7:08 AM - 7:13 AM | A New Core Outcome Set For Evaluating AAA Repairs: This Will Reflect What Is Currently Most Valued By Patients, Surgeons, Nurses, Industry And Others Involved In Patient Care |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 7:14 AM - 7:19 AM | Update On Tissue Engineered Biological Arterial Grafts (Humacyte) In Various Vascular Beds: How Well Are They Working In Patients: 6-Year Durability Data |
| Presenter(s):Todd E. Rasmussen, MD, FACS / Alexander Kersey, MD / Jeffrey H. Lawson, MD, PhD | |
| View Slides in PDF | |
| 7:20 AM - 7:25 AM | Progress In Developing A Curved Angioplasty Balloon: How It Works And Why It’s Important |
| Presenter(s):Timothy A.M. Chuter, MD | |
| View Slides in PDF | |
| 7:26 AM - 7:31 AM | Panel Discussion |
| 7:31 AM - 7:36 AM Power Point Presentation with Synched Audio |
Relining Occluded Vein Grafts With Viabahn (Gore) Stent-Grafts Or Supera (Abbott) Bare Stents Can Restore Patency And Avoid Thrombolysis Or Clot Removal: Techniques And Results |
| Presenter(s):Hans Lindgren, MD, PhD | |
| View Slides in PDF | |
| 7:37 AM - 7:42 AM | Measuring Aortic Diameters Is Inaccurate And Subjective: Even With Newer Imaging Technology, One Can Make The Diameter What You Want: How Does It Invalidate Many Studies And Trials |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 7:43 AM - 7:48 AM | Provider Skill Is Not Getting Appropriate Attention In The Health Care Value Equation Of Value = Outcome/Cost: Even Within A Specialty All Doctors Are Not Equal: What To Do About It |
| Presenter(s):Lars B. Lonn, MD, PhD | |
| View Slides in PDF | |
| 7:49 AM - 7:54 AM | Performing Transplants In Ukraine During The Russian Invasion: Limitations And Gratification |
| Presenter(s):Robert A. Montgomery, MD, D.Phil | |
| View Slides in PDF | |
| 7:55 AM - 8:00 AM | Pediatric Vascular Surgery – A New Subspecialty Within Vascular Surgery: What Pathologies Are Involved; Why Is It Necessary And What Resources Are Needed To Optimize Care |
| Presenter(s):Alex Fairman, MD | |
| View Slides in PDF | |
| 8:01 AM - 8:06 AM | A Tribute To Roger M. Greenghalgh (1941-2023) |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 8:07 AM - 8:12 AM | Panel Discussion |
| END OF SESSION 47 | |
| SESSION 48 SCHEDULE | |
|
Thursday
SESSION 48:
PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
|
|
| x | |
| 8:12 AM - 8:17 AM | The “Shaggy Aorta”: What Is It; How Is It Determined And Quantitated; How Shaggy Does It Have To Be To Matter |
| Presenter(s):Germano C.G. Melissano, MD | |
| View Slides in PDF | |
| 8:18 AM - 8:23 AM | The US Aortic Research Consortium (US-ARC): What Is It And How Do Multicenter Systematic Studies Like It With F/B/EVAR Better Answer Clinical Questions: Is There Still Value To Single Center Studies |
| Presenter(s):Andres Schanzer, MD | |
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | Value Of Parallel Endografts In The Management Of TAAAs And Other Aorto-Iliac Pathology: Why Do They Fail And How To Make Them Work |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | Branched EVAR For TAAA Repair Can Be Performed With Only Transfemoral Access Using Steerable Sheaths: How To Stabilize The Distal End Of The Sheath |
| Presenter(s):Tilo Koelbel, MD, PhD | |
| View Slides in PDF | |
| 8:36 AM - 8:41 AM | With Steerable Sheaths Upper Extremity Access With B/EVAR Is Rarely Necessary: Which Sheath Is Best And Pitfalls To Be Avoided |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
| View Slides in PDF | |
| 8:42 AM - 8:47 AM | Why Balloon Expandable Bridging Stent-Grafts Are Best For F/B/EVAR: Which One Is Best And Why: A US Perspective On The Advantages Of The Gore VBX Stent Graft |
| Presenter(s):Mark A. Farber, MD | |
| View Slides in PDF | |
| 8:48 AM - 8:53 AM | Updated Advantages And Disadvantages Of The BeGraft, BeGraft Plus (Bentley) And Advanta (iCAST™ – Getinge) Bridging Stents For F/B/EVAR: Experience With >2000 Target Vessels |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD | |
| View Slides in PDF | |
| 8:54 AM - 8:59 AM | Advantages Of The Cook Inner Branched Endograft For Repair Of TAAAs: Which Is The Best Covered Stent For The Branches |
| Presenter(s):Martin J. Austermann, MD / Giovanni B. Torsello, MD | |
| View Slides in PDF | |
| 9:00 AM - 9:05 AM Power Point Presentation with Synched Audio |
New Cook Endograft With Bidirectional Inner Branches For B/EVAR: Advantages And Early Results |
| Presenter(s):Nuno V. Dias, MD, PhD | |
| View Slides in PDF | |
| 9:06 AM - 9:11 AM | With Complex AAAs, When F/B/EVAR; When Parallel Grafts; When Open Repair: All Have Their Pros And Cons |
| Presenter(s):Chang Shu, MD | |
| View Slides in PDF | |
| 9:12 AM - 9:17 AM | How To Deal With Bad Necks Or No Necks In AAAs: We Need All Options: Chimneys, Endoanchors, Fenestrated And Branched Solutions: Case Selection Is The Key: How To Do It |
| Presenter(s):Götz M. Richter, MD, PhD | |
| View Slides in PDF | |
| 9:18 AM - 9:26 AM | Panel Discussion |
| 9:26 AM - 9:38 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 48 | |
| SESSION 49 SCHEDULE | |
|
Thursday
SESSION 49:
MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
|
|
| x | |
| 9:38 AM - 9:43 AM | Update On Aortic Neck Dilatation Occurring After F/EVAR: What Causes It And Is It Harmful To Patients |
| Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
| View Slides in PDF | |
| 9:44 AM - 9:49 AM | Percutaneous Femoral And Axillary Access For Complex Endovascular AAA Repair: How To Do It Safely And To Safely Downsize Femoral Sheaths To More Rapidly Restore Lower Extremity Flow: Why Is It Important |
| Presenter(s):Darren B. Schneider, MD | |
| View Slides in PDF | |
| 9:50 AM - 9:55 AM | Use Of Parallel Grafts To Treat Common Iliac Aneurysms And Preserve Hypogastric Flow: Techniques, Advantages Over IBDs, Long-Term Results |
| Presenter(s):Armando C. Lobato, MD, PhD | |
| View Slides in PDF | |
| 9:56 AM - 10:01 AM | Advantages And Short-Comings Of Off-The-Shelf Endografts (Industry Made And Parallel) For Complex AAAs And TAAAs: When Are They Helpful And When Not |
| Presenter(s):Mark A. Farber, MD | |
| View Slides in PDF | |
| 10:02 AM - 10:07 AM | DEBATE: The Case Against Ch/EVAR And Parallel Grafts For Complex AAA And TAAA Repairs: F/B/EVAR Is Much Better |
| Presenter(s):Adam Beck, MD | |
| View Slides in PDF | |
| 10:08 AM - 10:13 AM | DEBATE: Nonsense! Ch/EVAR And Parallel Grafts If Done Right Are As Safe And Effective As F/B/EVAR And In Some Cases Better And Cheaper |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 10:14 AM - 10:19 AM | Parallel Endografts For Aorto-Iliac Lesions: The Good, The Bad And The Ugly: A Balanced View |
| Presenter(s):Grace J. Wang, MD, MSCE | |
| View Slides in PDF | |
| 10:20 AM - 10:25 AM | Pros And Cons Of Inner Versus Outer Branches In Off-The-Shelf Endovascular TAAA Repair |
| Presenter(s):Timothy A. Resch, MD, PhD | |
| View Slides in PDF | |
| 10:26 AM - 10:31 AM | Technical Tips To Deploy F/EVAR Endografts Precisely With Tortuous Anatomy: How To Compensate For Endograft Rotation And Still Match Fenestrations To Branch Orifices Perfectly |
| Presenter(s):Neal S. Cayne, MD / Bjõrn Sonesson, MD, PhD | |
| View Slides in PDF | |
| 10:32 AM - 10:37 AM | Advantages Of Steerable (Variable Curve) Sheaths For Complex AAA And TAAA Repairs And TBADs: Which One Is Best And Why: Pitfalls And How To Prevent Them |
| Presenter(s):W. Anthony Lee, MD | |
| View Slides in PDF | |
| 10:38 AM - 10:43 AM | Although Some Recommend That F/EVAR Always Include 3 Vessels, 2 Vessel F/EVAR Is Effective And Durable In Some Anatomies: Which Ones, Based On A Single Center Experience And Systematic Review |
| Presenter(s):Geert Willem H. Schurink, MD, PhD | |
| View Slides in PDF | |
| 10:44 AM - 10:52 AM | Panel Discussion |
| END OF SESSION 49 | |
| SESSION 50 SCHEDULE | |
|
Thursday
SESSION 50:
A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; INNOVATIVE TECHNOLOGIES SUPPORTED BY THE DEFENSE DEPARTMENT
Moderators:Todd E. Rasmussen, MD, FACS / Wayne F. Yakes, MD
|
|
| x | |
| 10:52 AM - 11:02 AM | Battle of Takur Ghar: 20 US Army Airborne Rangers Go To Rescue 7 Navy Seals And 1 Air Force Spotter Attacked By Over 400 Al-Qaeda Forces And 2 Congressional Medal Of Honor Winners Later In That 17-Hour Battle (10-Minute Talk) |
| Presenter(s):Wayne F. Yakes, MD | |
| View Slides in PDF | |
| 11:03 AM - 11:13 AM | Can The US Military Avoid The Damage Of The “Peace Time Effect” And Recent Wokeness Changes To Maintain Real Combat And Surgical Readiness To Win And Avoid Needless Loss Of Life When The Next War Starts (10-Minute Talk) |
| Presenter(s):Todd E. Rasmussen, MD, FACS | |
| View Slides in PDF | |
| 11:14 AM - 11:24 AM | A Vascular Surgeon’s Impressions About The Terrible War In The Ukraine: Analysis Of Vascular Trauma And Late Outcomes Of Vascular Reconstructions In 70 Wounded Soldiers (10-Minute Talk) |
| Presenter(s):Andriy O. Nykonenko, MD | |
| View Slides in PDF | |
| 11:25 AM - 11:30 AM | Humanitarian Vascular Surgery: A Report On The War In Ukraine And The Role Of Non-Governmental Organizations (NGOs) To Deploy Talent To Combat Zones |
| Presenter(s):Charles J. Fox, MD, FACS | |
| View Slides in PDF | |
| 11:31 AM - 11:36 AM | Update Of Endovascular Resuscitation And Trauma Management: Use Of Catheter Based Treatments, Endografts And Other Devices |
| Presenter(s):Tal M. Hoerer, MD, PhD | |
| View Slides in PDF | |
| 11:37 AM - 11:42 AM | Updated Progress And Precautions With REBOA (Resuscitative Endovascular Balloon Occlusion Of The Aorta): How Will They Make It Worthwhile For Battlefield Hemorrhage And Other Conditions |
| Presenter(s):Jonathan J. Sexton, MD / Brandon Propper, MD | |
| View Slides in PDF | |
| 11:43 AM - 11:48 AM | How Will We Train The Next Generation Of Surgeons To Treat Vascular Trauma: For Military Practice: For Civilian Practice: What Issues Complicate It |
| Presenter(s):Paul W. White, MD | |
| View Slides in PDF | |
| 11:49 AM - 11:54 AM | Update On Isolated Limb Perfusion To Enable Traumatically Amputated Limb Reimplantation |
| Presenter(s):Zachary M. Arthurs, MD | |
| View Slides in PDF | |
| 11:55 AM - 12:00 PM | Unique Aspects Of Major Vascular Injury And Its Treatment In The Ukraine War: From An Experience With Over 700 Major Arterial And Venous Injuries |
| Presenter(s):Yuliia Nahaliuk, MD | |
| View Slides in PDF | |
| 12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 50 | |
| SESSION 51 SCHEDULE | |
|
Thursday
SESSION 51:
PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
|
|
| x | |
| 1:00 PM - 1:05 PM | Complications After EVAR For Ruptured AAAs: How To Prevent Them And How To Treat Them |
| Presenter(s):Tal M. Hoerer, MD, PhD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | The Frequency Of Ruptured AAAs Is Plummeting: What Is The Reason And Why Is It A Challenge To Training And Treatment |
| Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Only One-Third Of Ruptured AAA Patients Were Randomized In The 3 RCTs Comparing EVAR With Open Repair: Why Does That Invalidate The Conclusion Of The RCTs That EVAR Is No Better Than Open Repair |
| Presenter(s):Thomas L. Forbes, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Long-Term Results Of The AJAX RCT Comparing EVAR With Open Repair For Ruptured AAAs: Despite Its Flaws, EVAR Wins In The End – Especially In Patients >80 |
| Presenter(s):Willem Wisselink, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Variation In Use Of EVAR Versus Open Repair For Ruptured AAAs Depends On Training And Bias Rather Than Data, Logic Or Facts: EVAR Is Clearly The Best Treatment If It Can Be Done |
| Presenter(s):Martin Malina, MD, PhD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM Power Point Presentation with Synched Audio |
EVAR Should Be The Standard Of Care For Most Ruptured AAAs: Reasons Why It Is Not So And How To Overcome Them |
| Presenter(s):Hans-Henning Eckstein, MD, PhD / Christoph Knappich, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | A New System For Estimating AAA Wall Weakness From Gated Dynamic CT Scans: A Better Way To Predict Rupture Risk (From ViTAA Medical): How Does It Work And Where Does It Stand |
| Presenter(s):Randy D. Moore, MD / Mark A. Farber, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Outcomes Of Ruptured AAA Repair Are Better In High Volume Institutions Both For EVAR And Open Repair: From A Meta-Analysis With >120,000 Cases |
| Presenter(s):George A. Antoniou, MD. PhD, MSc, FEBVS | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Aortic Endograft Diameter Sizing With Ruptured Aneurysms: Why Is It Different And How To Do It |
| Presenter(s):Zoran Rancic, MD, PhD, EMBA HSG | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | With Ruptured Complex AAAs And TAAAs Parallel Grafts Are The Best Treatment: They Are Simpler, More Effective And Less Costly Than Other Treatments |
| Presenter(s):Manish Mehta, MD, MPH | |
| View Slides in PDF | |
| 2:00 PM - 2:06 PM | Panel Discussion |
| END OF SESSION 51 | |
| SESSION 52 SCHEDULE | |
|
Thursday
SESSION 52:
MORE NEW DEVELOPMENTS IN RUPTURED AAAs AND TAAAs; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
|
|
| x | |
| NEW DEVELOPMENTS IN EVAR SURVEILLANCE AND AAA SCREENING | |
| 2:06 PM - 2:11 PM | Why We Are Doing More EVAR Surveillance Than Is Needed: The EVAR Surveillance Paradox: From A Meta-Analysis Of 23,000 EVAR Patients |
| Presenter(s):George A. Antoniou, MD. PhD, MSc, FEBVS | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Update On Current Screening For AAAs In The US: Most Ruptured AAAs Occur In Patients Not Being Screened: How Should US PSTF Recommendations Be Changed And How Should Screening Groups Be Expanded |
| Presenter(s):Marc L. Schermerhorn, MD / Thomas F.X. O'Donnell, MD | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | New Developments In AAA Screening: Is It Overused Or Underused: Has It Decreased Rupture Rates In Denmark Or Elsewhere: Should We Change Who Is Being Screened |
| Presenter(s):Jes S. Lindholt, MD | |
| View Slides in PDF | |
| MORE ABOUT AAA RUPTURES AND THEIR TREATMENT | |
| 2:24 PM - 2:29 PM | AAA Rupture After EVAR: Endovascular Treatment Is Best In This Setting And How To Do It |
| Presenter(s):David T. McGreevy, MD | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | AAA Rupture After EVAR Behaves Differently From De Novo Rupture: How Should Treatment Be Modified In Patients With Post EVAR Ruptures |
| Presenter(s):Piotr Szopinski, MD, PhD | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | Update On Treating All (100%) Ruptured Thoracic And Abdominal Aneurysms Endovascularly: A 13-Year Experience Shows It Is The Best Treatment And Lowers The Turndown Rate |
| Presenter(s):David T. McGreevy, MD / Thomas Larzon, MD, PhD / Mario L. Lachat, MD / Tal M. Hoerer, MD, PhD | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | Applicability And Results Of Cook t-Branch OTS Endograft In Complex Aortic Aneurysms (Ruptured And Elective) With Narrow Internal Aortic Lumens: Advantages And Limitations |
| Presenter(s):Ciro Ferrer, MD, PhD / Rocco Giudice, MD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | In Situ Laser Fenestration To Facilitate Endograft Treatment Of Ruptured TAAAs: When Is It Needed; How To Do It And Results |
| Presenter(s):Stephan Haulon, MD / Dominique Fabre, MD, PhD | |
| View Slides in PDF | |
| 2:54 PM - 2:59 PM | Role Of In Situ F/EVAR For Treating Ruptured Complex AAAs: How To Do It And Results |
| Presenter(s):Sukgu Han, MD / Fred A. Weaver, MD, MMM | |
| View Slides in PDF | |
| 3:00 PM - 3:05 PM | How Can The Turndown Rate For Invasive Treatment Of Ruptured AAAs Be Decreased And Is It Worthwhile |
| Presenter(s):Matthew W. Mell, MD, MS | |
| View Slides in PDF | |
| 3:06 PM - 3:11 PM | Urgent And Emergent Treatment Of Symptomatic And Ruptured Aortic Pathologies Using Physician Modified Endografts (PMEGs) Based On 3D Aortic Models: Is This A Limited Or Generalizable Technique |
| Presenter(s):Benjamin W. Starnes, MD | |
| View Slides in PDF | |
| 3:12 PM - 3:17 PM | Update On Advances In Treatment Of Abdominal Compartment Syndrome Associated With Ruptured AAAs: When And How To Treat Medically And When And How To Treat With Opening The Abdomen |
| Presenter(s):Martin Björck, MD, PhD | |
| View Slides in PDF | |
| 3:18 PM - 3:30 PM | Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors) |
| END OF SESSION 52 | |
| SESSION 53 SCHEDULE | |
|
Thursday
SESSION 53:
EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
Moderators:Luis A. Sanchez, MD / Reese A. Wain, MD
|
|
| x | |
| ATHERECTOMY RELATED TOPICS | |
| 3:30 PM - 3:35 PM | The CHOCO-CABANA RCT Shows The Chocolate PTA Balloon (From Medtronic) Sustained Increased Lumen Gain Compared To POBA For BTK Lesions |
| Presenter(s):Gunnar Tepe, MD / Andrew Holden, MBChB / Thomas Zeller, MD | |
| View Slides in PDF | |
| 3:36 PM - 3:41 PM | Novel Application Of Polymer Technology To Create Endogenous Tissue With Host Collagen And Endothelium Compatible With Flowing Blood: 1-Year Clinical Results Of The aXess Graft (From Xeltis) |
| Presenter(s):Frans L. Moll, MD, PhD | |
| View Slides in PDF | |
| 3:42 PM - 3:47 PM | Progress With The Retrievable Rescue Stent-Graft To Control Massive Aortic Or Caval Bleeding: How Does It Work, How Is The Device Retrieved And When Will It Be Widely Available |
| Presenter(s):Bryan W. Tillman, MS, PhS | |
| View Slides in PDF | |
| 3:48 PM - 3:53 PM Power Point Presentation with Synched Audio |
Value And Limitations Of The 355 nm Auryon B-Laser™ (From AngioDynamics) For The Treatment Of Infrainguinal Atherosclerotic Disease: Results And How It Can Help Facilitate The Safe Crossing Of Otherwise Uncrossable Lesions |
| Presenter(s):Luis R. Leon, MD, RVT, FACS | |
| View Slides in PDF | |
| 3:54 PM - 3:59 PM | Transradial Approaches With The Terumo R2P System Enable Endovascular Treatment Of Complex Renal, Visceral, And Lower Extremity Stenotic And Occlusive Lesions Including CTOs: Do They Work For Lesions Below The Knee |
| Presenter(s):David O'Connor, MD | |
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | Improving The Function Of A Hybrid Room: What Are The Elements And How Does The “OR Black Box System” Help To Improve Operator Performance And Decrease Radiation Exposure |
| Presenter(s):Isabelle Van Herzeele, MD, PhD | |
| View Slides in PDF | |
| 4:06 PM - 4:11 PM | Update On A Clampless Sutureless Technique For Performing Difficult Arterial Anastomoses Using Endograft Connectors: The VORTEC Technique – Useful When Arterial Dissection, Control And Suturing Are Challenging Or Impossible As With Heavily Calcified Arteries |
| Presenter(s):Mario L. Lachat, MD | |
| View Slides in PDF | |
| 4:12 PM - 4:17 PM | IVUS Studies Before And After PTAs With The Ultrascore Scoring Balloons (From BD) Show The Benefits Of Such Balloons And How They Work |
| Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI | |
| View Slides in PDF | |
| 4:18 PM - 4:23 PM | Femoral Vein Grafts For Arterial Procedures: How To Harvest Them Safely And Expeditiously Without Consequences To The Donor Limb: When Can They Be Uniquely Beneficial |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 4:24 PM - 4:31 PM | Panel Discussion |
| END OF SESSION 53 | |
| SESSION 54 SCHEDULE | |
|
Thursday
SESSION 54:
PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
Moderators:Lindsay Machan, MD / Glenn Jacobowitz, MD
|
|
| x | |
| WHAT’S NEW IN RADIATION SAFETY | |
| 4:32 PM - 4:37 PM | Myths And Facts Regarding Radiation Protection And Safety: Imperfections In Protection From Leaded Glasses And Light Weight Leaded Gowns |
| Presenter(s):Lindsay Machan, MD | |
| View Slides in PDF | |
| 4:38 PM - 4:43 PM | Cancer Risk To Patients And Operators From Radiation Exposure From EVAR Peri- And Post-Operatively: Role Of Radiation Sparing Technologies |
| Presenter(s):Bijan Modarai, PhD, FRCS | |
| View Slides in PDF | |
| 4:44 PM - 4:49 PM | Small Tips And Modifications In Radiation Safety Can Make A Huge Impact On Staff Exposure: What Are They |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 4:50 PM - 4:56 PM | Panel Discussion |
| NEW CONCEPTS, ETC. | |
| 4:56 PM - 5:01 PM | The No Intervention Option For Treatment Is More Commonly Elected For Women Than Men With CLTI, AAAs, Ruptured AAAs And Thoracic Aneurysms: It Is Wrong Headed And Unfair: From The WARRIORS Trial |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 5:02 PM - 5:07 PM | Endovascular Emergency Treatment Of Carotid Blowout From Head And Neck Cancer Or Carotid Patch Infections: Planning, Preparation And Technical Tips Are Essential |
| Presenter(s):Michael B. Silva, Jr., MD | |
| View Slides in PDF | |
| 5:08 PM - 5:13 PM | Hybrid Superficial Venous Arterialization For REAL No Option CLTI; Step-By-Step Technical Tips And Patterns Of Failure Which Is Common |
| Presenter(s):Miguel F. Montero-Baker, MD / John H. Rundback, MD, FSIR, FAHA, FSVMB | |
| View Slides in PDF | |
| 5:14 PM - 5:19 PM | What's New In Transvenous Liver Biopsies |
| Presenter(s):Jacob Cynamon, MD, FACR, FSIR | |
| View Slides in PDF | |
| 5:20 PM - 5:25 PM | Management Of Pediatric Vascular Trauma: Evolving Endovascular Strategies, Expanded Device Availability, Technical Tips And How To Deal With Spasm |
| Presenter(s):Dawn M. Coleman, MD, FACS | |
| View Slides in PDF | |
| 5:26 PM - 5:31 PM | The Aortyx Aortic Patch: A More Compliant Way To Seal Aortic Defects: A New Endovascular Approach: How Does It Work, Improved Delivery System And Progress To Date |
| Presenter(s):Vicente Riambau, MD, PhD | |
| View Slides in PDF | |
| 5:32 PM - 5:37 PM | Results From The AFX2-LIVE Registry: An Experience With The Outcomes Of >500 AFX EVAR Cases: Benefits, Complications And Conversions |
| Presenter(s):Pasqualino Sirignano, MD, PhDS / Francesco Speziale, MD | |
| View Slides in PDF | |
| 5:38 PM - 5:43 PM | With Esophageal Cancer, When Is Prophylactic TEVAR Indicated To Prevent An Aorto-Esophageal Fistula: It Improves Palliation But Does It Improve Survival |
| Presenter(s):I-Hui Wu, MD, PhD | |
| View Slides in PDF | |
| 5:44 PM - 5:49 PM | Digital Patient Data: Artificial Intelligence (AI), Machine Learning (ML) And Sensor Technology In The New Era Of Research And Clinical Medicine: What Are They And Why You Better Get Ready |
| Presenter(s):Peter A. Schneider, MD | |
| View Slides in PDF | |
| 5:50 PM - 5:58 PM | Panel Discussion End of Program G |
| END OF SESSION 54 | |
| SESSION 55 SCHEDULE | |
|
Thursday
SESSION 55:
NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR
|
|
| x | |
| 7:00 AM - 7:05 AM | Real World Outcomes With The TREO Endograft (Terumo Aortic): Results From The TIGER Registry |
| Presenter(s):Vicente Riambau, MD, PhD | |
| View Slides in PDF | |
| 7:06 AM - 7:11 AM | Update On The Gore Conformable Excluder With Variable Neck Angulation Control For AAAs: Does It Enable EVARs In Patients With Otherwise Unsuitable Necks: Update On Status Of The IDE Trial And FDA Approval |
| Presenter(s):Robert Y. Rhee, MD | |
| View Slides in PDF | |
| 7:12 AM - 7:17 AM | UK Status Of The Gore Conformable Excluder For EVAR: Results From The CLEVAR Registry: CE Marked Since 2016 |
| Presenter(s):Colin D. Bicknell, MD, FRCS / Marc R.H.M. van Sambeek, MD, PhD | |
| View Slides in PDF | |
| 7:18 AM - 7:23 AM | Altura Endograft With Kissing Proximal Stents For Standard EVAR: Advantages And Limitations: From An Updated Experience With >150 Patients And 5-Year Follow-Up |
| Presenter(s):Dainis K. Krievins, MD | |
| View Slides in PDF | |
| 7:24 AM - 7:29 AM | Advantages And Limitations Of The Cook ZENITH Alpha (Low Profile) Endograft For EVAR: Based On 3-Year Results Of The European Multicenter ZEPHYR TRIAL |
| Presenter(s):Philippe W.M. Cuypers, MD, PhD / Marc R.H.M. van Sambeek, MD, PhD / Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 7:30 AM - 7:35 AM | Panel Discussion |
| 7:36 AM - 7:41 AM | How And Why Do The Endurant Endograft Results For EVAR In France Differ From The Global Results: What Are The Implications |
| Presenter(s):Frank R. Arko, MD / Jean Pierre Becquemin, MD, FRCS | |
| View Slides in PDF | |
| 7:42 AM - 7:47 AM | AAA Repairs With The Endurant Endograft Outside The IFU Can Provide Acceptable Results In Some Patients: When Is This So And When Not: From The EAGLE Registry |
| Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
| View Slides in PDF | |
| 7:48 AM - 7:53 AM | Head To Head Comparison Of Endurant And Excluder Endografts For EVAR In Challenging Asian AAA Anatomy |
| Presenter(s):Naoki Fujimura, MD, PhD | |
| View Slides in PDF | |
| 7:54 AM - 7:59 AM | AFX 2 Anatomically Fixed Endografts For AAA Repair: The LEOPARD RCT 5-Year Results Show It Has Similar Outcomes To Other Widely Used Proximally Fixed Endografts |
| Presenter(s):Christopher J. Kwolek, MD, MBA | |
| View Slides in PDF | |
| 8:00 AM - 8:05 AM | Why AFX Endografts Work Well In Conical (Flared) AAA Necks: Favorable 3-Year Results And Are There Disadvantages |
| Presenter(s):Naoki Fujimura, MD, PhD | |
| View Slides in PDF | |
| 8:06 AM - 8:11 AM | Panel Discussion |
| END OF SESSION 55 | |
| SESSION 56 SCHEDULE | |
|
Thursday
SESSION 56:
NEW OR UPDATED DEVICES FOR STANDARD EVAR, EVAS (ENDOVASCULAR ANEURYSM SEALING) AND F/EVAR; ENDOGRAFTS FOR TREATMENT OF CONNECTIVE TISSUE DISORDERS
Moderators:James H. Black, III, MD / Margaret Tracci, MD, JD
|
|
| x | |
| 8:12 AM - 8:17 AM | Alto Endograft (From Endologix) For Standard EVAR: This Latest Modification Of The Ovation Endograft Has More Proximal Polymer Sealing Rings: Results From The ELEVATE Trial And 4+-Year Results From The New Zealand Experience Show Advantages: What Is The JAGUAR RCT |
| Presenter(s):Sean P. Lyden, MD / Andrew Holden, MBChB | |
| View Slides in PDF | |
| 8:18 AM - 8:23 AM | Update On The Alto Ultra Low-Profile Endograft With Adaptive Sealing Technology (From Endologix): From The ALTAIR Registry With Long-Term Results |
| Presenter(s):Gianmarco de Donato, MD | |
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | Experience With The Nellix Endograft In 120 Patients With Up To 10 Years Follow-Up: What Is The Device's Future |
| Presenter(s):Dainis K. Krievins, MD | |
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | Update Of A New Hybrid Device (Thoracoflo From Terumo Aortic) For TAAA Repair: How It Works, Clinical Experience And Advantages |
| Presenter(s):Sabine H. Wipper, MD, PhD / Sebastian E. Debus, MD, PhD / Tilo Koelbel, MD, PhD | |
| View Slides in PDF | |
| F/EVAR RELATED TOPICS | |
| 8:36 AM - 8:41 AM | Technical Tips To Perform F/EVAR Through Unilateral Iliac Access: Useful When Contralateral Access Is Impossible |
| Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 8:42 AM - 8:47 AM | Update On Multicenter Real World Results With F/EVAR Using The Fenestrated Anaconda (Terumo Aortic) Endograft: Advantages And Limitations |
| Presenter(s):Clark J. Zeebregts, MD, PhD / Michel M.P. Reijnen, MD, PhD / Afshin Assadian, MD | |
| View Slides in PDF | |
| ENDOVASCULAR AORTIC REPAIRS FOR CONNECTIVE TISSUE DISORDERS | |
| 8:48 AM - 8:53 AM | Endovascular Repairs In Genetic Connective Tissue Aortopathies: How Genotype-Surgical Phenotype Correlation Impacts Endovascular Repair Outcomes |
| Presenter(s):Sherene Shalhub, MD, MPH | |
| View Slides in PDF | |
| 8:54 AM - 8:59 AM | F/B/EVAR In Patients With Connective Tissue Disorders: When And When Not: How Well Do They Work And When Not To Do Them |
| Presenter(s):Piergiorgio Cao, MD, FRCS | |
| View Slides in PDF | |
| 9:00 AM - 9:05 AM | Value Of Endo TAAA Repair In Patients With Connective Tissue Disorders And Why Is The Gap Between Fenestration And Aortic Wall Important In F/EVAR |
| Presenter(s):Gustavo S. Oderich, MD, FACS | |
| View Slides in PDF | |
| 9:06 AM - 9:20 AM | Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 56 | |
| SESSION 57 SCHEDULE | |
|
Thursday
SESSION 57:
NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH
Moderators:Tilo Koelbel, MD, PhD / Rodney A. White, MD
|
|
| x | |
| 9:20 AM - 9:25 AM | Endovascular Repair Of Aortic Arch Lesions With In Situ Fenestration Of A Lifetech Endograft For The Graft Vessels As An Alternative To Branched Endografts |
| Presenter(s):Ralf R. Kolvenbach, MD | |
| View Slides in PDF | |
| 9:26 AM - 9:31 AM | Changes In The Aortic Valve And Aortic Morphometrics After Ascending Aorta And Arch Endograft Placement |
| Presenter(s):Jean Bismuth, MD / Ross Milner, MD | |
| View Slides in PDF | |
| 9:32 AM - 9:37 AM | New Developments With Terumo Ascending Aorta Endograft |
| Presenter(s):Vicente Riambau, MD, PhD / Afshin Assadian, MD / Mo S. Hamady, MD, FRCR, EBIR, FSIR | |
| View Slides in PDF | |
| 9:38 AM - 9:43 AM | Status In The US Of The Relay Branch Investigational Device (Terumo Aortic) For Repair Of Aortic Arch Lesions: How Many Branches Can And Should Be Revascularized: Advantages And Limitations |
| Presenter(s):Luis A. Sanchez, MD / Eric E. Roselli, MD | |
| View Slides in PDF | |
| 9:44 AM - 9:49 AM | Nexus OTS Endograft From Endospan For Treating Zone 0 And 1 Lesions Of The Aortic Arch: How Does It Work And 4-Year Clinical Results: Status In The US |
| Presenter(s):Mario L. Lachat, MD / Ross Milner, MD / Jean M. Panneton, MD / Andrew Holden, MBChB / Daniel G. Clair, MD / Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 9:50 AM - 9:55 AM | Status Of And When And How To Use The Gore Conformable CTAG Endograft With Variable Angulation Control Optimally: Advantages And Limitations |
| Presenter(s):Sukgu Han, MD | |
| View Slides in PDF | |
| 9:56 AM - 10:02 AM | Panel Discussion |
| END OF SESSION 57 | |
| SESSION 58 SCHEDULE | |
|
Thursday
SESSION 58:
NEW OR IMPROVED DEVICES FOR THORACIC AORTIC LESION REPAIRS (TEVAR) AND FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS
Moderators:Giovanni B. Torsello, MD / Carlos H. Timaran, MD
|
|
| x | |
| DEVICES FOR TEVAR | |
| 10:02 AM - 10:07 AM | Low Profile Devices For TEVAR And B/EVAR: Disadvantages And Advantages Based On A 10-Year Experience With Matched Patients |
| Presenter(s):Giovanni B. Torsello, MD | |
| View Slides in PDF | |
| 10:08 AM - 10:13 AM | Long-Term Results With The Cook ZENITH Alpha Thoracic Endograft For TEVAR In More Than 500 Patients In A Real World 10-Year Experience |
| Presenter(s):Germano C.G. Melissano, MD / Roberto L.V. Chiesa, MD | |
| View Slides in PDF | |
| 10:14 AM - 10:19 AM | A Modified Candy Plug Technique For False Lumen Treatment After TEVAR For TBAD |
| Presenter(s):Ali Azizzadeh, MD | |
| View Slides in PDF | |
| 10:20 AM - 10:25 AM | Fenestrated Endovascular Aortic Repair Plus Chimney Graft For TAAA Repairs: The FEVARCh Technique |
| Presenter(s):Ross Milner, MD | |
| View Slides in PDF | |
| 10:26 AM - 10:31 AM | Urgent And Emergent Endovascular Repair Of Complex AAAs And TAAAs Are Possible With Off-The-Shelf (OTS) Devices And PMEGs: When Are OTS Devices Preferable |
| Presenter(s):Bernardo C. Mendes, MD | |
| View Slides in PDF | |
| 10:32 AM - 10:37 AM | Panel Discussion |
| 10:37 AM - 10:42 AM | The Relay Pro (Terumo Aortic) Endograft For TEVAR And Its Advantages In Treating TBADs: Why Is It Better Than The Older Relay Plus Device |
| Presenter(s):Javairiah Fatima, MD / Steven D. Abramowitz, MD / Edward Y. Woo, MD | |
| View Slides in PDF | |
| 10:43 AM - 10:48 AM Power Point Presentation with Synched Audio |
Patient Specific Custom Designed Relay Pro Endografts (Terumo Aortic): How Do They Work And What Are Their Advantages In Various Circumstances |
| Presenter(s):David M. Williams, MD / Mazin Foteh, MD | |
| View Slides in PDF | |
| 10:49 AM - 10:54 AM | Relay Custom-Made Endografts (Terumo Aortic) For TEVAR: Why Do They Provide Better Wall Apposition For Sealing |
| Presenter(s):Fadi Taher, MD / Afshin Assadian, MD | |
| View Slides in PDF | |
| NEW OR IMPROVED ENDO DEVICES FOR TAAA REPAIRS | |
| 10:55 AM - 11:00 AM | The Novel Artivion (Formerly CryoLife/Jotec) Off-The-Shelf (OTS) Inner Branched Device For TAAAs: Results And Why Is It Better Than Outer Branched OTS Devices: Are There Limitations |
| Presenter(s):Lee Bouwman, MD, PhD | |
| View Slides in PDF | |
| 11:01 AM - 11:16 AM | Colt 2.0 – The Technology That Evolved From An Outer To Multi Inner Branched Device: How It Works And Mid-Term Outcomes |
| Presenter(s):Piotr Szopinski, MD, PhD | |
| View Slides in PDF | |
| 11:07 AM - 11:12 AM | To Treat Complex TAAAs: Combination Of Relay (Terumo Aortic) TEVAR And Fenestrated And Branched EVAR Is Best: How Has The Treatment Evolved: Technical Tips And Outcomes |
| Presenter(s):Mo S. Hamady, MD, FRCR, EBIR, FSIR | |
| View Slides in PDF | |
| 11:13 AM - 11:18 AM | Panel Discussion |
| 11:19 AM - 11:24 AM | Preloaded Fenestrated Endografts With A Modified Biport Handle (From Cook): A Way To Make F/EVAR Easier: Results From An International Multicenter Study |
| Presenter(s):Nikolaos Tsilimparis, MD, PhD | |
| View Slides in PDF | |
| 11:25 AM - 11:30 AM | Comparison Of The Cook t-Branch OTS Endograft Device With The E-nside (Artivion) Multibranched Device For Juxta- And Pararenal AAAs: Advantages And Limitations Of Each |
| Presenter(s):Matteo Orrico, MD / Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 11:31 AM - 11:36 AM | Comparison Of 2 OTS Endografts For Urgent TAAA Repairs: E-nside (Artivion) Versus t-Branch (Cook): Advantages And Disadvantages Of Each |
| Presenter(s):Luca Bertoglio, Professor / Roberto L.V. Chiesa, MD / Germano C.G. Melissano, MD | |
| View Slides in PDF | |
| 11:37 AM - 11:42 AM | Valiant Manifold OTS Endograft Device (Medtronic) For Repairing TAAAs: How Does It Work; Update On Clinical Experience And Future Prospects |
| Presenter(s):Murray L. Shames, MD | |
| View Slides in PDF | |
| 11:43 AM - 11:48 AM | Innovative Treatment Of The Thoracoabdominal And Pararenal Aortic Aneurysms Using Fenestrated TREO Endografts (Terumo) And Parallel VBX Stent-Grafts (Gore): Use Of The Shape Memory Impede-FXPlug To Treat Gutter Endoleaks |
| Presenter(s):James F. McKinsey, MD | |
| View Slides in PDF | |
| 11:49 AM - 11:54 AM | Is There A Role For Hyperbaric Oxygen Therapy In Preventing Or Treating Spinal Cord Ischemia After TAAA Repair |
| Presenter(s):Thomas F. Lindsay, MDCM, FRCS | |
| View Slides in PDF | |
| 11:55 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 58 | |
| SESSION 59 SCHEDULE | |
|
Thursday
SESSION 59:
NEW OR UPDATED INFORMATION ON RE-ENTRY DEVICES, LOWER EXTREMITY PROSTHETIC GRAFTS (SEE ALSO SESSION 28), PERIGRAFT SEROMA AND VALUE OF A PROSTHETIC PERIGRAFT SIROLIMUS PATCH
Moderators:Samuel R. Money, MD, MBA / Patrick J. Lamparello, MD
|
|
| x | |
| A NEW LOOK AT RE-ENTRY DEVICES | |
| 1:00 PM - 1:05 PM | Pros And Cons Of Re-Entry Devices In Treating CTOs: Why, Where And When To Use Them |
| Presenter(s):Maria A. Ruffino, MD, EBIR, FCIRSE | |
| View Slides in PDF | |
| PROSTHETIC GRAFTS | |
| 1:06 PM - 1:11 PM | Final 5-Year Results Of The ZILVERPASS RCT Comparing Prosthetic PTFE Bypasses With Zilver PTX (Cook) Stents To Treat Long Fempop Lesions: Clinical And Financial Results And Their Implications |
| Presenter(s):Michel J. Bosiers, MD / Marc Bosiers, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | The BioMimics 3D Spiral Flow Prosthetic Graft From Veryan Medical: Does It Prevent Neointimal Hyperplasia In Leg Bypasses Or A-V Access |
| Presenter(s):Hosam F. El Sayed, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Heparin Coated (Propaten) PTFE Grafts (Gore) Versus Autologous Vein Grafts For Bypasses To Targets Above And Below The Knee: The Heparin Coated Grafts Are Better And Worth The Cost: Based On A Propensity Matching Analysis |
| Presenter(s):David J. Dexter, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Perigraft Seromas After PTFE Lower Extremity And Aortic Arterial Grafts: Frequency, Etiology And What To Do About Them |
| Presenter(s):Jae S. Cho, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Update On External Sirolimus Patch Wrap-Arounds For PTFE Graft Anastomoses: Do They Decrease Neointimal Hyperplasia |
| Presenter(s):Sriram S. Iyer, MD; FACC | |
| 1:36 PM - 1:42 PM | Panel Discussion |
| END OF SESSION 59 | |
| SESSION 60 SCHEDULE | |
|
Thursday
SESSION 60:
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, TACKS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
|
|
| x | |
| 1:42 PM - 1:47 PM | The Serranator® Balloon Catheter (From Cagent Vascular) For Vessel Prep In BTK Arteries: It Makes Microserrations, Prevents Dissections, Lessens Elastic Recoil With PTA: Current Status |
| Presenter(s):Steven Kum, MD / Andrew Holden, MBChB | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | A Balanced View Of Atherectomy In Ambulatory Surgicenters (ASCs) And OBLs In 2023: Are There Differences And Is The Procedure Overused |
| Presenter(s):Krishna Jain, MD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | Atherectomy: When Is It The Best Vessel Prep: What Are Its Complications: How To Prevent And Treat Them: Which Device Is Best |
| Presenter(s):Theodosios Bisdas, MD | |
| View Slides in PDF | |
| 2:00 PM - 2:05 PM | Orbital And Laser Atherectomy: Indications, Advantages And Precautions With Above And Below Knee De Novo Lesions And ISR |
| Presenter(s):Craig M. Walker, MD | |
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | The Value Of Directional Atherectomy Followed By DCBs For Long Calcified Fempop Lesions As Demonstrated By The Results Of The REALITY Trial |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Value of Wingman Catheter (Reflow Medical) For Crossing Difficult Lesions: How Does It Work And Results |
| Presenter(s):John R. Laird, MD | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | New Dedicated Special Tools And Devices To Facilitate Trans-Radial Access For Lower Extremity Lesion Treatments: How Far Distally Can It Be Effective |
| Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) | |
| View Slides in PDF | |
| 2:24 PM - 2:30 PM | Panel Discussion |
| NEW INFORMATION ON STENTS | |
| 2:30 PM - 2:35 PM | Advantages Of Supera Stent (Vasculomimetic – VMI; From Abbott) For Complex Fempop Occlusive Lesions: Technical Tips: They Work Even In The Subintimal Position |
| Presenter(s):Erwin Blessing, MD | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | Updated Value Of The Supera VMI Stent For Common Femoral Artery (CFA) Occlusive Lesions: Better Than Endarterectomy: 3-Year Results And Status Of The SUPERSURG RCT (Versus Open Surgery) |
| Presenter(s):Yann Gouëffic, MD, PhD | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | Why Are Stents In The Common Femoral Artery (CFA) Bad News: Standard Open Surgery Is Still The Best Option For Treating CFA Lesions |
| Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | Temporary Stent Assisted DCB Angioplasty In BTK Lesions With The Spur Spiked Stent System (Reflow Medical): Update On The DEEPER OUS Trial |
| Presenter(s):Thomas Zeller, MD | |
| View Slides in PDF | |
| 2:54 PM - 2:59 PM | 10-Year Experience With Transcatheter Arterialization Of The Deep Veins: My Early Failures; The Lessons I Have Learned; How I Do Them Now With More Success: Can It Be Improved More: Value Of The LimFlow Device |
| Presenter(s):Steven Kum, MD | |
| View Slides in PDF | |
| 3:00 PM - 3:06 PM | Panel Discussion |
| 3:06 PM - 3:18 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 60 | |
| SESSION 61 SCHEDULE | |
|
Thursday
SESSION 61:
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOONS
Moderators:John R. Laird, MD / Thomas Zeller, MD
|
|
| x | |
| 3:18 PM - 3:23 PM | Subset Analysis From The TOBA II BTK Trial Of The Tack Device (From Philips) Shows No Loss Of Efficacy With Treatment Of Longer Lesions And A High Percentage Of CTOs |
| Presenter(s):Patrick J... Geraghty, MD | |
| View Slides in PDF | |
| 3:24 PM - 3:29 PM | Value Of High-Pressure Non-Compliant Balloons For BTK Arterial Lesion Treatment: Why They Work Better And Other Technical Tips |
| Presenter(s):Steven Kum, MD | |
| View Slides in PDF | |
| 3:30 PM - 3:35 PM | How To Obtain Retrograde Access Through The Medial Or Lateral Plantar Arteries |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| View Slides in PDF | |
| 3:36 PM - 3:41 PM | Value Of The Passeo-18Lux DCB For Treating BTK And Popliteal Lesions With Or Without Bare Metal Stents |
| Presenter(s):Gunnar Tepe, MD | |
| View Slides in PDF | |
| 3:42 PM - 3:47 PM | Unfavorable Balloon (Candy) Wrap Can Cause Dissections With Angioplasty: What Is The Mechanism: How Can It Be Recognized And Dissection Avoided: When Does Dissection Have To Be Treated And When Not |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| View Slides in PDF | |
| 3:48 PM - 3:53 PM | Evidence-Based Considerations For Repairing Dissections After Angioplasty Of BTK Lesions: The Value Of Tacks |
| Presenter(s):Andrew Holden, MBChB | |
| View Slides in PDF | |
| 3:54 PM - 3:59 PM | Chocolate Touch DCBs (From TriReme Medical): How Do They Work, Advantages And Updated Clinical Results From The CHOCALATE TOUCH Trial |
| Presenter(s):Thomas Zeller, MD / Andrew Holden, MBChB | |
| View Slides in PDF | |
| 4:00 PM - 4:06 PM | Panel Discussion |
| END OF SESSION 61 | |
| SESSION 62 SCHEDULE | |
|
Thursday
SESSION 62:
NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
Moderators:William D. Jordan Jr., MD / Jean-Paul de Vries, MD, PhD
|
|
| x | |
| 4:06 PM - 4:11 PM | Endoanchors Improve Seal Zones And Outcomes With Fenestrated Endografts: When Should They Be Used And Technical Tips |
| Presenter(s):Shadi J. Abu-Halimah, MD | |
| View Slides in PDF | |
| 4:12 PM - 4:17 PM | New Developments From The ANCHOR Registry With Over 5 Years Of Follow-Up Show The Value Of Endoanchors (Medtronic) When Used Prophylactically For Certain Indications Prevent Endoleaks And Migration: Large Diameter Necks Are One Of Those Indications |
| Presenter(s):William D. Jordan Jr., MD | |
| View Slides in PDF | |
| 4:18 PM - 4:23 PM | New Developments From The ANCHOR Registry With >5 Years Follow-Up Show That Endoanchors Can Be Used To Treat Endoleaks And Migration Effectively In Hostile Neck Anatomy: The Proof |
| Presenter(s):Jean-Paul de Vries, MD, PhD | |
| View Slides in PDF | |
| 4:24 PM - 4:29 PM | Update On The VESTECK Catheter Based Endosuturing Technology For EVAR And TEVAR Fixation: How Does It Work; How Is It Different From Endoanchors And Early Successful Clinical Results |
| Presenter(s):Dainis K. Krievins, MD / Sean P. Lyden, MD / David H. Deaton, MD, FACS | |
| View Slides in PDF | |
| 4:30 PM - 4:35 PM | Balloon Optimized Molding For Better Deployment And Sealing Of Ovation Alto (From Endologix) Low Profile Endografts For EVAR: How To Do It And How It Helps Prevent Endoleaks And Migration |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 4:36 PM - 4:42 PM | Panel Discussion |
| END OF SESSION 62 | |
| SESSION 63 SCHEDULE | |
|
Thursday
SESSION 63:
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
Moderators:James F. Benenati, MD / Timothy M. Sullivan, MD
|
|
| x | |
| CLOT REMOVING DEVICES | |
| 4:42 PM - 4:47 PM | Newer Pharmaco-Mechanical Endovascular Clot Removal Systems: When And Why Is Each Device Best To Use |
| Presenter(s):Guillermo A. Escobar, MD | |
| View Slides in PDF | |
| 4:48 PM - 4:53 PM | Catheter Based Vacuum Assisted Thrombectomy With The Indigo Aspiration System From Penumbra For Acute Limb Ischemia: How Does It Work: Advantages And Limitations: From A Multicenter Study: Key Findings From The INDIAN Trial |
| Presenter(s):Gianmarco de Donato, MD / Carlo Setacci, MD | |
| View Slides in PDF | |
| 4:54 PM - 4:59 PM | Improved Mechanical Catheter And Computer Based Clot Removal Indigo Systems From Penumbra: Modulated Pulsed Aspiration Technology (Lightning Bolt And Thunder Bolt) For The Treatment Of Acute Arterial Clot: How It Works And Why It Improves Clot Removal In Various Vascular Beds |
| Presenter(s):James F. Benenati, MD | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | Different Options For Thrombosuction Devices For Thrombo-Embolectomy For Treating ALI: Which Device In Which Circumstance: When Is Their Use Limited Or Ineffective |
| Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
| View Slides in PDF | |
| 5:06 PM - 5:11 PM | Technical Tips For Effective Coil Embolization: Importance Of Dense Packing; Why Non-Fibered Coils Are Better Than Fibered Coils |
| Presenter(s):James F. Benenati, MD / Constantino Pena, MD | |
| View Slides in PDF | |
| 5:12 PM - 5:17 PM | How To Treat Type 1A Endoleaks And Persistent Enlarging False Lumens After TEVAR For TBAD: Coils, Plugs And New Polymer Based Options: When Will They Work; When Will They Not: Technical Tips |
| Presenter(s):Mazin Foteh, MD | |
| View Slides in PDF | |
| 5:18 PM - 5:23 PM | Newer Vascular Occlusion Device: The Azur Device: How Does It Work And Advantages And Limitations |
| Presenter(s):Karthik Kasirajan, MD | |
| View Slides in PDF | |
| 5:24 PM - 5:29 PM | How To Insert Large Vessel Embolization Devices (POD® From Penumbra) Through Low Profile Access |
| Presenter(s):Frank R. Arko, MD | |
| View Slides in PDF | |
| 5:30 PM - 5:35 PM | Update On Onyx Liquid Embolic Occlusive Agent (From Medtronic): When And Where Is It Advantageous: Technical Tips For Use |
| Presenter(s):Tal M. Hoerer, MD, PhD | |
| View Slides in PDF | |
| 5:36 PM - 5:41 PM | Update On A New Liquid Embolic Agent (Lava LES) To Control Bleeding; How Does It Work, Advantages And Pivotal Trial Results |
| Presenter(s):Mahmood Razavi, MD | |
| View Slides in PDF | |
| 5:42 PM - 5:52 PM | Panel Discussion End of Program H |
| END OF SESSION 63 | |
| SESSION 64 SCHEDULE | |
|
Thursday
SESSION 64:
VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
|
|
| x | |
| 7:00 AM - 7:04 AM | Introduction To Veins At VEITH |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| 7:05 AM - 7:10 AM | Anatomy And Physiology Of The Venous And Lymphatic Glycocalyx |
| Presenter(s):Joseph D. Raffetto, MD | |
| View Slides in PDF | |
| 7:11 AM - 7:16 AM | What Happens When The Glycocalyx Is Damaged In The Venous And/Or The Lymphatic System |
| Presenter(s):Sergio Gianesini, MD, PhD, FACS | |
| View Slides in PDF | |
| 7:17 AM - 7:22 AM | What We Know About Genetics And Venous Disease |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh / Sarah Onida, MD, PhD | |
| View Slides in PDF | |
| 7:23 AM - 7:28 AM | Is It Time To Revise The Definition Of Venous Reflux |
| Presenter(s):Fedor Lurie, MD, PhD | |
| View Slides in PDF | |
| 7:29 AM - 7:34 AM | How To Measure DUS Venous Reflux Volume: Is It More Important Than Reflux Time |
| Presenter(s):Sergio Gianesini, MD, PhD, FACS | |
| View Slides in PDF | |
| 7:35 AM - 7:40 AM | What Can Be Done To Repair Endogenously Or Exogenously The Glycocalyx |
| Presenter(s):Joseph D. Raffetto, MD | |
| View Slides in PDF | |
| 7:41 AM - 7:46 AM | Hemodynamics Of Reflux |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| View Slides in PDF | |
| 7:47 AM - 7:52 AM | Panel Discussion |
| END OF SESSION 64 | |
| SESSION 65 SCHEDULE | |
|
Thursday
SESSION 65:
VENOUS GUIDELINES, IMPORTANT PAPERS AND REIMBURSEMENT
Moderators:Peter Gloviczki, MD / Armando Mansilha, MD, PhD, FEBVS
|
|
| x | |
| 7:53 AM - 7:58 AM | European Society for Vascular Surgery Venous Guidelines |
| Presenter(s):Armando Mansilha, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 7:59 AM - 8:04 AM | SVS, AVF, AVLS Varicose Vein Guidelines – Part 1 |
| Presenter(s):Peter F. Lawrence, MD | |
| View Slides in PDF | |
| 8:05 AM - 8:10 AM | SVS, AVF, AVLS Varicose Vein Guidelines – Part 2 |
| Presenter(s):Peter Gloviczki, MD | |
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | So Many Different Guidelines: Does It Make Sense |
| Presenter(s):Armando Mansilha, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 8:17 AM - 8:22 AM | Summary Of Important Venous And Lymphatic Articles – Journal of Phlebology – Editor’s Choice |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
| View Slides in PDF | |
| 8:23 AM - 8:28 AM | Summary Of Important Venous And Lymphatic Articles – |
| Presenter(s):Peter Gloviczki, MD | |
| View Slides in PDF | |
| 8:29 AM - 8:34 AM | Primary Venous Insufficiency Increases Risk Of Deep Vein Thrombosis |
| Presenter(s):Maxim Shaydakov, MD, PhD | |
| View Slides in PDF | |
| 8:35 AM - 8:40 AM | Forecast Of Venous Reimbursement And What Can Be Done |
| Presenter(s):John Blebea, MD, MBA | |
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | Sclerotherapy Of Lower Limb - Consensus Document UIP 2023 |
| Presenter(s):Sergio Gianesini, MD, PhD, FACS | |
| View Slides in PDF | |
| 8:47 AM - 8:52 AM | Panel Discussion |
| View Slides in PDF | |
| END OF SESSION 65 | |
| SESSION 66 SCHEDULE | |
|
Thursday
SESSION 66:
SUPERFICIAL VEIN TREATMENT STRATEGIES 1
Moderators:Edward G. Mackay, MD / Kursat A. Bozkurt, MD
|
|
| x | |
| 8:53 AM - 8:58 AM | The Length Of Treated Great Saphenous Vein As A Marker Of Post-Procedural Improvement In Clinical And Patient Reported Outcomes |
| Presenter(s):Faisal Aziz, MD | |
| View Slides in PDF | |
| 8:59 AM - 9:04 AM | Is Cyanoacrylate Safe To Use For Venous Ablation |
| Presenter(s):Kursat A. Bozkurt, MD | |
| View Slides in PDF | |
| 9:05 AM - 9:10 AM | What Do You Treat First In C2s With Reflux Of The GSV, SSV, And Vein Of Giacomini |
| Presenter(s):Jean Luc Gerard, MD | |
| View Slides in PDF | |
| 9:11 AM - 9:16 AM | Saphenous Sparing: Why And Instructions For Users |
| Presenter(s):Sergio Gianesini, MD, PhD, FACS | |
| View Slides in PDF | |
| 9:17 AM - 9:22 AM | Thermal Saphenous Vein Recanalization: Risk Factors |
| Presenter(s):Edward G. Mackay, MD | |
| View Slides in PDF | |
| 9:23 AM - 9:28 AM | Strategies For Recurrent Varicose Vein Disease |
| Presenter(s):Felipe Coelho Neto, MD, MSc, PhD | |
| View Slides in PDF | |
| 9:29 AM - 9:34 AM | US Glue: When I Do Not Use Cyanoacrylate |
| Presenter(s):Kathleen D. Gibson, MD | |
| View Slides in PDF | |
| 9:35 AM - 9:40 AM | Synchronous Trial 6 Months Follow-Up Data (Simultaneous AASV Treatment For Patients Undergoing GSV Ablation) |
| Presenter(s):Tobias Hirsch, MD | |
| View Slides in PDF | |
| 9:41 AM - 9:46 AM | Effects Of Truncal Ablation On Pregnancy |
| Presenter(s):Kursat A. Bozkurt, MD | |
| View Slides in PDF | |
| 9:47 AM - 9:52 AM | Saphenous Ablation On Direct Oral Anticoagulants: Is It Safe, Effective And Durable |
| Presenter(s):Glenn Jacobowitz, MD | |
| View Slides in PDF | |
| 9:53 AM - 9:58 AM | Panel Discussion |
| END OF SESSION 66 | |
| SESSION 67 SCHEDULE | |
|
Thursday
SESSION 67:
SUPERFICIAL VEIN TREATMENT STRATEGIES II
|
|
| x | |
| 9:59 AM - 10:04 AM | Decision Making In Saphenous Ablation: What To Use When |
| Presenter(s):Steve Elias, MD | |
| View Slides in PDF | |
| 10:05 AM - 10:10 AM | Endovenous Foam Therapy Complications – What Now (French Government) |
| Presenter(s):Matthieu M.J. Josnin, MD | |
| View Slides in PDF | |
| 10:11 AM - 10:16 AM | Systematic Review: Cyanoacrylate Truncal Ablation And Its Complications |
| Presenter(s):Omar L. Esponda, MD | |
| View Slides in PDF | |
| 10:17 AM - 10:22 AM | Treatment For The Incompetent Sciatic Vein |
| Presenter(s):Julianne Stoughton, MD, FACS | |
| View Slides in PDF | |
| 10:23 AM - 10:28 AM | SVT Treatment During Pregnancy: Treatment Choices |
| Presenter(s):Kathleen J. Ozsvath, MD | |
| View Slides in PDF | |
| 10:29 AM - 10:34 AM | Would Treatment Of The Whole Length Of The GSV Reduce Recurrence/Reinterventions |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
| View Slides in PDF | |
| 10:35 AM - 10:40 AM | Thermal Ablation: Still The Gold Standard |
| Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF | |
| View Slides in PDF | |
| 10:41 AM - 10:46 AM | American Venous Forum: Venous Patient Outreach Study |
| Presenter(s):Faisal Aziz, MD | |
| View Slides in PDF | |
| 10:47 AM - 10:52 AM | Panel Discussion |
| END OF SESSION 67 | |
| SESSION 68 SCHEDULE | |
|
Thursday
SESSION 68:
SUPERFICIAL VEIN TREATMENT STRATEGIES III
Moderators:Mohamed A. Nagib, MD / Manj S. Gohel, MD, FRCS, FEBVS
|
|
| x | |
| 10:53 AM - 10:58 AM | When To Use Simultaneous Foam Sclerotherapy And Thermal Treatment In Varicose Vein Treatment |
| Presenter(s):Tobias Hirsch, MD | |
| View Slides in PDF | |
| 10:59 AM - 11:04 AM | Complications Of Endovenous Thermal Ablation Of The GSV |
| Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF | |
| View Slides in PDF | |
| 11:05 AM - 11:10 AM | When Is It OK To Ablate The Truncal Leg Veins With Chronic Iliofemoral Outflow Obstruction |
| Presenter(s):Houman Jalaie, MD, PhD | |
| View Slides in PDF | |
| 11:11 AM - 11:16 AM | SVT Management: Anything New In 2023 |
| Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS | |
| View Slides in PDF | |
| 11:17 AM - 11:22 AM | How To Treat Vulvar Varicose Veins: Phlebectomy And/Or Sclerotherapy |
| Presenter(s):Aleksandra Jaworucka-Kaczorowska, MD, PhD | |
| View Slides in PDF | |
| 11:23 AM - 11:28 AM | Chronic Venous Disease Is Indicative Of A Shorter Life |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
| View Slides in PDF | |
| 11:29 AM - 11:32 AM | What You Should Know About Klippel-Trenaunay Syndrome |
| Presenter(s):Byung-Boong Lee, MD | |
| View Slides in PDF | |
| 11:33 AM - 11:38 AM | Treatment And Pitfalls: Lateral Marginal Vein |
| Presenter(s):Peter Gloviczki, MD | |
| View Slides in PDF | |
| 11:39 AM - 11:44 AM | Overview Of Multicenter Venclose Study And Early Results |
| Presenter(s):Erin H. Murphy, MD | |
| View Slides in PDF | |
| 11:45 AM - 11:50 AM | Great Saphenous Vein “Crossectomy” For Recurrence Prevention Of Varicose Vein |
| Presenter(s):Mohamed A. Nagib, MD | |
| View Slides in PDF | |
| 11:51 AM - 11:56 AM | Panel Discussion |
| 11:57 AM - 12:24 PM | Lunch Break – Rhinelander Gallery, 2nd FloorVisit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 68 | |
| SESSION 69 SCHEDULE | |
|
Thursday
SESSION 69:
SUPERFICIAL VEIN TREAMENT STRATEGIES IV
|
|
| x | |
| 12:25 PM - 12:30 PM | Does Deep Venous Reflux Matter With Superficial Ablation |
| Presenter(s):Mikel Sadek, MD | |
| View Slides in PDF | |
| 12:31 PM - 12:36 PM | JURY Trial |
| Presenter(s):Antonios P. Gasparis, MD | |
| View Slides in PDF | |
| 12:37 PM - 12:42 PM | The Thresholds Of Caprini Score Associated With Increased Risk Of Venous Thromboembolism Across Different Specialties: A Systematic Review |
| Presenter(s):Tomasz Urbanek, MD | |
| View Slides in PDF | |
| 12:43 PM - 12:48 PM | Proposed EFIT Classification |
| Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF | |
| View Slides in PDF | |
| 12:49 PM - 12:54 PM | Adjunctive Techniques To Minimize Thrombotic Complications Following Microfoam Ablation Of Symptomatic Truncal And Tributary Vein |
| Presenter(s):Juan Carlos Jimenez, MD, MBA | |
| View Slides in PDF | |
| 12:55 PM - 1:00 PM | Treatment And Contemporary Outcomes Associated With Adjunct Tourniquet Use During Phlebectomy Of Complex, Voluminous Truncular Varicosities |
| Presenter(s):Thomas W. Wakefield, MD | |
| View Slides in PDF | |
| 1:01 PM - 1:06 PM | Foam Therapies (PCF Versus Pem): When To Use And Does It Make A Difference |
| Presenter(s):Edward G. Mackay, MD | |
| View Slides in PDF | |
| 1:07 PM - 1:12 PM | Risks And Contraindications Of Medical Compression Treatment – A Critical Reappraisal – An International Consensus Statement |
| Presenter(s):Mark H. Meissner, MD | |
| View Slides in PDF | |
| 1:13 PM - 1:18 PM | Sclerotherapy Of Pudendal And Vulvar Varicose Veins |
| Presenter(s):Claudine M. Hamel-Desnos, MD | |
| View Slides in PDF | |
| 1:19 PM - 1:24 PM | Panel Discussion |
| END OF SESSION 69 | |
| SESSION 70 SCHEDULE | |
|
Thursday
SESSION 70:
SUPERFICIAL VEIN TREAMENT STRATEGIES V
|
|
| x | |
| 1:25 PM - 1:30 PM | Randomized Controlled Study Of EVLA And Foam In The SSV-FOVELASS Study: 3-Year Results |
| Presenter(s):Claudine M. Hamel-Desnos, MD | |
| View Slides in PDF | |
| 1:31 PM - 1:36 PM | US Based Ultrasound Guided Sclerotherapy 3,565 Consecutive Cases: Efficacy And Complication Rates |
| Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD | |
| View Slides in PDF | |
| 1:37 PM - 1:42 PM | Which Saphenous Vein Recanalization Should Be Treated And By What Method – Evidence Based |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| View Slides in PDF | |
| 1:43 PM - 1:48 PM | Patterns Of Anterior Saphenous Vein Reflux (A.K.A AAGSV) And Implications Of Treatment |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| View Slides in PDF | |
| 1:49 PM - 1:54 PM | Is There Any Evidence For Compression Trial Prior To Insurance Approval |
| Presenter(s):Omar L. Esponda, MD | |
| View Slides in PDF | |
| 1:55 PM - 2:00 PM | HIFU: What Do We Know And Report – Global Report |
| Presenter(s):Steve Elias, MD | |
| View Slides in PDF | |
| 2:01 PM - 2:06 PM | New Device (Compression, Oxygen, And Humidification) – Does It Improve Wound Healing |
| Presenter(s):Joann M. Lohr, MD | |
| View Slides in PDF | |
| 2:07 PM - 2:12 PM | New Devices And Not Yet Approved |
| Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF | |
| View Slides in PDF | |
| 2:13 PM - 2:18 PM | Panel Discussion |
| END OF SESSION 70 | |
| SESSION 71 SCHEDULE | |
|
Thursday
SESSION 71:
AESTHETIC PHLEBOLOGY AND SCLEROTHERAPY STRATEGIES
Moderators:Victor M. Canata, MD, PhD / Steve Elias, MD
|
|
| x | |
| 2:19 PM - 2:24 PM Power Point Presentation with Synched Audio |
Venous Lesions Of The Face |
| Presenter(s):Kasuo Miyake, MD, PhD | |
| View Slides in PDF | |
| 2:25 PM - 2:30 PM | DEBATE: Foam Sclerotherapy Is The Best Treatment For C1: Pro |
| Presenter(s):Matthieu M.J. Josnin, MD | |
| View Slides in PDF | |
| 2:31 PM - 2:36 PM | DEBATE: Foam Sclerotherapy Is The Best Treatment For C1: Against |
| Presenter(s):Edward G. Mackay, MD | |
| View Slides in PDF | |
| 2:37 PM - 2:42 PM | Ultrasound Guided Foam Sclerotherapy For Reticular Venous Plexus: Systematization Of The Technique |
| Presenter(s):Alvaro Orrego, MD, FACS | |
| View Slides in PDF | |
| 2:43 PM - 2:48 PM | Ultrasound Imaging For Cosmetic Venous Issues |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| View Slides in PDF | |
| 2:49 PM - 2:54 PM Power Point Presentation with Synched Audio |
CLaCS Guided By Augmented Reality: Patient Selection, Method And Expected Results |
| Presenter(s):Kasuo Miyake, MD, PhD | |
| View Slides in PDF | |
| 2:55 PM - 3:00 PM | Tips And Tricks Of Sclerotherapy – What Makes It Easier And Successful |
| Presenter(s):Victor M. Canata, MD, PhD | |
| View Slides in PDF | |
| 3:01 PM - 3:06 PM | How To Avoid Complications From Sclerotherapy |
| Presenter(s):Harold J. Welch, MD | |
| View Slides in PDF | |
| 3:07 PM - 3:12 PM | Cosmetic Treatment Of Hand And Foot Veins |
| Presenter(s):Julianne Stoughton, MD, FACS | |
| View Slides in PDF | |
| 3:13 PM - 3:18 PM | Quick Case 1: Ask The Panel Or Audience What Would You Do (Cosmetic) |
| Presenter(s):Steve Elias, MD | |
| View Slides in PDF | |
| 3:19 PM - 3:24 PM | Quick Case 2: Ask The Panel Or Audience What Would You Do (Cosmetic) |
| Presenter(s):Edward G. Mackay, MD | |
| View Slides in PDF | |
| 3:25 PM - 3:30 PM | Panel Discussion |
| END OF SESSION 71 | |
| SESSION 72 SCHEDULE | |
|
Thursday
SESSION 72:
SUPERFICIAL VEIN TREATMENT STRATEGIES VI
Moderators:Raghu Kolluri, MD / Gloria Salazar, MD
|
|
| x | |
| 3:31 PM - 3:36 PM | Global Epidemiology Of Chronic Venous Disease: A Systematic Review With Pooled Prevalence Analysis |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh / Sarah Onida, MD, PhD | |
| View Slides in PDF | |
| 3:37 PM - 3:42 PM | When Evaluating Superficial Disease, When Do You Look For Deep Venous Obstruction |
| Presenter(s):Gloria Salazar, MD | |
| View Slides in PDF | |
| 3:43 PM - 3:48 PM | Not All C2 Disease Should Be Treated: An Algorithm To Predict Severity |
| Presenter(s):Mikel Sadek, MD | |
| View Slides in PDF | |
| 3:49 PM - 3:54 PM | Results Of Truncal Vein Ablation Utilizing Polidocanol Endovenous Microfoam Delivered In A Retrograde Fashion |
| Presenter(s):Steven T. Deak, MD, PhD | |
| View Slides in PDF | |
| 3:55 PM - 4:00 PM | Varithena® VLU Registry: The Effects Of Polidocanol Endovenous Microfoam On Wound Healing And Recurrence |
| Presenter(s):Raghu Kolluri, MD | |
| View Slides in PDF | |
| 4:01 PM - 4:06 PM | Phlebectomy And Foam Sclerotherapy For Varicose Veins: Which Is Better And When |
| Presenter(s):Felipe Coelho Neto, MD, MSc, PhD | |
| View Slides in PDF | |
| 4:07 PM - 4:12 PM | Ambulatory Phlebectomy – Utilization And Clinical Outcomes |
| Presenter(s):John Blebea, MD, MBA | |
| View Slides in PDF | |
| 4:13 PM - 4:18 PM | Outcome Of A Single Center Trial Comparing A Large Patient Cohort With Retrograde Administration Of Ultrasound-Guided Polidocanol Endovenous Microfoam Versus Endovenous Laser |
| Presenter(s):Steven T. Deak, MD, PhD | |
| View Slides in PDF | |
| 4:19 PM - 4:24 PM | Radiofrequency Ablation Versus Polidocanol Endovenous Microfoam Ablation Of Large Diameter Saphenous And Tributary Veins |
| Presenter(s):Juan Carlos Jimenez, MD, MBA | |
| View Slides in PDF | |
| 4:25 PM - 4:30 PM | How To Survive An Insurance Audit |
| Presenter(s):Harold J. Welch, MD | |
| View Slides in PDF | |
| 4:31 PM - 4:36 PM | Venaseal Spectrum RCT: Update |
| Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS | |
| View Slides in PDF | |
| 4:37 PM - 4:42 PM | VERITAS Study: Polidocanol Endovenous Microfoam Versus Thermal |
| Presenter(s):Steve Elias, MD | |
| View Slides in PDF | |
| 4:43 PM - 4:48 PM | How To Avoid Complications Of The Small Saphenous Vein |
| Presenter(s):Jean Luc Gerard, MD | |
| View Slides in PDF | |
| 4:49 PM - 5:04 PM | Panel Discussion |
| END OF SESSION 72 | |
| SESSION 73 SCHEDULE | |
|
Thursday
SESSION 73:
LIPEDEMA, LYMPHEDEMA, PHLEBOLYMPHEDEMA, AND ULCERS
Moderators:Thomas F. O'Donnell, Jr., MD / Mark D. Iafrati, MD
|
|
| x | |
| 5:05 PM - 5:10 PM | Lower Extremity Edema Workup |
| Presenter(s):Antonios P. Gasparis, MD | |
| View Slides in PDF | |
| 5:11 PM - 5:16 PM | What is Lipedema And The Current Management |
| Presenter(s):Steven M. Dean, DO | |
| View Slides in PDF | |
| 5:17 PM - 5:22 PM | Overview Of Lymphatic Anatomy And Physiology |
| Presenter(s):Thomas F. O'Donnell, Jr., MD | |
| View Slides in PDF | |
| 5:23 PM - 5:28 PM | The American Venous Forum, American Vein & Lymphatic Society, And The Society for Vascular Medicine Expert Opinion Consensus On Lymphedema Diagnosis And Treatment |
| Presenter(s):Mark D. Iafrati, MD | |
| View Slides in PDF | |
| 5:29 PM - 5:34 PM | The Critical Role Of Phlebolymphedema And Cellulitis (85,000 Patients) |
| Presenter(s):Thomas F. O'Donnell, Jr., MD | |
| View Slides in PDF | |
| 5:35 PM - 5:40 PM | Venolymphatic Edema And Its Treatment Options |
| Presenter(s):Raghu Kolluri, MD | |
| View Slides in PDF | |
| 5:41 PM - 5:46 PM | The Need For Lymphatic-Specific Treatment In Phlebolymphedema And Its Results |
| Presenter(s):Thomas F. O'Donnell, Jr., MD | |
| View Slides in PDF | |
| 5:47 PM - 5:52 PM | Role Of Hydrotherapy In Lymphedema Treatment |
| Presenter(s):Mohamed A. Nagib, MD | |
| View Slides in PDF | |
| 5:53 PM - 5:58 PM | Are Lymphedema, Lipedema, And Edema Related |
| Presenter(s):Steven M. Dean, DO | |
| View Slides in PDF | |
| 5:59 PM - 6:04 PM | Pharmacological Treatment For Lymphedema |
| Presenter(s):Monika L. Gloviczki, MD, PhD | |
| View Slides in PDF | |
| 6:05 PM - 6:10 PM | Risks And Contraindications Of Medical Compression Treatment – A Critical Reappraisal: An International Consensus Statement |
| Presenter(s):Tomasz Urbanek, MD | |
| View Slides in PDF | |
| 6:11 PM - 6:16 PM | Venous Ulcers: The Contributions Of Deep, Perforator, And Superficial Procedures On Wound Healing |
| Presenter(s):Peter F. Lawrence, MD | |
| View Slides in PDF | |
| 6:17 PM - 6:22 PM | What Type Of Skin Graft And When To Use |
| Presenter(s):Mark D. Iafrati, MD | |
| View Slides in PDF | |
| 6:23 PM - 6:28 PM | Adjuvant Pharmacologic Therapy For Venous Leg Ulcer |
| Presenter(s):Monika L. Gloviczki, MD, PhD | |
| View Slides in PDF | |
| 6:29 PM - 6:34 PM | Review Of Current Evidence For Topical Treatment For Venous Leg Ulcers |
| Presenter(s):Maxim Shaydakov, MD, PhD | |
| View Slides in PDF | |
| 6:35 PM - 6:40 PM | Panel Discussion End of Program I |
| END OF SESSION 73 | |
| SESSION 74 SCHEDULE | |
|
Thursday
SESSION 74:
EMERGING TRENDS IN ISCHEMIC STROKE TREATMENT
Moderators:Allan L. Brook, MD / Joshua A. Hirsch, MD
|
|
| x | |
| 8:00 AM - 8:10 AM | Introduction |
| Presenter(s):Allan L. Brook, MD | |
| 8:11 AM - 8:18 AM Power Point Presentation with Synched Audio |
Latest Trials Update: Understanding The Evidence – ASPECTS 3-5 |
| Presenter(s):David S. Liebeskind, MD | |
| View Slides in PDF | |
| 8:19 AM - 8:26 AM | Latest Trials Update: ASPECTS 3-5 Nuances And Practicality |
| Presenter(s):Rafael A. Ortiz, MD | |
| View Slides in PDF | |
| 8:27 AM - 8:34 AM | Imaging Predictors Of Outcomes – Association Between New Water Uptake And Functional Outcome In Patients With Low ASPECTS |
| Presenter(s):Richard L. Zampolin, MD | |
| View Slides in PDF | |
| END OF SESSION 74 | |
| SESSION 75 SCHEDULE | |
|
Thursday
SESSION 75:
ACCESS ISSUES (PROXIMAL AND DISTAL): PEARLS
Moderators:Allan L. Brook, MD / Joshua A. Hirsch, MD
|
|
| x | |
| 8:35 AM - 8:42 AM | Can You Be Too Distal For Thrombectomy |
| Presenter(s):David Fiorella, MD, PhD | |
| View Slides in PDF | |
| 8:43 AM - 8:50 AM | Tandem Occlusions: Should We Stent |
| Presenter(s):James Milburn, MD | |
| View Slides in PDF | |
| 8:51 AM - 8:58 AM Power Point Presentation with Synched Audio |
Direct Carotid Access: Has The Time Emerged |
| Presenter(s):Ajay K. Wakhloo, MD, PhD, FAHA, FSNIS | |
| View Slides in PDF | |
| 8:59 AM - 9:06 AM | Mevo And Devo: Definition And Review Literature, When And How I Do It |
| Presenter(s):Sudhakar R. Satti, MD | |
| View Slides in PDF | |
| 9:07 AM - 9:14 AM | Intrasaccular Treatments Are Now The Standard Of Care And Why |
| Presenter(s):Neil Haranhalli, MD | |
| View Slides in PDF | |
| END OF SESSION 75 | |
| SESSION 76 SCHEDULE | |
|
Thursday
SESSION 76:
ACUTE STROKE THROMBECTOMY MASTERS SESSION
Moderators:David Gordon, MD / Neil Haranhalli, MD
|
|
| x | |
| 9:15 AM - 9:22 AM | DAPT: Acute Platelet Loading Protocols, Cangrelor, And Optimizing Blood Pressure Post-Thrombectomy When Acute Stenting |
| Presenter(s):David Fiorella, MD, PhD | |
| View Slides in PDF | |
| 9:23 AM - 9:30 AM | Radial Access And Complication Management |
| Presenter(s):Eytan Raz, MD | |
| View Slides in PDF | |
| 9:31 AM - 9:38 AM | Step-By-Step How I Choose My Thrombectomy Equipment |
| Presenter(s):Chirag D. Gandhi, MD | |
| View Slides in PDF | |
| 9:39 AM - 9:46 AM | What Are The Limits To Acute Stroke Thrombectomy In Our Population |
| Presenter(s):Ansaar T. Rai, MD | |
| View Slides in PDF | |
| 9:47 AM - 9:54 AM | Acute Ischemic Stroke – Who We Should NOT Treat |
| Presenter(s):Johanna Seiden, MD, MPH | |
| View Slides in PDF | |
| END OF SESSION 76 | |
| SESSION 77 SCHEDULE | |
|
Thursday
SESSION 77:
CAROTID AND CEREBRAL ANEURYSMS LATEST TRENDS
Moderators:Peter K. Nelson, MD / Allan L. Brook, MD
|
|
| x | |
| 9:55 AM - 10:10 AM | Keynote Presentation: An Endovascular Experience From The War Zone In Ukraine |
| Presenter(s):Peter K. Nelson, MD | |
| View Slides in PDF | |
| 10:11 AM - 10:18 AM | Carotid Blowout: Role Of Endovascular Care And Timing Of Treatment |
| Presenter(s):Guilherme Dabus, MD | |
| View Slides in PDF | |
| 10:19 AM - 10:26 AM | The Posterior Circulation Is Different And Why It Matters |
| Presenter(s):Maksim Shapiro, MD | |
| View Slides in PDF | |
| 10:27 AM - 10:34 AM | A Neiman Fellow Analyzes Trends In Stroke |
| Presenter(s):Joshua A. Hirsch, MD | |
| View Slides in PDF | |
| 10:35 AM - 10:42 AM | Stroke Imaging Triage: Pearls And Nuances Of Daily Practice |
| Presenter(s):Reade A. De Leacy, MBBS | |
| View Slides in PDF | |
| 10:43 AM - 10:50 AM | Pediatric Stroke Issues |
| Presenter(s):Mario Muto, MD | |
| View Slides in PDF | |
| 10:51 AM - 10:58 AM | CTA For Stroke And Aneurysm Detection And Optimization |
| Presenter(s):Lawrence N. Tanenbaum, MD | |
| View Slides in PDF | |
| 10:59 AM - 11:06 AM | When My Partners Have Stroke Complications, How I Manage |
| Presenter(s):Peter K. Nelson, MD | |
| View Slides in PDF | |
| 11:07 AM - 11:14 AM | Dural Sinus Stenosis: Is There A Standard Of Care |
| Presenter(s):Seon-Kyu Lee, MD, PhD | |
| View Slides in PDF | |
| 11:15 AM - 11:22 AM | Artificial Intelligence And Telemedicine: How It Is Changing And Influencing Our Daily Practice |
| Presenter(s):Allan L. Brook, MD | |
| View Slides in PDF | |
| 11:23 AM - 11:30 AM | MMA Embolization: SDH – When And When Not To Do |
| Presenter(s):J Mocco, MD, MS | |
| View Slides in PDF | |
| END OF SESSION 77 | |
| SESSION 78 SCHEDULE | |
|
Thursday
SESSION 78:
CAROTID ARTERY THERAPY STARS AND LATEST TRENDS
|
|
| x | |
| 11:31 AM - 11:38 AM | Carotid Artery Disease: New Trials And Best Literature 2023 |
| Presenter(s):Thomas G. Brott, MD | |
| View Slides in PDF | |
| 11:39 AM - 11:46 AM | TCAR Is Better Than True Percutaneous Carotid Stenting: Myth Or Reality |
| Presenter(s):Peter A. Schneider, MD | |
| View Slides in PDF | |
| 11:47 AM - 11:54 AM | CAS Versus CEA: Optimum Cases For Each (Kumbaya) |
| Presenter(s):Don Heck, MD | |
| View Slides in PDF | |
| 11:55 AM - 12:02 PM | CEA Done Through A Micro-Incision Versus TCAR: Reality Drama At Its Best |
| Presenter(s):Enrico Ascher, MD | |
| View Slides in PDF | |
| 12:03 PM - 12:10 PM | Long-Term Value Of The C-Guard MicroNet Mesh Covered Stent For CAS In High Risk Carotid Lesions Versus Surgery: TCAR Pearls And Wisdom Of Data |
| Presenter(s):D. Christopher Metzger, MD / Piotr Musialek, MD, DPhil | |
| View Slides in PDF | |
| 12:10 PM - 12:30 PM | Panel Discussion End of Program J |
| END OF SESSION 78 | |
|
Friday, November 17, 2023
Print Entire 2023 Program:
|
|
| SESSION 79 SCHEDULE | |
|
Friday
SESSION 79:
PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
|
|
| x | |
| 6:40 AM - 6:45 AM | Key New Concepts Presented At A Recent International Summit Conference On Spinal Cord Ischemia (SCI) |
| Presenter(s):Hamdy Awad, MD | |
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | With Complex AAAs And Type IV TAAAs, The Incidence Of SCI Is 3 Times Greater With Endovascular Repairs Than Open Repairs: Why Is This A Controversial Finding |
| Presenter(s):George Geroulakos, MD, PhD | |
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | With Endovascular Repair Of TAAAs, Analysis Of Aortic Anatomy And Extent Of Endograft Coverage Allows Prediction Of SCI And Its Neurological Consequences: What Can Be Done To Reduce This Risk |
| Presenter(s):Bijan Modarai, PhD, FRCS | |
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | Shifts In Prevention Protocols For SCI During Open And Endovascular TAAA Repairs: What Is Agreed On And What Remains Controversial |
| Presenter(s):Germano C.G. Melissano, MD / Roberto L.V. Chiesa, MD | |
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | Update On The Value Of Motor Evoked Potentials (MEPs) To Decrease SCI With TAAA Repairs: What Is The Difference Between Peripheral And Central SCI |
| Presenter(s):Geert Willem H. Schurink, MD, PhD / Barend M.E. Mees, MD, PhD, FEBVS / Michael J. Jacobs, MD | |
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | DEBATE: Why Cerebrospinal Fluid (CSF) Drainage To Decrease SCI With TAAA Repair Is Not A Benign Procedure: When To Use It Not When Not |
| Presenter(s):Gustavo S. Oderich, MD, FACS | |
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | DEBATE: CSF Drainage Need Not Be Associated With High Rates Of Complications: How To Prevent Them And The Case For Wide Prophylactic Placement |
| Presenter(s):Sal Scali, MD | |
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | Prevention Of Spinal Cord Ischemia In Endovascular TAAA Repairs: Lessons Learned From The US Aortic Research Consortium (USARC): Why An RCT Is Still Needed And Being Initiated |
| Presenter(s):Adam Beck, MD / Mark A. Farber, MD / Andres Schanzer, MD | |
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | Near Infrared Spectrometry (NIRS) Monitoring Is Helpful In Decreasing SCI And Avoiding Spinal Drainage With TAAA Repairs: When And How Should It Be Used |
| Presenter(s):Carlos H. Timaran, MD | |
| View Slides in PDF | |
| 7:34 AM - 7:39 AM | Current Strategies To Minimize SCI With TAAA Repairs (Endo And Open) By Improving The Intraspinal Collateral Arterial Network: Status Of Intercostal Embolization As Preconditioning To Prevent Ischemia (MIS2ACE): Progress Of The PAPA-ARTIS RCT |
| Presenter(s):Christian D. Etz, MD, PhD | |
| View Slides in PDF | |
| 7:40 AM - 7:45 AM | Updated Single Center Clinical Experience With Intercostal Coil Embolization (MIS2ACE) To Prevent SCI With Endovascular TAAA Repair |
| Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD / Christian D. Etz, MD, PhD | |
| View Slides in PDF | |
| 7:46 AM - 7:53 AM | Panel Discussion |
| END OF SESSION 79 | |
| SESSION 80 SCHEDULE | |
|
Friday
SESSION 80:
NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Moderators:Klaus D. Mathias, MD / Sumaira Macdonald, MD, PhD
|
|
| x | |
| MESH COVERED STENTS | |
| 7:53 AM - 7:58 AM | Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter |
| Presenter(s):D. Christopher Metzger, MD / Max Amor, MD | |
| View Slides in PDF | |
| 7:59 AM - 8:04 AM | Update On The MicroNet-Covered Stents (C-Guard From InspireMD) For CAS: Value Overall, With High-Risk Lesions And With TCAR: Are There Any Downsides |
| Presenter(s):Piotr Musialek, MD, DPhil / Stefan Mueller-Huelsbeck, MD | |
| View Slides in PDF | |
| 8:05 AM - 8:10 AM | New Multicenter Data Showing The Long-Term Value Of The C-Guard MicroNet Mesh Covered Stent For CAS In High Risk Carotid Lesions (Thrombotic, Calcified And Symptomatic) From The FLOW-GUARD And Other Trials |
| Presenter(s):D. Christopher Metzger, MD / Piotr Musialek, MD, DPhil | |
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | Results From A Multicenter Italian Study Of The C-Guard Micromesh Stent For CAS: Advantages And Complications |
| Presenter(s):Pasqualino Sirignano, MD, PhDS / Francesco Speziale, MD / Gianmarco de Donato, MD / Wassim Mansour, MD / Carlo Setacci, MD | |
| View Slides in PDF | |
| 8:17 AM - 8:22 AM | Real-World Results Of ~2,000 Patients Treated With The Roadsaver (Terumo) Dual-Layer Micro Mesh Carotid Stent: Advantages And Limitations |
| Presenter(s):Stefan Mueller-Huelsbeck, MD | |
| View Slides in PDF | |
| 8:23 AM - 8:28 AM | Panel Discussion |
| TCAR RELATED TOPICS | |
| 8:29 AM - 8:34 AM | DEBATE: TCAR Versus CEA (Carotid Endarterectomy): 3-Year Results From A Large Propensity Matched VQI-Medicare Database Show Similar Stroke, And Death Rates At 3 Years For Symptomatic And Asymptomatic Patients: At 3-Years: TCAR Can Replace CEA More Widely |
| Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD / Vik S. Kashyap, MD | |
| View Slides in PDF | |
| 8:35 AM - 8:40 AM | DEBATE: Not So Fast: TCAR Is Not Yet Ready To Replace CEA Widely: We Still Need Further Proof And More Studies Possibly Including An RCT |
| Presenter(s):Bruce A. Perler, MD, MBA | |
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | How Adjunctive Techniques (EEG And IVUS) Help With TCAR And Decrease Stroke Rates |
| Presenter(s):Todd R. Vogel, MD, MPH | |
| View Slides in PDF | |
| 8:47 AM - 8:52 AM | DEBATE: TCAR Is Better Than TFCAS And Brachial/Radial Access For CAS |
| Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS | |
| View Slides in PDF | |
| 8:53 AM - 8:58 AM | DEBATE: Not So: TCAR Is No Better And Is More Costly Than TFCAS And Brachial/Radial Access CAS If One Has Appropriate Skills |
| Presenter(s):D. Christopher Metzger, MD / William A. Gray, MD | |
| View Slides in PDF | |
| 8:59 AM - 9:04 AM | Should TCAR Replace Most CEAs Or Is CEA Still The Gold Standard For Most Cases Requiring Invasive Treatment Based On A Cost Analysis |
| Presenter(s):Michel Makaroun, MD | |
| View Slides in PDF | |
| 9:05 AM - 9:10 AM | TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why It Should Be The Procedure Of Choice In Those Conditions |
| Presenter(s):Peter A. Schneider, MD | |
| View Slides in PDF | |
| 9:11 AM - 9:16 AM | Pre-Dilatation And Post Dilatation Strategies For TCAR: Do They Differ From TFCAS: Does Patient Sex Affect TCAR Outcomes |
| Presenter(s):Vik S. Kashyap, MD | |
| View Slides in PDF | |
| 9:17 AM - 9:24 AM | Panel Discussion |
| 9:24 AM - 9:34 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 80 | |
| SESSION 81 SCHEDULE | |
|
Friday
SESSION 81:
MORE CAROTID HOT TOPICS RELATED TO TCAR, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS AND COGNITIVE FUNCTION
|
|
| x | |
| 9:35 AM - 9:40 AM | Image Analysis Using AI With Siemens I-Flow Can Improve Prediction Of Stroke Risk In Carotid Disease: How Does It Work And How Reliable Is It |
| Presenter(s):Ravi K. Veeraswamy, MD | |
| View Slides in PDF | |
| CAROTID STENOSIS AND COGNITIVE FUNCTION | |
| 9:41 AM - 9:46 AM | Asymptomatic Carotid Stenosis (ACS) Is Associated With Cognitive Impairment In CREST 2: Will CREST 2 Provide Evidence That Invasive Intervention Will Stop Or Improve Cognitive Deterioration: Has It Yet Done So |
| Presenter(s):Wesley S. Moore, MD / Brajesh K. Lal, MD / Thomas G. Brott, MD | |
| View Slides in PDF | |
| 9:47 AM - 9:52 AM | DEBATE: Carotid Intervention Improves Cognitive Function Of Patients With Severe Carotid Atherosclerosis: What About In Octogenarians: Should More ACS Patients Undergo Invasive Treatment |
| Presenter(s):Wei Zhou, MD | |
| View Slides in PDF | |
| 9:53 AM - 9:58 AM | DEBATE: Not So Fast: There Is Still Great Doubt That Eliminating ACS Improves Cognitive Function: It Should Not Be A Reason For Treating More ACS Patients |
| Presenter(s):Kosmas I. Paraskevas, MD | |
| View Slides in PDF | |
| SIGNIFICANCE OF SMALL DW MRI DEFECTS AFTER CEA/CAS | |
| 9:59 AM - 10:04 AM | DEBATE: Silent DWI MRI Brain Lesions (Small Infarcts) After CEA/CAS Don’t Matter |
| Presenter(s):Thomas G. Brott, MD / James F. Meschia, MD | |
| View Slides in PDF | |
| 10:05 AM - 10:10 AM | DEBATE: Not So: Silent Brain Infarcts (DW MRI Defects) After CEA/CAS Really Matter And Affect Cognitive Changes: The Size And Number Of DW MRI Defects Are Critical |
| Presenter(s):Wei Zhou, MD | |
| View Slides in PDF | |
| 10:11 AM - 10:16 AM | Highlights Of The 2022 SVS US Guidelines For The Management Of Carotid Disease: How Important Is Medical Treatment And Has It Changed |
| Presenter(s):Ali F. AbuRahma, MD | |
| View Slides in PDF | |
| 10:17 AM - 10:22 AM | Highlights Of The 2023 European Guidelines For The Management Of Carotid Disease And How They Differ From The US Guidelines |
| Presenter(s):Ross Naylor, MD, FRCS | |
| View Slides in PDF | |
| 10:23 AM - 10:30 AM | Panel Discussion |
| END OF SESSION 81 | |
| SESSION 82 SCHEDULE | |
|
Friday
SESSION 82:
MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
|
|
| x | |
| 10:30 AM - 10:35 AM | Comparative Cost Effectiveness Of TCAR, CEA, TFCAS: CEA Is More Cost Effective Than TCAR And TCAR Is More Cost Effective Than TFCAS |
| Presenter(s):Mohammad H. Eslami, MD, MPH | |
| View Slides in PDF | |
| 10:36 AM - 10:41 AM | DEBATE: Since TCAR Already Has It, Reimbursement For Transfemoral And Transbrachial Carotid Stenting Should Be Expanded To Include Asymptomatic Patients |
| Presenter(s):Thomas G. Brott, MD | |
| View Slides in PDF | |
| 10:42 AM - 10:47 AM | DEBATE: There Should Be No Reimbursement For Carotid Stenting (CAS Or TCAR) For Asymptomatic Or Symptomatic Patients |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| View Slides in PDF | |
| 10:48 AM - 10:53 AM | Value Of Lithotripsy (Shockwave) For CAS In Heavily Calcified Lesions: How To Do It Safely And Technical Tips: Limitations And Precautions: A Quick Word About The Value Of Lithotripsy In All Vascular Beds |
| Presenter(s):Frank R. Arko, MD / Max Amor, MD | |
| View Slides in PDF | |
| 10:54 AM - 10:59 AM | OCT Optical Coherence Tomography (OCT) Proves CAS Is Rendered Safer Because Emboli Are Decreased By Mesh Covered Stents: The Imaging Evidence And What It Shows About The Interaction Between Stent And Plaque |
| Presenter(s):Carlo Setacci, MD / Francesco Setacci, MD | |
| View Slides in PDF | |
| 11:00 AM - 11:05 AM | Minimal Incision CEA (MICE) Versus TCAR: Technical Tips For MICE, Cost Effectiveness, Advantages And Limitations Of Both |
| Presenter(s):Enrico Ascher, MD | |
| View Slides in PDF | |
| 11:06 AM - 11:12 AM | Panel Discussion |
| TIMING OF CAROTID INTERVENTIONS AFTER SYMPTOM ONSET | |
| 11:12 AM - 11:17 AM | Optimal Timing Of Carotid Revascularization (CEA, TFCAS, TCAR) After Symptom Onset: Within 48 Hours Stroke Risk Is Increased For All Procedures; After 48 Hours Risk Is Less With CEA And TCAR Than With TFCAS: Based On A Large National Database Study: Can Artificial Intelligence (AI) Help To Predict Stroke Risk |
| Presenter(s):Mahmoud B. Malas, MD, MHS | |
| View Slides in PDF | |
| 11:18 AM - 11:23 AM | DEBATE: It’s Reasonable To Perform CEA Within 48 Hours After A Stroke’s Symptoms Start: Under What Conditions And What Precautions Should Be Taken |
| Presenter(s):R. Clement Darling III, MD | |
| View Slides in PDF | |
| 11:24 AM - 11:29 AM | DEBATE: Not So Fast: If The Presenting Stroke Is Severe By NIH Severity Score, The Outcome Of Urgent Interventions (CEA, CAS, TCAR, Etc.) Is Poor: Should They Always Be Avoided |
| Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS | |
| View Slides in PDF | |
| 11:30 AM - 11:35 AM | With Crescendo TIAs And Thrombus Overlying A Plaque What Is The Best Invasive Treatment And When Should It Be Performed |
| Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS | |
| View Slides in PDF | |
| 11:36 AM - 11:41 AM | When Is Urgent (Within 48 Hours) CEA Or CAS Fairly Indicated After A Stroke: How Does Use Of tPA Influence Indications And Neurologic Outcomes In This Setting |
| Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS | |
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | What Is The Best Medical Treatment For Patients With Carotid Stenosis (Asymptomatic And Symptomatic): Can High Risk Plaques Be Made Low Risk And Smaller: All Stroke Patients Should Be On Statins Because They Decrease Recurrent Stroke And Mortality Rates Markedly |
| Presenter(s):J. David Spence, MD | |
| View Slides in PDF | |
| 11:48 AM - 11:53 AM | Technical Tips And Maneuvers To Make Treatment Of High Carotid Lesions Safe And Relatively Simple |
| Presenter(s):Richard J. Powell, MD | |
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 12:54 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 82 | |
| SESSION 83 SCHEDULE | |
|
Friday
SESSION 83:
MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs; NEW INFORMATION ON TREATMENT OF TANDEM LESIONS, CAROTID ANEURYSMS AND STROKES DURING INTERVENTION
|
|
| x | |
| 12:54 PM - 12:59 PM | Current Best Treatment For Strokes Apparent During Or Right After CEA, CAS Or TCAR: Best Diagnostic Modalities And Treatments: Who Should Be Involved And What Skills Are Needed |
| Presenter(s):Gert J. de Borst, MD, PhD | |
| View Slides in PDF | |
| UPDATE ON CAROTID RCTs | |
| 1:00 PM - 1:05 PM Power Point Presentation with Synched Audio |
5-Year Results From SPACE 2: CEA Versus Best Medical Treatment (BMT) And CAS Versus BMT For ACS: These Results Support A More Conservative Approach To ACS: What More Is Needed |
| Presenter(s):Hans-Henning Eckstein, MD, PhD / Christoph Knappich, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | DEBATE: Update On ACST 2: This RCT Found That CEA And CAS For ACS Had Comparable Adverse Event Rates And Implied That Both Invasive Treatments Were Superior To BMT: Does CEA Prevent Dementia |
| Presenter(s):Richard Bulbulia, MA, MD, FRCS / Alison Halliday, MS, FRCS | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | DEBATE: Not So Fast! ACST 2 – Like CREST – Has Flaws That Invalidate Their Conclusions: Invasive Therapies May NOT Be Better Than BMT |
| Presenter(s):J. David Spence, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Update On CREST 2: CEA Versus BMT And CAS Versus BMT For ACS: Recruitment And Findings To Date: Why Not Present The 30-Day And 1 Year Results: If BMT Showed No Difference In Stroke And Death Rates With Those Of CAS Or CEA, Wouldn’t It Remove Justification For Invasive Treatment Of ACS |
| Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Consecutive Monocenter Results With CAS For Asymptomatic Carotid Stenosis (ACS): We Should Not Need A RCT: Why Do We Still Need One |
| Presenter(s):Klaus D. Mathias, MD / Anna Zeller, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | CEA Versus CAS For High-Grade ACS: RCTs (ACT 1 And CREST) Analyzed By Age And Sex: Are There Important Differences |
| Presenter(s):Jon S. Matsumura, MD | |
| View Slides in PDF | |
| TANDEM CAROTID LESIONS | |
| 1:36 PM - 1:41 PM | DEBATE: Tandem Lesions At The Carotid Bifurcation Plus The Common Carotid Or Innominate Arteries: Stroke And Mortality Risks Are Higher Than For Simple Bifurcation Lesions: How Best To Treat: Endo, Open, Staged, Hybrid |
| Presenter(s):W. Darrin Clouse, MD / Mark Conrad, MD, MMSc | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | DEBATE: Tandem Carotid Lesions: Treatment Risks Need NOT Be Increased: Based On A Meta-Analysis: How Best To Treat To Minimize Risk |
| Presenter(s):Ross Naylor, MD, FRCS | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Silent Coronary Ischemia As Detected By FFRCT Is Common In Carotid Stenosis Patients: Coronary Revascularization In Such Patients Decreases Mortality: When Should It Be Done – Before Or After Carotid Treatment |
| Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD | |
| View Slides in PDF | |
| 1:54 PM - 2:02 PM | Panel Discussion |
| END OF SESSION 83 | |
| SESSION 84 SCHEDULE | |
|
Friday
SESSION 84:
MORE HOT CAROTID TOPICS: TREATMENT IN 2023 OF PATCH INFECTIONS, STRING SIGN, CAROTID DISSECTIONS AND WEBS; MANAGEMENT OF ARTERIAL INJURIES DURING CENTRAL VENOUS CATHETERIZATION; OPTIMAL PLATELET AND PROTAMINE STRATEGIES; BENIGNANCY OF ACS; VALUE OF LOCAL ANESTHESIA; STROKE RISK WITH ACS PLAQUES - A WAY TO PREDICT HIGH RISK PLAQUES
|
|
| x | |
| 2:02 PM - 2:07 PM | Optimal Management Of Carotid Patch Infections: Which Is The Best Material For Carotid Patching: How About None |
| Presenter(s):Clark J. Zeebregts, MD, PhD | |
| View Slides in PDF | |
| 2:08 PM - 2:13 PM | How Best To Diagnose And Treat Near Occlusion Of The Internal Carotid Artery (ICA) In 2023: Based On A Meta-Analysis: Is This The ICA String Sign Of Past Descriptions |
| Presenter(s):Gert J. de Borst, MD, PhD | |
| View Slides in PDF | |
| 2:14 PM - 2:19 PM | Update On Isolated Carotid Webs As A Cause Of Cryptogenic Stroke: How Best To Diagnose And Treat: How Should Asymptomatic Webs Be Treated |
| Presenter(s):W. Charles Sternbergh III, MD / Clayton J. Brinster, MD | |
| View Slides in PDF | |
| 2:20 PM - 2:25 PM | Value Of Protamine Use During CEA, CAS And TCAR: When And How Should It Be Used And With What Precautions |
| Presenter(s):David H. Stone, MD | |
| View Slides in PDF | |
| 2:26 PM - 2:31 PM | The Number Of Carotid Interventions For Symptomatic Carotid Disease Has Declined In The UK Over The Last Decade: Why Is This So |
| Presenter(s):Ross Naylor, MD, FRCS | |
| View Slides in PDF | |
| 2:32 PM - 2:38 PM | Panel Discussion |
| 2:38 PM - 2:43 PM | Restenosis After CEA And CAS Is Benign And Should Rarely Be Treated: When Can It Cause Strokes Justifying Prophylactic Treatment |
| Presenter(s):Ross Naylor, MD, FRCS | |
| View Slides in PDF | |
| 2:44 PM - 2:49 PM Power Point Presentation with Synched Audio |
DEBATE: Local Anesthesia And Intraoperative Control With Duplex Or Angiography Is Key To Safe CEA: How To Do Them |
| Presenter(s):Hans-Henning Eckstein, MD, PhD / Christoph Knappich, MD | |
| View Slides in PDF | |
| 2:50 PM - 2:55 PM | DEBATE: Not So: CEA Can Be Performed Safely And Optimally Under General Anesthesia And Without Completion Duplex Or Angio Control: What Is Required To Do So And Are There Downsides To Duplex Or Angio Controls |
| Presenter(s):Ali F. AbuRahma, MD | |
| View Slides in PDF | |
| 2:56 PM - 3:01 PM | Are Symptomatic And Asymptomatic Carotid Stenosis Really 2 Different Diseases With Different Pathology As Some Suggest |
| Presenter(s):Thomas G. Brott, MD / James F. Meschia, MD | |
| View Slides in PDF | |
| 3:02 PM - 3:07 PM | What Vascular Surgeons And Vascular Specialists Need To Know About What Can Be Learned From MRI And MRA Studies Of The Head And Neck |
| Presenter(s):Emmanuel M. Houdart, MD | |
| View Slides in PDF | |
| 3:08 PM - 3:13 PM | When An Asymptomatic Carotid Stenosis (ACS) Patient Has An Unheralded Stroke, How Does Its Magnitude And Outcome Differ From Other Strokes: Does It Make The Case For More Or Fewer Prophylactic CEAs And CASs |
| Presenter(s):Gianluca Faggioli, MD | |
| View Slides in PDF | |
| 3:14 PM - 3:20 PM | Panel Discussion |
| 3:20 PM - 3:30 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 84 | |
| SESSION 85 SCHEDULE | |
|
Friday
SESSION 85:
NEW OR UPDATED CONCEPTS FOR ENDOVASCULAR TREATMENTS AND MORE HOT AND CONTROVERSIAL CAROTID TOPICS
|
|
| x | |
| NEW OR UPDATED CONCEPTS FOR ENDO TREATMENTS | |
| 3:30 PM - 3:35 PM | Bronchial Artery Embolization For Massive Hemoptysis: A Life Saving Procedure: How To Do It |
| Presenter(s):Jacob Cynamon, MD, FACR, FSIR | |
| View Slides in PDF | |
| 3:36 PM - 3:41 PM Power Point Presentation with Synched Audio |
Endovascular Suturing Devices At The Tip Of An 8-9 French Catheter To Close Large Bore Sheath Access From Inside: The Novelrad Device: How Does It Work And Present Status |
| Presenter(s):Elchanan Bruckheimer, MBBS | |
| View Slides in PDF | |
| 3:42 PM - 3:47 PM | Clinical Judgment Is Required In The Application Of Evidence Based Medicine: RCTs Can Have Flaws Leading To Misleading Conclusions |
| Presenter(s):J. David Spence, MD | |
| View Slides in PDF | |
| 3:48 PM - 3:53 PM | A Recent Multicenter Propensity Matched Comparison Of Endo Versus Open Infrainguinal Treatment For CLTI Shows That Open Treatment Is Superior And Supports The Findings Of BEST-CLI |
| Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
| View Slides in PDF | |
| 3:54 PM - 3:59 PM | How Vascular Surgeons Can Cure Erectile Dysfunction: Diagnosis And Treatment Of Cavernous Leak And Other Pathology |
| Presenter(s):Eric Allaire, MD, PhD | |
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | Embolic Treatment Of Hemorrhoids: How To Do It And How Well Does It Work |
| Presenter(s):Gloria Salazar, MD | |
| View Slides in PDF | |
| 4:06 PM - 4:11 PM | Panel Discussion |
| HOT CAROTID TOPICS | |
| 4:12 PM - 4:17 PM | Risks And Causes Of Non-Ipsilateral Stroke Complicating CEA |
| Presenter(s):Mark Conrad, MD, MMSc / W. Darrin Clouse, MD | |
| View Slides in PDF | |
| 4:18 PM - 4:23 PM | Surveillance Imaging Following CEA: Are We Looking For Recurrence, Progression Of Contralateral Disease Or Is It Really Unnecessary |
| Presenter(s):Reese A. Wain, MD | |
| View Slides in PDF | |
| 4:24 PM - 4:29 PM | Performing CEA In Recently Symptomatic Patients With Dual Platelet Therapy On Board: The Benefits Outweigh The Risks: What Precautions Should Be Taken |
| Presenter(s):Ross Naylor, MD, FRCS | |
| View Slides in PDF | |
| 4:30 PM - 4:35 PM | DEBATE: CAS Is The Best Treatment For Young Healthy Patients With A High-Grade Asymptomatic Carotid Stenosis (ACS) |
| Presenter(s):D. Christopher Metzger, MD | |
| View Slides in PDF | |
| 4:36 PM - 4:41 PM | DEBATE: Not So: Even Young Patients With A High-Grade ACS Should Not Be Treated By CAS Or CEA |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| View Slides in PDF | |
| 4:42 PM - 4:47 PM | Why We Need A RCT Comparison Of TCAR With TFCAS, Transradial CAS And Best Medical Treatment For ACS And Symptomatic Carotid Stenosis |
| Presenter(s):Michael H. Wholey, MD, MBA | |
| View Slides in PDF | |
| 4:48 PM - 4:53 PM | Panel Discussion |
| END OF SESSION 85 | |
| SESSION 86 SCHEDULE | |
|
Friday
SESSION 86:
NEW CONCEPTS AND NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE AND WOUND CARE
Moderators:Kenneth Ouriel, MD, MBA / Mark A. Adelman, MD
|
|
| x | |
| 4:54 PM - 4:59 PM Power Point Presentation with Synched Audio |
Update On Large Bore Percutaneous Access Closure: Current Status, New Devices, How To Avoid Complications And Where Do We Go From Here |
| Presenter(s):Zvonimir Krajcer, MD, FACC | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | The Femoral Fascial Suture Technique For Percutaneous Access Closure: Technique, Value And Contraindications |
| Presenter(s):Tal M. Hoerer, MD, PhD / Thomas Larzon, MD, PhD | |
| View Slides in PDF | |
| 5:06 PM - 5:11 PM | RCT Comparing Collagen (Femoseal) Versus Suture Based (Proglide) Vascular Closure Devices After Lower Extremity Endo Arterial Revascularizations |
| Presenter(s):Yann Gouëffic, MD, PhD | |
| View Slides in PDF | |
| PROGRESS IN WOUND CARE | |
| 5:12 PM - 5:17 PM | Management Of Lymphatic Fistulas After Vascular Surgery: What Are The Treatment Options |
| Presenter(s):Martin Storck, MD, PhD | |
| View Slides in PDF | |
| 5:18 PM - 5:23 PM | The TIVITA System To Predict Wound And Amputation Healing: Hyperspectral Imaging Can Non-Invasively Determine Oxygenation And Perfusion: How Does It Work And Results |
| Presenter(s):Jan-Willem Elshof, MD | |
| View Slides in PDF | |
| 5:24 PM - 5:29 PM | New Developments In Percutaneous Arterial Closure |
| Presenter(s):Maciej L. Dryjski , MD, PhD | |
| View Slides in PDF | |
| 5:30 PM - 5:35 PM | A Single Device (From AOTI) With Triple Therapy (Local Oxygen, Compression And Humidification) Enhances Healing Of Non-Healing Lower Extremity Incisions |
| Presenter(s):David J. Dexter, MD | |
| View Slides in PDF | |
| 5:36 PM - 5:41 PM | Optimal Treatment For Groin Infection After Prosthetic Bypasses From The Common Femoral Artery: How To Save The Graft And The Leg |
| Presenter(s):Hosam F. El Sayed, MD | |
| View Slides in PDF | |
| 5:42 PM - 5:47 PM | Optimizing Wound Healing Using A Fully Synthetic Resorbable Electros Spun Material: A New Approach |
| Presenter(s):Wayne J. Caputo, DPM | |
| View Slides in PDF | |
| 5:48 PM - 5:56 PM | Panel Discussion End of Program K |
| END OF SESSION 86 | |
| SESSION 87 SCHEDULE | |
|
Friday
SESSION 87:
POPLITEAL DISEASE TOPICS RELATED TO ANEURYSM TREATMENT (PRIMARY AND REDO), ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE LOWER EXTREMITY OCCLUSIVE LESION TREATMENT WITH DCBs AND ATHERECTOMY
Moderators:Enrico Ascher, MD / Martin Björck, MD, PhD
|
|
| x | |
| POPLITEAL ANEURYSMS AND THEIR BEST CURRENT TREATMENTS | |
| 6:52 AM - 6:57 AM | A Hybrid Approach To Repairing Large Popliteal Aneurysm: Technique, Results, And Advantages |
| Presenter(s):Enrico Ascher, MD | |
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | Treatment Of Popliteal Aneurysms: When Conservative, When Open, When Endovascular: What Are The Hard Data |
| Presenter(s):Martin Björck, MD, PhD | |
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | Endovascular Versus Open Repair: Why After 20 Years Of Selective Endografting, I Now Favor Open Repair In Most Patients |
| Presenter(s):Martin R. Back, MD | |
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | Update On Optimal Treatment For Popliteal Aneurysms: Should They Be Treated Differently In Women And Why: When Should They Best Be Observed |
| Presenter(s):Fred A. Weaver, MD, MMM | |
| View Slides in PDF | |
| 7:16 AM - 7:21 AM Power Point Presentation with Synched Audio |
Rescue Procedures For Failed Endovascular Repairs Of Popliteal Aneurysms: Observation May Be Enough: If Not, Hybrid Versus Open Repair: Technical Tips |
| Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS, FESC, FEBVS | |
| View Slides in PDF | |
| ENCOURAGING RESULTS FOR SELUTION SIROLIMUS DCBs | |
| 7:22 AM - 7:27 AM | Japanese Multicenter 12-Month Data For Selution Sirolimus DCB Treatment Of Femoropopliteal Lesions Show Unmatched Primary Patency And Freedom From Clinically Driven TLR |
| Presenter(s):Patrick J... Geraghty, MD | |
| View Slides in PDF | |
| 7:28 AM - 7:35 AM | Panel Discussion |
| POPLITEAL ENTRAPMENTS AND ADVENTITIAL CYSTIC DISEASE | |
| 7:36 AM - 7:41 AM | Update On Popliteal Entrapment Syndromes: Benefits Of Dynamic Imaging With Duplex Or Angiography In Diagnosis And Treatment |
| Presenter(s):Niten Singh, MD | |
| View Slides in PDF | |
| 7:42 AM - 7:47 AM | Management Of Functional Popliteal Artery Entrapment Syndrome In Athletes: What Is The Pathological Anatomy And What Symptoms Does It Cause: Technique Of Surgical Repair |
| Presenter(s):Jason T. Lee, MD | |
| View Slides in PDF | |
| 7:48 AM - 7:53 AM | Adventitial Cystic Disease Of The Popliteal Artery: Pathogenesis, Symptoms, And Optimal Treatment |
| Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
| View Slides in PDF | |
| POPLITEAL ARTERY INJURY | |
| 7:54 AM - 7:59 AM | Surgical Approach And Graft Usage For Popliteal Artery Injury From Posterior Knee Dislocation |
| Presenter(s):Charles J. Fox, MD, FACS | |
| View Slides in PDF | |
| POPLITEAL ARTERY ATHERECTOMY | |
| 8:00 AM - 8:05 AM | Value Of Orbital Atherectomy For Popliteal Artery Occlusive Lesions: New Developments And Expanded Versatility Of The Device |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 8:06 AM - 8:12 AM | Panel Discussion |
| END OF SESSION 87 | |
| SESSION 88 SCHEDULE | |
|
Friday
SESSION 88:
NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT INFECTIONS
Moderators:Keith D. Calligaro, MD / Peter F. Lawrence, MD
|
|
| x | |
| 8:12 AM - 8:17 AM | Update On The NAIS Procedure (Deep Vein Reconstruction For Infected Aortic Grafts): How To Make The Operation Easier And Better |
| Presenter(s):John F. Eidt, MD | |
| View Slides in PDF | |
| TREATMENT OF MYCOTIC ANEURYSMS | |
| 8:18 AM - 8:23 AM | Radical Or Less Radical Treatment Of Mycotic Aneurysms: What Are They: When And How Should They Be Performed: Can EVAR Ever Be The Definitive Treatment: Importance Of Drainage |
| Presenter(s):Martin Malina, MD, PhD | |
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | Rifampin Soaked Endografts To Treat Mycotic AAAs: How To Prepare Them And When To Use Them: Are They Stand-Alone Treatment Or Do They Need Adjunctive Techniques |
| Presenter(s):Guillermo A. Escobar, MD | |
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | Why Open Repair Is The Best Treatment For Mycotic AAAs: Is EVAR Ever Of Value |
| Presenter(s):Yamume Tshomba, MD | |
| View Slides in PDF | |
| 8:36 AM - 8:41 AM | TEVAR For The Treatment Of Aorto-Esophageal And Aorto-Bronchial Fistulas: Is It Only A Bridging Procedure Or Is It Ever A Definitive Treatment |
| Presenter(s):Markus K. Furrer, MD | |
| View Slides in PDF | |
| 8:42 AM - 8:48 AM | Panel Discussion |
| TREATMENT OF AORTIC AND ARTERIAL GRAFT AND ENDOGRAFT INFECTIONS | |
| 8:48 AM - 8:53 AM | Infected Endografts After EVAR: Etiological Factors, Diagnosis, Treatment, Outcomes: Does The Endograft Always Have To Be Removed |
| Presenter(s):Mohammad H. Eslami, MD, MPH | |
| View Slides in PDF | |
| 8:54 AM - 8:59 AM | Optimal Techniques For Treating Aorto-Iliac Graft And Endograft Infections In 2023 |
| Presenter(s):Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| 9:00 AM - 9:05 AM | Update Of Surgical Treatment For Infected Aortic Grafts And Aortic-Enteric And Aortic-Bronchial Fistulas: Current Results In A Committed Center: Value Of An Antimicrobial Silver/Triclosan Graft |
| Presenter(s):Germano C.G. Melissano, MD / Roberto L.V. Chiesa, MD / Luca Bertoglio, Professor / Andrea Kahlberg, MD | |
| View Slides in PDF | |
| 9:06 AM - 9:11 AM | Update On Progress In The Optimal Treatment Of Aortic And Arterial Graft Infections: What’s New In 2023: When Is Percutaneous Drainage Acceptable And Helpful |
| Presenter(s):Jean-Paul de Vries, MD, PhD | |
| View Slides in PDF | |
| 9:12 AM - 9:17 AM | Semi-Conservative Therapy – Saving All Or Part Of An Infected Aortic Graft: When Is It The Best Treatment And How To Make It Work: From The MAGIC Registry And VASGRA Study |
| Presenter(s):Zoran Rancic, MD, PhD, EMBA HSG | |
| View Slides in PDF | |
| 9:18 AM - 9:23 AM | EVAR Endograft Infections Can Be Treated By Local Catheter Techniques: How, When And When Not |
| Presenter(s):Tal M. Hoerer, MD, PhD | |
| View Slides in PDF | |
| 9:24 AM - 9:29 AM | When And What Is The Best Treatment For An Infected Aortic Endograft: Conservative, Antibiotics, Drainage And Excision Of Infected Tissue Or Graft Removal; Replacement: In Situ Or Extra-Anatomic |
| Presenter(s):Clark J. Zeebregts, MD, PhD | |
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | Management Of Mid-Visceral Aortic Infections (Mycotic Suprarenal And TAAAs Before And After Repair): Can Infected Grafts Sometimes Be Preserved |
| Presenter(s):Sal Scali, MD | |
| View Slides in PDF | |
| 9:36 AM - 9:52 AM | Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors) |
| END OF SESSION 88 | |
| SESSION 89 SCHEDULE | |
|
Friday
SESSION 89:
PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
|
|
| x | |
| VASCULAR HOLOGRAPHY | |
| 9:52 AM - 9:57 AM | The ARCUS System Of Augmented Reality (Derived From A Contrast CT) And Its Value In Vascular Surgery: How Will The Microsoft HoloLens 2 Project Vascular Anatomy And Its Lesions On Patients’ Bodies: How This Can Facilitate Surgical And Endovascular Procedures |
| Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 9:58 AM - 10:03 AM Power Point Presentation with Synched Audio |
Update On Real View Holographic Imaging: How Will It Help In Endovascular Treatments: Is It Available In The US |
| Presenter(s):Elchanan Bruckheimer, MBBS | |
| View Slides in PDF | |
| 10:04 AM - 10:09 AM | Holographic Guidance Of Endovascular Procedures Guidance (With Augmented Reality Goggles And No Screen): How Does It Work: What Is Possible And What Is Not |
| Presenter(s):Claude Mialhe, MD | |
| View Slides in PDF | |
| DUPLEX AND INTRAVASCULAR ULTRASOUND | |
| 10:10 AM - 10:15 AM | Duplex Ultrasound Guidance: How, Where And When Can It Replace Fluoroscopy For Endovascular Procedures: Advantages, Limitations, And Why Its Use Is Increasing |
| Presenter(s):Enrico Ascher, MD / Natalie A. Marks, MD, RPVI, RVT, FSVM | |
| View Slides in PDF | |
| 10:16 AM - 10:21 AM | Intravascular Ultrasound (IVUS) Assistance In EVAR And TEVAR: Advantages And Limitations - Based On A Multicenter Study |
| Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
| View Slides in PDF | |
| 10:22 AM - 10:28 AM | Panel Discussion |
| IMPROVED IMAGING | |
| 10:28 AM - 10:33 AM | Contrast Induced Nephropathy Is Over-Exaggerated: When Patients Need A Contrast Study, They Should Get It: How To Minimize Consequences |
| Presenter(s):Lindsay Machan, MD | |
| View Slides in PDF | |
| 10:34 AM - 10:39 AM | Totally Radiation Free Deployment Of A Complex AAA Endograft Using An Intraoperative Positioning System (IOPS From Centerline) And Positional Markers On Graft Components As Well As Catheters And Wires To Enable Accurate 3D Guidance: It Is Analogous To Precise GPS Targeting |
| Presenter(s):Gustavo S. Oderich, MD, FACS | |
| View Slides in PDF | |
| 10:40 AM - 10:45 AM | Update On Cydar Medical System’s Evolution To Facilitate Fusion With All Digital Fluoroscopes: How The System Uses AI To Improve EVAR Planning, Guidance And Deployment: Are There Disadvantages |
| Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 10:46 AM - 10:51 AM | Cydar Maps Joining In EVAR Planning, Intraprocedural Guidance And Outcome Assessment: How Does AI Help At Each Step And Compensate For Artery Movement Caused By Wires, Devices, Etc. |
| Presenter(s):Cynthia K. Shortell, MD | |
| View Slides in PDF | |
| 10:52 AM - 10:57 AM | New Imaging And Navigation Technologies To Facilitate And Improve Complex AAA Repair: Comparison Of Cydar, FORS (Philips) And Centerline Biomedical IOPS Systems: Are They Ready For Widespread Use |
| Presenter(s):Venkatesh G. Ramaiah, MD | |
| View Slides in PDF | |
| 10:58 AM - 11:05 AM | Panel Discussion |
| END OF SESSION 89 | |
| SESSION 90 SCHEDULE | |
|
Friday
SESSION 90:
AUGMENTED REALITY (AR), MIXED REALITY AND ARTIFICIAL INTELLIGENCE (AI): HOW WILL THEY IMPROVE OUTCOMES, IMAGING AND DEVICE GUIDANCE DURING VASCULAR PROCEDURES
Moderators:Gustavo S. Oderich, MD, FACS / Alan B. Lumsden, MD, FACS
|
|
| x | |
| 11:05 AM - 11:10 PM | Generative AI For Vascular Imaging – The Promise And Perils |
| Presenter(s):Elsie Ross, MD, MSc | |
| View Slides in PDF | |
| 11:11 AM - 11:16 AM | Personalized Treatment Of AAAs With AI: The Vascul-aid Project |
| Presenter(s):Kak Khee Yeung, MD, PhD | |
| View Slides in PDF | |
| 11:17 AM - 11:22 AM | Understanding Branch Stent-Graft Occlusions With Assessment Of Computational Fluid Dynamics |
| Presenter(s):Kenneth Tran, MD | |
| View Slides in PDF | |
| 11:23 AM - 11:28 AM | Learning Curve Of Endovascular Naïve Operators With Plain Fluoroscopy, Flat Plane And Augmented Reality Intraoperative Position System |
| Presenter(s):Sophia Khan, MD | |
| View Slides in PDF | |
| 11:29 AM - 11:34 AM | Intraoperative Position System To Minimize Radiation Exposure On Lateral Views During Catheterization Of Mesenteric Vessels |
| Presenter(s):Muhammad Ali A. Rana, MD | |
| View Slides in PDF | |
| 11:35 AM - 11:46 AM | Edited Case: Workflow For Endovascular FB-EVAR Of Thoracoabdominal Aortic Aneurysms |
| Presenter(s):Aleem K. Mirza, MD | |
| View Slides in PDF | |
| 11:47 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 90 | |
| SESSION 91 SCHEDULE | |
|
Friday
SESSION 91:
TWO PRESENTATIONS AND CHALLENGING RECORDED LIVE CASES FROM MÜNSTER, GERMANY
Moderators:Giovanni B. Torsello, MD / Marco V. Usai, MD
|
|
| x | |
| 1:00 PM - 1:05 PM Power Point Presentation with Synched Audio |
Muenster Strategy To Avoid SCI And Results |
| Presenter(s):Martin J. Austermann, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | In Situ Fenestration In The Arch During Complex EVAR: Early Experiences |
| Presenter(s):Marco V. Usai, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:44 PM Power Point Presentation with Synched Audio |
Live Recorded Cases By Drs. Austermann And Usai |
| Presenter(s):Martin J. Austermann, MD / Marco V. Usai, MD | |
| View Slides in PDF | |
| END OF SESSION 91 | |
| SESSION 92 SCHEDULE | |
|
Friday
SESSION 92:
NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
|
|
| x | |
| 1:44 PM - 1:49 PM | Neurogenic Thoracic Outlet Syndrome (NTOS) Can Be Effectively Treated By Injecting Botulinum Toxin (Botox) Into Scalene And Pectoral Muscles: Technique And Results |
| Presenter(s):Pierre-Olivier Thiney, Dr | |
| View Slides in PDF | |
| 1:50 PM - 1:55 PM Power Point Presentation with Synched Audio |
Supraclavicular Approach To Arterial And Neurogenic TOSs (Video Presentation) |
| Presenter(s):Mark A. Adelman, MD / Ramesh K. Tripathi, MD, FRCS, FRACS | |
| View Slides in PDF | |
| 1:56 PM - 2:01 PM | Minimally Invasive Transaxillary First Rib Resection Under Local And Regional Anesthesia: Advantages And Limitations |
| Presenter(s):Francesco Spinelli, MD | |
| View Slides in PDF | |
| 2:02 PM - 2:07 PM | Management Of Recurrent NTOS After Primary Surgery Fails: Strategy And Outcomes |
| Presenter(s):Michael J. Singh, MD | |
| View Slides in PDF | |
| 2:08 PM - 2:13 PM | Evolving Approaches For Venous Thoracic Outlet Syndrome |
| Presenter(s):Keith D. Calligaro, MD | |
| View Slides in PDF | |
| 2:14 PM - 2:19 PM | Assessment And Treatment Of Persistent Or Recurrent Symptoms After Surgical Treatment For Venous Thoracic Outlet Syndrome |
| Presenter(s):Robert W. Thompson, MD | |
| View Slides in PDF | |
| 2:20 PM - 2:26 PM | Panel Discussion |
| 2:26 PM - 2:36 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 92 | |
| SESSION 93 SCHEDULE | |
|
Friday
SESSION 93:
NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
Moderators:Caron B. Rockman, MD / James H. Black, III, MD
|
|
| x | |
| ANTIPLATELET REGIMENS | |
| 2:36 PM - 2:41 PM | Optimal Antiplatelet Management With CEAs, Lower Extremity Bypasses And Open AAA Repairs |
| Presenter(s):David H. Stone, MD | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | Current Optimal Anticoagulation And Antiplatelet Treatment For High Risk Lower Extremity Bypasses – Vein And PTFE: How Are DOACs Useful |
| Presenter(s):Peter Henke, MD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | What Is The Best Medical Treatment After Carotid, Aortic And Lower Extremity Endovascular Treatments |
| Presenter(s):Maciej L. Dryjski , MD, PhD | |
| View Slides in PDF | |
| 2:54 PM - 2:59 PM | Why Clopidogrel Is Effective In <50% Of Patients At Standard Doses: How To Identify And Fix This Problem |
| Presenter(s):Karthik Kasirajan, MD | |
| View Slides in PDF | |
| NEW DEVELOPMENTS IN LIPID MANAGEMENT – STATINS | |
| 3:00 PM - 3:05 PM | Safety And Benefit Of Statins And Medical Treatment In Vascular Patients: Why These Treatments Are Underutilized – Especially In Women: Statin Intolerance Has Been Over Emphasized: LDL-C Should Be Monitored And Treated To An Optimal Level |
| Presenter(s):Christian A. Behrendt, MD | |
| View Slides in PDF | |
| 3:06 PM - 3:11 PM | The Importance Of Lipoprotein Little a [Lp(a)] Levels In Determining Atherosclerotic Risk: When Should It Be Measured And If High, How Treated: Do PCSK-9 Inhibitors Help: Will An Oral PCSK-9 Inhibitor Be Available |
| Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC | |
| View Slides in PDF | |
| 3:12 PM - 3:17 PM | Lowering LDL-C And Controlling Elevated Blood Pressure Can Lower Cardiovascular Risk 80%: What To Do If Patients Can’t Tolerate A Statin Dose: Ezetimide, (Zetia), A PCSK9 Inhibitor, Inclisiran, Bempedoic Acid (Nexletol) |
| Presenter(s):Richard Bulbulia, MA, MD, FRCS | |
| View Slides in PDF | |
| 3:18 PM - 3:23 PM | Value And Limitations Of Statins And Non-Statin Lipid Lowering Agents In Patients With Carotid Artery Stenosis |
| Presenter(s):Kosmas I. Paraskevas, MD | |
| View Slides in PDF | |
| 3:24 PM - 3:32 PM | Panel Discussion |
| 3:32 PM - 3:37 PM | Diagnosis And Treatment Of Buerger’s Disease In 2023: Does It Exist Or Is It Just A Variant Of Atherosclerosis |
| Presenter(s):Kamphol Laohapensang, MD | |
| View Slides in PDF | |
| 3:38 PM - 3:43 PM | How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well |
| Presenter(s):James H. Black, III, MD | |
| View Slides in PDF | |
| 3:44 PM - 3:49 PM | Medical Treatment Of Patients With Vascular Ehlers Danlos Syndrome: How Does Celiprolol Treatment Work And How Does It Help |
| Presenter(s):Martin Björck, MD, PhD | |
| View Slides in PDF | |
| 3:56 PM - 4:00 PM | Panel Discussion (All Session 93 Topics) |
| END OF SESSION 93 | |
| SESSION 94 SCHEDULE | |
|
Friday
SESSION 94:
ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA
Moderators:Tal M. Hoerer, MD, PhD / Todd E. Rasmussen, MD, FACS
|
|
| x | |
| 4:00 PM - 4:05 PM | Advances In Endovascular Control Of Hemorrhage: Techniques: When Should They Be Used And When Not |
| Presenter(s):Ravi R. Rajani, MD | |
| View Slides in PDF | |
| UPDATE ON REBOA | |
| 4:06 PM - 4:11 PM | Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA): When Is It A Valuable Procedure And When Is It Not: Limitations And Precautions |
| Presenter(s):Gilbert R. Upchurch, MD | |
| View Slides in PDF | |
| 4:12 PM - 4:17 PM | Value Of REBOA For Pending And Actual Cardiac Arrest: What Is Partial And Intermittent REBOA And How Is It Helpful |
| Presenter(s):Tal M. Hoerer, MD, PhD | |
| View Slides in PDF | |
| 4:18 PM - 4:23 PM | Value Of Simulator Based Training For REBOA: How Does It Work: Can It Improve Results And Decrease Mishaps |
| Presenter(s):Lars B. Lonn, MD, PhD | |
| View Slides in PDF | |
| 4:24 PM - 4:29 PM | Transradial Access (R2P) For Endovascular Trauma Management Is Safe And Sometimes Better: Technical Tips And Devices |
| Presenter(s):Charles J. Fox, MD, FACS | |
| View Slides in PDF | |
| 4:30 PM - 4:35 PM | Contrary To Current Teaching, With Complex Extremity Injuries Involving Fractures And Large Blood Vessels, Why And How Revascularization Should PRECEDE External Bone Fixation: How To Get The Vascular Repair Length Right |
| Presenter(s):Erica L. Mitchell, MD, MEd | |
| View Slides in PDF | |
| 4:36 PM - 4:41 PM | Long-Term Results Of Arterial And Venous Reconstructions (Bypasses And Interposition Grafts) For Vascular Trauma: How Do They Compare To The Results For Similar Procedures For PAD |
| Presenter(s):Samy S. Nitecki, MD | |
| View Slides in PDF | |
| 4:42 PM - 4:47 PM | Update On Best Current Management Of Pediatric Vascular Injuries: When Conservative; When Open; When Endo And Precautions |
| Presenter(s):Michael C. Dalsing, MD | |
| View Slides in PDF | |
| 4:48 PM - 4:54 PM | Panel Discussion |
| BLUNT THORACIC AORTIC INJURY (BTAI) | |
| 4:54 PM - 4:59 PM | Classification Of BTAIs: Are We Overtreating Lesser Injuries |
| Presenter(s):Joseph J. DuBose, MD / Pedro Teixeira, MD | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | What Is The New Role Of Endovascular Repairs Of Thoracic Aortic Injuries: Concepts, Techniques, And Management |
| Presenter(s):Waclaw B. Kuczmik, MD, PhD | |
| View Slides in PDF | |
| 5:06 PM - 5:11 PM | BTAI In Pediatric Patients: When Should They Undergo Invasive Treatment: When Endo, When Open: Technical Tips And Precautions |
| Presenter(s):Elina Quiroga, MD, MPH | |
| View Slides in PDF | |
| 5:12 PM - 5:17 PM | How To Manage Heparin In TEVAR For BTAI When Head Or Other Injuries Are Also Present: Some, None Or Just Sheath Flushing |
| Presenter(s):Charles J. Fox, MD, FACS | |
| View Slides in PDF | |
| 5:18 PM - 5:23 PM | Why Rapid And Complete Aortic Healing After TEVAR For BTAI Allows Minimization Of The Seal Zone And Endograft Length Used |
| Presenter(s):Shang Loh, MD | |
| View Slides in PDF | |
| 5:24 PM - 5:29 PM | New Findings From The Aortic Trauma Foundation Global Registry On Outcomes Of TEVAR For Repair Of Traumatic Aortic Injuries: Do Lesser Degrees Of BTAI Require TEVAR |
| Presenter(s):Ali Azizzadeh, MD | |
| View Slides in PDF | |
| 5:30 PM - 5:40 PM | Panel Discussion End of Program L |
| END OF SESSION 94 | |
| SESSION 95 SCHEDULE | |
|
Friday
SESSION 95:
DEEP VENOUS WORK-UP, VENOUS STENT CHARACTERISTICS
|
|
| x | |
| 7:00 AM - 7:04 AM | Introduction: Deep System |
| Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF | |
| 7:05 AM - 7:10 AM | Iliocaval Duplex Ultrasound With Image Optimization |
| Presenter(s):Jan M. Sloves, RVT | |
| View Slides in PDF | |
| 7:11 AM - 7:16 AM | Noninvasive Measurement Of Ambulatory Venous Pressures |
| Presenter(s):Seshadri Raju, MD | |
| View Slides in PDF | |
| 7:17 AM - 7:22 AM | Physiologic Assessment Of The Severity Of Iliac Vein Obstruction |
| Presenter(s):Fedor Lurie, MD, PhD | |
| View Slides in PDF | |
| 7:23 AM - 7:28 AM | Validation Of A Chronic Venous Obstruction Classification System |
| Presenter(s):Houman Jalaie, MD, PhD | |
| View Slides in PDF | |
| 7:29 AM - 7:34 AM | Outcomes And Predictors Of Failure Of Iliac Vein Stenting |
| Presenter(s):Rabih A. Chaer, MD | |
| View Slides in PDF | |
| 7:35 AM - 7:40 AM | Iliac Vein Post-Thrombotic Disease Stent Considerations |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| View Slides in PDF | |
| 7:41 AM - 7:46 AM | What Is Aspect Ratio And What Does The Clinical Data Reveal |
| Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF | |
| View Slides in PDF | |
| 7:47 AM - 7:52 AM | Invasive Diagnostics To Indicate Stenting For MTS To Improve Outcome |
| Presenter(s):Cees H.A. Wittens, MD, PhD | |
| View Slides in PDF | |
| 7:53 AM - 7:58 AM | Impact Of Stent Structure On Venous Flow (In Vitro Investigations With A Designed Fluid Dynamic Model) |
| Presenter(s):Houman Jalaie, MD, PhD | |
| View Slides in PDF | |
| 7:59 AM - 8:04 AM | What Should The 3rd Generation Stents Look Like |
| Presenter(s):Cees H.A. Wittens, MD, PhD | |
| View Slides in PDF | |
| 8:05 AM - 8:10 AM | Calf Pump Dysfunction: What Is It |
| Presenter(s):Brajesh K. Lal, MD | |
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | Iliac Vein Obstruction And Associated Infrainguinal Reflux: Is There A Best Approach To Treatment |
| Presenter(s):Elna M. Masuda, MD | |
| View Slides in PDF | |
| 8:17 AM - 8:22 AM | Panel Discussion |
| END OF SESSION 95 | |
| SESSION 96 SCHEDULE | |
| x | |
| 8:23 AM - 8:28 AM | Reporting Standards For Acute Deep Vein Thrombosis Trials: Results Of The Delphi Consensus |
| Presenter(s):Raghu Kolluri, MD | |
| View Slides in PDF | |
| 8:29 AM - 8:34 AM | Reporting Standards For Stenting Chronic Iliofemoral Venous Obstructions: Results Of The Delphi Consensus |
| Presenter(s):Peter Gloviczki, MD | |
| View Slides in PDF | |
| 8:35 AM - 8:40 AM | The BEYOND Venous Stent Registry |
| Presenter(s):Michael K.W. Lichtenberg, MD | |
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | FIH Trial: RevCore Chronic Deep Venous Stent Occlusion For In Stent Restenosis |
| Presenter(s):Steven D. Abramowitz, MD | |
| View Slides in PDF | |
| 8:47 AM - 8:52 AM | The First Randomized Controlled Trial Comparing Venous Stenting With Conservative Treatment In Patients With Deep Venous Obstruction |
| Presenter(s):Houman Jalaie, MD, PhD | |
| View Slides in PDF | |
| 8:53 AM - 8:58 AM | Current Deep Vein Interventions: What Are They And When Are They Reasonable |
| Presenter(s):Iris Baumgartner, MD | |
| View Slides in PDF | |
| 8:59 AM - 9:04 AM | Living In The Post-SOX World: Update On Compression Trials |
| Presenter(s):Andrea T. Obi, MD | |
| View Slides in PDF | |
| 9:05 AM - 9:10 AM | Vernacular Trial: 3-Year Update |
| Presenter(s):Michael K.W. Lichtenberg, MD | |
| View Slides in PDF | |
| 9:11 AM - 9:16 AM | Zilver Vena Stent Trial: 3-Year Outcomes |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| View Slides in PDF | |
| 9:17 AM - 9:22 AM | ABRE Trial Results |
| Presenter(s):Erin H. Murphy, MD | |
| View Slides in PDF | |
| 9:23 AM - 9:28 AM | Will The BEST Trial Answer The Question On Iliac Stenting |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
| View Slides in PDF | |
| 9:29 AM - 9:34 AM | Panel Discussion |
| END OF SESSION 96 | |
| SESSION 97 SCHEDULE | |
|
Friday
SESSION 97:
FEMORO-ILIOCAVAL CHRONIC TOTAL OCCLUSIONS, RECANALIZATION TECHNIQUES AND OTHER CONSIDERATIONS
Moderators:Jose I. Almeida, MD, FACS, RPVI, RVT / Steve Elias, MD
|
|
| x | |
| 9:35 AM - 9:40 AM | Options To Improve Inflow When Stenting – ACCESS PTS/SSTA With Chameleon/Angioplasty Alone |
| Presenter(s):Steve Elias, MD | |
| View Slides in PDF | |
| 9:41 AM - 9:46 AM | Utilizing The Radiofrequency Power Wire To Vaporize A Channel Through Chronic Iliocaval Venous Obstructions (CICVO) |
| Presenter(s):Patrick E. Muck, MD, FACS | |
| View Slides in PDF | |
| 9:47 AM - 9:52 AM | Azygous Vein Stenting: Alternate Route For Caval Agenesis |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| View Slides in PDF | |
| 9:53 AM - 9:58 AM | My Techniques For Recanalizing Thrombosed IVC Filters And Iliocaval Occlusions |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| View Slides in PDF | |
| 9:59 AM - 10:04 AM | Endovascular Techniques And Indications For Retroperitoneal/Extravascular Iliocaval Reconstruction |
| Presenter(s):Steven D. Abramowitz, MD | |
| View Slides in PDF | |
| 10:05 AM - 10:10 AM | Sniper Technique To Treat Difficult And Chronic Central Venous Occlusions |
| Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR | |
| View Slides in PDF | |
| 10:11 AM - 10:16 AM | Hybrid Open And Endovascular Techniques For Complex Iliofemoral Disease |
| Presenter(s):Erin H. Murphy, MD | |
| View Slides in PDF | |
| 10:17 AM - 10:22 AM | Why Iliofemoral Deep Venous Stents Fail, And How To Manage It |
| Presenter(s):Kush R. Desai, MD | |
| View Slides in PDF | |
| 10:23 AM - 10:28 AM | Panel Discussion |
| END OF SESSION 97 | |
| SESSION 98 SCHEDULE | |
|
Friday
SESSION 98:
VENOUS THROMBOSIS SCIENCE AND TREATMENT STRATEGIES
Moderators:Thomas W. Wakefield, MD / Peter Henke, MD
|
|
| x | |
| 10:29 AM - 10:34 AM | Venous Thromboembolism In The Context Of Chronic Venous Disease |
| Presenter(s):Thomas W. Wakefield, MD | |
| View Slides in PDF | |
| 10:35 AM - 10:40 AM | Should All Patients With Acute VTE Be Treated With A Statin: When And Dose |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| View Slides in PDF | |
| 10:41 AM - 10:46 AM | Our Experience With DVT/PE During The COVID Era |
| Presenter(s):Young Erben, MD | |
| View Slides in PDF | |
| 10:47 AM - 10:52 AM | Inflammation, Selectins And Venous Thrombosis |
| Presenter(s):Thomas W. Wakefield, MD | |
| View Slides in PDF | |
| 10:53 AM - 10:58 AM | Update On Experimental DVT Pathogenesis And Resolution |
| Presenter(s):Peter Henke, MD | |
| View Slides in PDF | |
| 10:59 AM - 11:04 AM | Comprehensive Thrombus Removal Strategies Versus Selective Stenting In Acute Symptomatic Iliofemoral Venous Thrombosis |
| Presenter(s):Arjun Jayaraj, MD | |
| View Slides in PDF | |
| 11:05 AM - 11:10 AM | Panel Discussion |
| END OF SESSION 98 | |
| SESSION 99 SCHEDULE | |
|
Friday
SESSION 99:
THROMBUS REMOVAL THROMBECTOMY DEVICES AND OTHER ISSUES TO CONSIDER
Moderators:Patrick E. Muck, MD, FACS / Brian G. DeRubertis, MD
|
|
| x | |
| 11:11 AM - 11:16 AM | P-Max Study: Mechanical Thrombectomy For Iliofemoral DVT With Aspirex |
| Presenter(s):Michael K.W. Lichtenberg, MD | |
| View Slides in PDF | |
| 11:17 AM - 11:22 AM | Thrombolysis For Acute DVT: Guidance From Current Clinical Trials |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 11:23 AM - 11:28 AM | New Percutaneous Thrombectomy Reperfusion System |
| Presenter(s):Patrick E. Muck, MD, FACS | |
| View Slides in PDF | |
| 11:29 AM - 11:34 AM | CLOUT Registry For The Inari CloTriever |
| Presenter(s):David J. Dexter, MD | |
| View Slides in PDF | |
| 11:35 AM - 11:40 AM | Mechanical Thrombectomy Of Acute DVT: What Are The Ideal Device Features That We Are Missing |
| Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR | |
| View Slides in PDF | |
| 11:41 AM - 11:46 AM | The Dexterity Study: Anti-Inflammatory Potential In Treating Venous Disease |
| Presenter(s):Mahmood Razavi, MD | |
| View Slides in PDF | |
| 11:47 AM - 11:52 AM | Management Of IVC Thrombus Using Large Bore Mechanical Thrombectomy |
| Presenter(s):Constantino Pena, MD | |
| View Slides in PDF | |
| 11:53 AM - 11:58 AM | Panel Discussion |
| END OF SESSION 99 | |
| SESSION 100 SCHEDULE | |
| x | |
| 11:59 AM - 12:04 PM | Deep Venous Reflux In Patients Undergoing Venous Treatments |
| Presenter(s):Mikel Sadek, MD | |
| View Slides in PDF | |
| 12:05 PM - 12:09 PM | Deep Reflux: What Happens After Concomitant Obstruction Correction |
| Presenter(s):Marzia Lugli, MD | |
| 12:10 PM - 12:15 PM | When Deep Venous Reflux Repair Is Not Effective: What Next |
| Presenter(s):Marzia Lugli, MD | |
| 12:16 PM - 12:21 PM | Does Vein Stenting Reduce Great And Small Saphenous Venous Reflux |
| Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM | |
| View Slides in PDF | |
| 12:22 PM - 12:27 PM | Long-Term Fate Of Limb Reflux After Iliac Vein Stenting |
| Presenter(s):Seshadri Raju, MD | |
| View Slides in PDF | |
| 12:28 PM - 12:33 PM | Panel Discussion |
| 12:34 PM - 12:57 PM | Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 100 | |
| SESSION 101 SCHEDULE | |
| x | |
| 12:58 PM - 1:03 PM | FDA Compliant Patient-Reported Outcome Measure For Use In Clinical Trials For Venous Origin Chronic Pelvic Pain In Women |
| Presenter(s):Neil M. Khilnani, MD | |
| View Slides in PDF | |
| 1:04 PM - 1:09 PM | RCT Of Pelvic Venous Embolization Versus Sham Procedure For Venous Origin Chronic Pelvic Pain In Women |
| Presenter(s):Neil M. Khilnani, MD | |
| View Slides in PDF | |
| 1:10 PM - 1:15 PM | Venographic Techniques To Identify Pelvic Anatomy And Escape Points |
| Presenter(s):Mark H. Meissner, MD | |
| View Slides in PDF | |
| 1:16 PM - 1:21 PM | Male Pelvic Congestion And Varicose Veins: How Much Of A Problem |
| Presenter(s):Mark S. Whiteley, MS, FRCS, FCPhleb | |
| View Slides in PDF | |
| 1:22 PM - 1:27 PM | Ovarian Vein Embolization: Which Patient Benefits And Reimbursement |
| Presenter(s):Kathleen D. Gibson, MD | |
| View Slides in PDF | |
| 1:28 PM - 1:33 PM | We Need Dedicated Venous Stents For Nutcracker Syndrome And We Need Them Now |
| Presenter(s):Peter Gloviczki, MD | |
| View Slides in PDF | |
| 1:34 PM - 1:39 PM | Outcomes Of Left Renal Vein Stenting In Patients With Nutcracker Syndrome |
| Presenter(s):Rabih A. Chaer, MD | |
| View Slides in PDF | |
| 1:40 PM - 1:45 PM | Open Surgery For Nutcracker: Techniques And Results |
| Presenter(s):Cynthia K. Shortell, MD | |
| View Slides in PDF | |
| 1:46 PM - 1:51 PM | Management Of Symptomatic Vulvar Varices With And Without Pelvic Symptoms |
| Presenter(s):Steve Elias, MD | |
| View Slides in PDF | |
| 1:52 PM - 1:57 PM | Panel Discussion |
| END OF SESSION 101 | |
| SESSION 102 SCHEDULE | |
|
Friday
SESSION 102:
MORE VENOUS THROMBOSIS, IVC
Moderators:Thomas S. Maldonado, MD / Timothy K. Liem, MD, MBA
|
|
| x | |
| 1:58 PM - 2:03 PM | What To Do With Fractured Filters And Embolic Filter Fragments |
| Presenter(s):Constantino Pena, MD | |
| View Slides in PDF | |
| 2:04 PM - 2:09 PM | Update On Heparin-Induced Thrombocytopenia |
| Presenter(s):Timothy K. Liem, MD, MBA | |
| View Slides in PDF | |
| 2:10 PM - 2:15 PM | Advanced IVC Filter Retrieval: When And How |
| Presenter(s):Kush R. Desai, MD | |
| View Slides in PDF | |
| 2:16 PM - 2:21 PM | Which DOAC For What Disease: Review Of Ongoing Trials |
| Presenter(s):Andrea T. Obi, MD | |
| View Slides in PDF | |
| 2:22 PM - 2:27 PM | Who Needs Lifelong Anticoagulation |
| Presenter(s):Rachel Rosovsky, MD, MPH | |
| View Slides in PDF | |
| 2:28 PM - 2:33 PM | SVT Treatment Options: DOAC, LMWH, Nothing |
| Presenter(s):Steve Elias, MD | |
| View Slides in PDF | |
| 2:34 PM - 2:39 PM | Update On Reversal Agents For The DOACs |
| Presenter(s):Timothy K. Liem, MD, MBA | |
| View Slides in PDF | |
| 2:40 PM - 2:45 PM | IVC Management In Pregnant Patients |
| Presenter(s):Joann M. Lohr, MD | |
| View Slides in PDF | |
| 2:46 PM - 2:51 PM | Pediatric DVT: An Evidence Summary |
| Presenter(s):Dawn M. Coleman, MD, FACS | |
| View Slides in PDF | |
| 2:52 PM - 2:57 PM | The Future Of Lymphedema Care: Non-Pneumatic Compression Results In Improved Outcomes And Greater Patient Compliance |
| Presenter(s):Thomas S. Maldonado, MD | |
| View Slides in PDF | |
| 2:58 PM - 3:03 PM | The Preserve IVC Filter Study Results |
| Presenter(s):Timothy K. Liem, MD, MBA | |
| View Slides in PDF | |
| 3:04 PM - 3:09 PM | Role Of Thrombophilia Testing |
| Presenter(s):Rachel Rosovsky, MD, MPH | |
| View Slides in PDF | |
| 3:10 PM - 3:15 PM | Why Temporary Filters Are Not Removed: Clinical Predictors In 1,000 Consecutive Cases |
| Presenter(s):Heron E. Rodriguez, MD | |
| View Slides in PDF | |
| 3:16 PM - 3:21 PM | Open Removal Of Chronically Occluded IVC And Iliofemoral Stents |
| Presenter(s):Steven D. Abramowitz, MD | |
| View Slides in PDF | |
| 3:22 PM - 3:27 PM | Breakthrough DVT – Aren’t They All |
| Presenter(s):Peter Henke, MD | |
| View Slides in PDF | |
| 3:28 PM - 3:33 PM | Panel Discussion |
| END OF SESSION 102 | |
| SESSION 103 SCHEDULE | |
|
Friday
SESSION 103:
DEEP VEIN VALVE TECHNOLOGIES, MORE STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION
|
|
| x | |
| 3:34 PM - 3:39 PM | Tips And Tricks For Optimal Management Of Primary And Secondary IVC Tumors |
| Presenter(s):Jill J. Colglazier, MD | |
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | Deep Vein Valve Devices: What Outcome Measures Should Be Used |
| Presenter(s):Fedor Lurie, MD, PhD | |
| View Slides in PDF | |
| 3:46 PM - 3:51 PM | US Experience Of The BlueLeaf®Endovenous Valve Formation: Update |
| Presenter(s):William A. Marston, MD | |
| View Slides in PDF | |
| 3:52 PM - 3:57 PM | Novel Transcatheter Endovascular Device For Treatment Of Deep Venous Reflux |
| Presenter(s):Jorge H. Ulloa, MD, FACS | |
| View Slides in PDF | |
| 3:58 PM - 4:03 PM | Three-Year Outcomes Of An Implantable Bioprosthetic Valve For The Treatment Of Deep Venous Reflux |
| Presenter(s):Jorge H. Ulloa, MD, FACS | |
| View Slides in PDF | |
| 4:04 PM - 4:09 PM | An Update On The Cook Venous Valve Project |
| Presenter(s):Paul J. Gagne, MD | |
| View Slides in PDF | |
| 4:10 PM - 4:15 PM | Outcome Of Venous Stents In Adolescents, Teenagers, And Pregnancy |
| Presenter(s):Mahmood Razavi, MD | |
| View Slides in PDF | |
| 4:16 PM - 4:21 PM | Acute Iliofemoral DVT In Adolescents And Young Adults And Whether They Should Undergo Stenting For May Thurner At The Time Of DVT Intervention |
| Presenter(s):William A. Marston, MD | |
| View Slides in PDF | |
| 4:22 PM - 4:27 PM | Shortcomings Of Stents: Positioning, Migration, Patency And Anticoagulation |
| Presenter(s):Cees H.A. Wittens, MD, PhD | |
| View Slides in PDF | |
| 4:28 PM - 4:33 PM | Ruptured IVC And Iliac Vein: Now What |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| View Slides in PDF | |
| 4:34 PM - 4:39 PM | IVC Reconstruction Options |
| Presenter(s):Erin H. Murphy, MD | |
| View Slides in PDF | |
| 4:40 PM - 4:45 PM | Panel Discussion |
| END OF SESSION 103 | |
| SESSION 104 SCHEDULE | |
|
Friday
SESSION 104:
VENOUS ANEURYSMS, MORE IMPORTANT DEEP VENOUS CONCEPTS
Moderators:Peter F. Lawrence, MD / Houman Jalaie, MD, PhD
|
|
| x | |
| 4:46 PM - 4:51 PM | Venous Aneurysms: Should They Be Treated |
| Presenter(s):Peter F. Lawrence, MD | |
| View Slides in PDF | |
| 4:52 PM - 4:57 PM | Closed Plication Is A Safe And Effective Method For Treating Popliteal Venous Aneurysm |
| Presenter(s):Thomas W. Wakefield, MD | |
| View Slides in PDF | |
| 4:58 PM - 5:03 PM | Do Venous Stent Fractures Matter |
| Presenter(s):David J. Dexter, MD | |
| View Slides in PDF | |
| 5:04 PM - 5:09 PM | Most Common Venous Stenting Complications And How To Avoid Them |
| Presenter(s):Erin H. Murphy, MD | |
| View Slides in PDF | |
| 5:10 PM - 5:15 PM | Suprainguinal Lymphatic Disease In Patients Undergoing Stenting For Chronic Iliofemoral Venous Obstruction |
| Presenter(s):Arjun Jayaraj, MD | |
| View Slides in PDF | |
| 5:16 PM - 5:21 PM | Outcomes Of Acute Superior Mesenteric Venous Thrombosis |
| Presenter(s):Rabih A. Chaer, MD | |
| View Slides in PDF | |
| 5:22 PM - 5:27 PM | Open Surgical And Endovascular Treatment Of Superior Vena Cava Syndrome |
| Presenter(s):Manju Kalra, MBBS | |
| View Slides in PDF | |
| 5:28 PM - 5:33 PM | Endophlebectomy Of Common Femoral Vein: When And How |
| Presenter(s):Houman Jalaie, MD, PhD | |
| View Slides in PDF | |
| 5:34 PM - 5:39 PM | Contralateral Limb Improvement After Unilateral Iliac Vein Stenting: Argument Against Simultaneous Bilateral Stenting |
| Presenter(s):Seshadri Raju, MD | |
| View Slides in PDF | |
| 5:40 PM - 5:45 PM | Stenting Across The IVC Filter Is A Safe And Effective Alternative To Complex Removal |
| Presenter(s):Efthymios (Makis) Avgerinos, MD | |
| View Slides in PDF | |
| 5:46 PM - 5:51 PM | Venous Stent For The Iliofemoral Vein Investigational Clinical Trial Using The Duo Venous Stent System: The VIVID Trial |
| Presenter(s):Mahmood Razavi, MD | |
| View Slides in PDF | |
| 5:52 PM - 5:57 PM | Panel Discussion End of Program M |
| END OF SESSION 104 | |
|
Saturday, November 18, 2023
Print Entire 2023 Program:
|
|
| SESSION 105 SCHEDULE | |
|
Saturday
SESSION 105:
LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
|
|
| x | |
| 7:00 AM - 7:05 AM | Despite Recent Improved Endo Techniques, Acute Limb Ischemia (ALI) Still Has High Amputation And Mortality Rates: Why, Is It Because The Disease Has Evolved And Become More Complex: What Is Needed To Improve Results |
| Presenter(s):Loay S. Kabbani, MD, MHSA | |
| View Slides in PDF | |
| 7:05 AM - 7:10 AM | When Should Endovascular Treatments Be The First Choice For Common Femoral Artery (CFA) Occlusive Lesions: When Are They Contraindicated |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | The Open Treatment First For CLTI In The Era Of BEST-CLI |
| Presenter(s):Yana Etkin, MD | |
| View Slides in PDF | |
| 7:15 AM - 7:20 AM | With Arterialization Of Pedal Veins (DVA) Improved Foot Perfusion Persists After The DVA Occludes: The “Pramook Phenomenon”: What Is The Mechanism |
| Presenter(s):Steven Kum, MD | |
| View Slides in PDF | |
| 7:20 AM - 7:25 AM | DEBATE: An Endo First Approach Is Best For Treating CLTI In Almost All Patients: The Role For Open Bypasses Is Very Limited: Has BEST-CLI And BASIL 2 Changed My Practice |
| Presenter(s):Christopher J. Abularrage, MD | |
| View Slides in PDF | |
| 7:25 AM - 7:30 AM | DEBATE: Open Bypass Should Be The First Treatment For Many CLTI Patients: When Is This So And In What Percentage Of CLTI Patients |
| Presenter(s):Karan Garg, MD | |
| View Slides in PDF | |
| 7:30 AM - 7:35 AM | Panel Discussion |
| 7:35 AM - 7:40 AM | Four Pillars To Optimize The Salvage Of Threatened Limbs: Metabolic Management, Revascularization, Good Wound Care, And Spinal Stimulation For Diabetic Neuropathy: How Does The Latter Help |
| Presenter(s):Krishna Jain, MD | |
| View Slides in PDF | |
| 7:40 AM - 7:45 AM | Pedal Medial Arterial Calcification (pMAC); Is It A Predictor Of Poor Outcomes: Does It Make Limb Salvage Hopeless |
| Presenter(s):Michael S. Conte, MD | |
| View Slides in PDF | |
| 7:45 AM - 7:50 AM | DEBATE: Multivessel Tibial Revascularization Does Not Improve Limb Salvage In CLTI Patients: From A VQI Study |
| Presenter(s):Venita Chandra, MD | |
| View Slides in PDF | |
| 7:50 AM - 7:55 AM | DEBATE: Not So: In Some Circumstances Multivessel Tibial Revascularization Does Improve Outcomes In CLTI Patients: Which Circumstances |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 7:55 AM - 8:00 AM | Panel Discussion |
| 8:00 AM - 8:05 AM | Indication And Technical Tips For Performing Retrograde Popliteal Artery Access |
| Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS | |
| View Slides in PDF | |
| 8:05 AM - 8:10 AM | Prograde SFA Access Can Be Safe And Effective For Lower Extremity Endo Procedures; When And How To Do It Safely |
| Presenter(s):Todd Berland, MD / Karan Garg, MD | |
| View Slides in PDF | |
| 8:10 AM - 8:15 AM | Isolated Pedal Interventions For CLTI: When Are They Worthwhile And Who Should Do Them |
| Presenter(s):Mark G. Davies, MD | |
| View Slides in PDF | |
| 8:15 AM - 8:20 AM | What Defines The No-Option CLTI Foot As A Candidate For Venous Arterialization: What Is The Medial Arterial Calcium (MAC) Score And How Does It Help |
| Presenter(s):Miguel F. Montero-Baker, MD | |
| View Slides in PDF | |
| 8:20 AM - 8:25 AM | Panel Discussion |
| END OF SESSION 105 | |
| SESSION 106 SCHEDULE | |
|
Saturday
SESSION 106:
MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
Moderators:David J. Minion, MD / R. Clement Darling III, MD
|
|
| x | |
| 8:25 AM - 8:30 AM | Below The Ankle Recanalizations Of Occlusive Lesions: Why Are They Important; Is The Restored Patency Durable; Technical Tips To Do Them |
| Presenter(s):Lorenzo Patrone, MD | |
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | Value Of Shockwave Lithotripsy For The Treatment Of Calcified Lesions Above And Below The Knee In Patients With CLTI And Those On Hemodialysis |
| Presenter(s):Venita Chandra, MD | |
| View Slides in PDF | |
| 8:35 AM - 8:40 AM | Impact Of A Dedicated Limb Preservation/Limb Salvage Service On Amputation Rates: Must It Include An Open Bypass Surgery Component |
| Presenter(s):Niten Singh, MD | |
| View Slides in PDF | |
| 8:40 AM - 8:45 AM | Atherectomy In Patients With CLTI, ISR And Diabetes: When Is It Helpful; How Durable Is It: Which Devices Are The Best |
| Presenter(s):Ignacio Escotto, MD | |
| View Slides in PDF | |
| 8:45 AM - 8:50 AM Power Point Presentation with Synched Audio |
Long-Term Outcomes Of Atherectomy – Stand Alone Or With DCBs – For Fempop Lesions: Indications, Limitations: Which Device Is Best: Update On The FLEX Vessel Prep System |
| Presenter(s):Eric A. Secemsky, MD, MSc | |
| View Slides in PDF | |
| 8:50 AM - 8:55 AM | Panel Discussion |
| 8:55 AM - 9:00 AM | Duplex Flow Waveform And Flow Volume (In Addition To Flow Velocity) Can Determine Failing Vein Grafts So Patency Can Be Preserved |
| Presenter(s):Kimihiro Komori, MD, PhD | |
| View Slides in PDF | |
| 9:00 AM - 9:05 AM | Impact Of The Severity Of Chronic Kidney Disease On The Outcomes Of Lower Extremity Bypasses For CLTI: Is There A Difference Between Vein And Prosthetic Bypasses |
| Presenter(s):Heepeel Chang, MD | |
| View Slides in PDF | |
| 9:05 AM - 9:10 AM | Updated Experience With Open Leg Bypasses After Multiple Endo Treatment Failures For CLTI: They Can Produce Long-Term (>10 Years) Limb Salvage |
| Presenter(s):Julien G. Sfeir, MD | |
| View Slides in PDF | |
| 9:10 AM - 9:15 AM | Patient Survival In 2023 After Below-Knee Amputation (BKA), Above-Knee Amputation (AKA), Bilateral Amputations For Trauma; For Vascular Disease: Saving Limbs Especially In Vascular Patients Enhances Survival |
| Presenter(s):Philip P. Goodney, MD, MS | |
| View Slides in PDF | |
| 9:15 AM - 9:25 AM | Panel Discussion |
| 9:25 AM - 9:30 AM | Value Of Duplex Gray Scale In Predicting Successful SFA CTO Crossing, Re-Entry And The Need For Distal Access |
| Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM | |
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | Effect Of Short-Term Complications Of Lower Extremity Revascularizations On Long-Term Outcomes And Patient Survival |
| Presenter(s):Panos Kougias, MD, MSc / Sherene E. Sharath, PhD, MPH / Joseph L. Mills, MD | |
| View Slides in PDF | |
| 9:35 AM - 9:40 AM | Role Of Atherectomy For Lower Extremity Lesions In The Post BEST CLI Era |
| Presenter(s):James F. McKinsey, MD | |
| View Slides in PDF | |
| 9:40 AM - 9:45 AM | How To Use Microcatheters To Facilitate Complex Peripheral Interventions |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| View Slides in PDF | |
| 9:45 AM - 9:50 AM | Panel Discussion |
| 9:50 AM - 10:00 AM | Break - Visit Exhibits And Pavilions (3rd Floor) |
| END OF SESSION 106 | |
| SESSION 107 SCHEDULE | |
|
Saturday
SESSION 107:
AORTIC TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS) AND SPINE EXPOSURE (6- MINUTE TALKS)
Moderators:Timur P. Sarac, MD / Mark A. Adelman, MD
|
|
| x | |
| 10:00 AM - 10:05 AM | Fenestrated EVAR Versus Chimney EVAR For Juxtarenal AAAs: When Is One Better Than The Other And What Are The Critical Considerations |
| Presenter(s):Piergiorgio Cao, MD, FRCS | |
| View Slides in PDF | |
| 10:05 AM - 10:10 AM | Improved System For Evaluating Aortic Neck Anatomy And Suitability For EVAR And Need For F/EVAR |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 10:10 AM - 10:15 AM | Hybrid Preservation Of Hypogastric Artery Flow Using A Viabahn Stent-Graft Followed By Open Repair For Large Hypogastric Aneurysms |
| Presenter(s):Benjamin J. Pearce, MD | |
| View Slides in PDF | |
| SPINE EXPOSURE SURGERY | |
| 10:15 AM - 10:21 AM | Technical Tips And Tools For The Vascular Surgeon To Provide Anterior Exposure For Spine Procedures (6-Minute Presentation) |
| Presenter(s):Jeffrey Jim, MD, MPHS | |
| View Slides in PDF | |
| 10:22 AM - 10:28 AM | Vascular Complications Of Anterior Spine Exposures; How To Avoid Them And How To Treat Them If They Occur (6-Minute Presentation) |
| Presenter(s):William P. Robinson, MD | |
| View Slides in PDF | |
| 10:28 AM - 10:33 AM | Outcomes Of EVAR In Over 18,000 High-Risk Patients Ineligible For Open Repair: When Is EVAR Justified Over No Intervention In Such Patients: Why Is EVAR 2 No Longer Relevant |
| Presenter(s):George A. Antoniou, MD. PhD, MSc, FEBVS | |
| View Slides in PDF | |
| 10:34 AM - 10:39 AM | Should The Celiac Artery Be Stented Or Not During Complex Aortic Aneurysm Repair In Patients With Median Arcuate Ligament Syndrome (MALS) Or In Any Patients With MALS |
| Presenter(s):Jesse M. Manunga, MD | |
| View Slides in PDF | |
| 10:40 AM - 10:45 AM | Open Versus Endovascular Treatment For Chronic Mesenteric Ischemia: Operative Outcomes And Patient Survival |
| Presenter(s):Michael C. Stoner, MD | |
| View Slides in PDF | |
| 10:45 AM - 10:50 AM | Panel Discussion |
| 10:50 AM - 10:55 AM | DEBATE: Evolution Of Stent-Graft Design And Changes In Appropriate Neck Lengths Make F/EVAR Superior To Ch/EVAR |
| Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
| View Slides in PDF | |
| 10:55 AM - 11:00 AM | DEBATE: Not So: Properly Performed Ch/EVAR Can Have Comparable Outcomes To F/EVAR: Technical Tips For Optimal Ch/EVAR Performance |
| Presenter(s):Manish Mehta, MD, MPH | |
| View Slides in PDF | |
| 11:00 AM - 11:05 AM | The Vascular Surgeon’s Role In TAVR Procedures Via The Common Carotid Artery: Pitfalls And Technical Tips |
| Presenter(s):Gregg S. Landis, MD | |
| View Slides in PDF | |
| 11:05 AM - 11:10 AM | With Juxtarenal Aorto-Iliac Occlusive Disease, Infrarenal Aortic Transection And Endarterectomy Combined With Thrombectomy Avoids Supraceliac Clamping: How To Do It Without Renovisceral Embolization: 10-Year Experience And Technical Tips |
| Presenter(s):Wayne W. Zhang, MD | |
| View Slides in PDF | |
| 11:10 AM - 11:15 AM | Transcaval Access For TEVAR: When And How To Do It Without Aortic Or Retroperitoneal Bleeding |
| Presenter(s):Ross Milner, MD | |
| View Slides in PDF | |
| 11:15 AM - 11:20 AM | Panel Discussion |
| END OF SESSION 107 | |
| SESSION 108 SCHEDULE | |
|
Saturday
SESSION 108:
AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
|
|
| x | |
| 11:20 AM - 11:25 AM | DEBATE: The Vast Majority Of Failed EVARs Can Be Treated Endovascularly |
| Presenter(s):Ross Milner, MD | |
| View Slides in PDF | |
| 11:25 AM - 11:30 AM | DEBATE: Not So: Many Failed EVARs Are Best Repaired By Open Conversion |
| Presenter(s):Michel Makaroun, MD | |
| View Slides in PDF | |
| 11:30 AM - 11:35 AM | Techniques For Improving Proximal Landing Zones For TEVARs And Aortic Dissections Involving The Aortic Arch; Parallel Grafts And Extra-Anatomic Bypasses |
| Presenter(s):R. Clement Darling III, MD | |
| View Slides in PDF | |
| 11:35 AM - 11:40 AM | Comparison Of Results Of Primary F/EVAR With Those Of F/EVAR After Failed EVAR: Technical Tips For The Latter |
| Presenter(s):Marc L. Schermerhorn, MD | |
| View Slides in PDF | |
| TOPICS RELATED TO THE AORTA AND ITS BRANCHES | |
| 11:40 AM - 11:45 AM | When And How To Treat Isolated Visceral Artery Aneurysms: The Value Of Embolization Coils |
| Presenter(s):Paulo E. Ocke Reis, MD, PhD | |
| View Slides in PDF | |
| 11:45 AM - 11:50 AM | Primary Use Of Endoanchors For Hostile Proximal Neck Anatomy With EVAR: Mid-Term Results Show Their Value |
| Presenter(s):Apostolos K. Tassiopoulos, MD | |
| View Slides in PDF | |
| 11:50 AM - 11:55 AM | Reinterventions After F/EVAR: What Are They And What Is Their Individual Impact On Survival |
| Presenter(s):Jason T. Lee, MD | |
| View Slides in PDF | |
| 11:55 AM - 12:05 PM | Panel Discussion |
| CAROTID TOPICS | |
| 12:05 PM - 12:10 PM | Avoidable Errors During TCAR And How To Avoid Them: How To Detect And Manage Intolerance To Flow Reversal |
| Presenter(s):Thomas S. Maldonado, MD | |
| View Slides in PDF | |
| 12:10 PM - 12:15 PM | Tips And Tricks For Successful TCAR And When Is CEA And Best Medical Treatment Better Than TCAR |
| Presenter(s):Jeffrey Jim, MD, MPHS | |
| View Slides in PDF | |
| 12:15 PM - 12:20 PM | How To Use The Silk Road TCAR Device In The Treatment Of Tandem Carotid Lesions: Technical Tips And Results |
| Presenter(s):Michael C. Stoner, MD | |
| View Slides in PDF | |
| 12:20 PM - 12:25 PM | Radiation To The Neck Creates Significant Risk For Carotid Artery Complications Without And With Surgery (CEA): Can Anything Be Done About Them |
| Presenter(s):Cynthia K. Shortell, MD | |
| View Slides in PDF | |
| 12:25 PM - 12:30 PM | Techniques For Dealing With Challenging Carotid Lesions: How Does TCAR Facilitate Treatment When Nothing Else Could Work |
| Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS | |
| View Slides in PDF | |
| 12:30 PM - 12:35 PM | Mini-Incision CEA With Standard Or Eversion Techniques: How To Do It Safely: It’s Better Than Transfemoral CAS Or TCAR |
| Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
| View Slides in PDF | |
| 12:35 PM - 12:40 PM | Panel Discussion End of Program N VEITHsymposium continues with the A-V Access Program in the Grand Ballroom West. |
| END OF SESSION 108 | |
| SESSION 109 SCHEDULE | |
|
Saturday
SESSION 109:
IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
Moderators:Larry A. Scher, MD / Anton N. Sidawy, MD, MPH
|
|
| x | |
| 8:00 AM - 8:05 AM | Introduction |
| Presenter(s):Larry A. Scher, MD / Anton N. Sidawy, MD, MPH | |
| 8:06 AM - 8:13 AM | Vascular Access Cosmesis: Does It Really Matter |
| Presenter(s):Charmaine Lok, MD | |
| View Slides in PDF | |
| 8:14 AM - 8:21 AM | Put The Books Aside! Novel Tools For Teaching Vascular Access To The Millennials |
| Presenter(s):Samira S. Farouk, MD, MS | |
| View Slides in PDF | |
| 8:22 AM - 8:29 AM | 40-Year Lack Of Progress In Hemodialysis Access Cannulation |
| Presenter(s):Deborah Brouwer-Maier, RN, CNN | |
| View Slides in PDF | |
| 8:30 AM - 8:37 AM | Buttonhole Dialysis Access Cannulation: A 2023 Update |
| Presenter(s):Dori R. Schatell, MS | |
| View Slides in PDF | |
| 8:38 AM - 8:45 AM | Home Dialysis And Self-Cannulation: What Are The Challenges From A Patient's Perspectives |
| Presenter(s):Lissette Ramos-Multani | |
| 8:46 AM - 8:53 AM | Ultrasound Guided Cannulation Of HD Access: Pearls And Pitfalls |
| Presenter(s):Vandana D. Niyyar, MD | |
| View Slides in PDF | |
| 8:54 AM - 9:04 AM | Panel Discussion |
| 9:05 AM - 9:12 AM | Improving Kidney Care For The Geriatric Population |
| Presenter(s):Charmaine Lok, MD | |
| View Slides in PDF | |
| 9:13 AM - 9:20 AM | Surgeon Factors Have A Greater Effect On Vascular Access Type And Outcomes Than Patient Factors |
| Presenter(s):Peter F. Lawrence, MD / Karen Woo, MD, PhD | |
| View Slides in PDF | |
| 9:21 AM - 9:28 AM | Are Long-Term Tunneled Catheters Ever The Best Option For Hemodialysis |
| Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS | |
| View Slides in PDF | |
| 9:29 AM - 9:36 AM | Cannulation Of Deep AV Fistulas – What Are My Options |
| Presenter(s):John R. Ross, Sr., MD | |
| View Slides in PDF | |
| 9:37 AM - 9:44 AM | Creating Successful Hemodialysis Access In Children |
| Presenter(s):Vincent L. Rowe, MD | |
| View Slides in PDF | |
| 9:45 AM - 9:52 AM | Clinical Trial Management: Pitfalls And Lessons Learned |
| Presenter(s):Karl A. Illig, MD | |
| View Slides in PDF | |
| 9:53 AM - 10:03 AM | Panel Discussion |
| 10:04 AM - 10:25 AM | Break - Visit Exhibits And Pavilions (3rd Floor) |
| END OF SESSION 109 | |
| SESSION 110 SCHEDULE | |
|
Saturday
SESSION 110:
MORE IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
|
|
| x | |
| 10:26 AM - 10:33 AM | Tracking Dialysis Access Outcomes: Frustrations Of A Practicing Dialysis Access Surgeon |
| Presenter(s):John F. Lucas III, MD | |
| View Slides in PDF | |
| 10:34 AM - 10:41 AM | Can The SVS Vascular Quality Initiative Provide Practical Quality Measures For Hemodialysis Access |
| Presenter(s):Evan C. Lipsitz, MD, MBA | |
| View Slides in PDF | |
| 10:42 AM - 10:49 AM | Does Preoperative Vascular Mapping Matter Before Access Creation |
| Presenter(s):Charmaine Lok, MD | |
| View Slides in PDF | |
| 10:50 AM - 10:57 AM | Intraoperative Vascular Mapping During Hemodialysis Access Surgery Should Be Incorporated Into Routine Practice |
| Presenter(s):Yana Etkin, MD | |
| View Slides in PDF | |
| 10:58 AM - 11:05 AM | Volume Flow Measurement In Dialysis Access: Why Is It Important |
| Presenter(s):Deborah Brouwer-Maier, RN, CNN | |
| View Slides in PDF | |
| 11:06 AM - 11:13 AM | Flow Reduction Techniques And Their Importance In Access Durability |
| Presenter(s):William Jennings, MD | |
| View Slides in PDF | |
| 11:14 AM - 11:24 AM | Panel Discussion |
| MANAGEMENT OF HEMODIALYSIS ACCESS ANEURYSMS | |
| 11:25 AM - 11:32 AM | Use Of Deep Learning To Classify Arteriovenous Access Aneurysms |
| Presenter(s):Peter Kotanko, MD | |
| View Slides in PDF | |
| 11:33 AM - 11:40 AM | Risk Stratification For Hemodialysis Access Aneurysms |
| Presenter(s):Christian Ochoa, MD | |
| View Slides in PDF | |
| 11:41 AM - 11:48 AM | Surgical Options For Managing AV Access Aneurysms |
| Presenter(s):Vicki J. Teodorescu, MD | |
| View Slides in PDF | |
| 11:49 AM - 11:59 AM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break - Mercury Rotunda & Ballroom, 3rd Floor |
| END OF SESSION 110 | |
| SESSION 111 SCHEDULE | |
|
Saturday
SESSION 111:
POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
Moderators:Larry A. Scher, MD / Anton N. Sidawy, MD, MPH
|
|
| x | |
| 1:00 PM - 1:07 PM | Current Landscape Of Legal Enforcement In The Vascular Access World |
| Presenter(s):Terry Litchfield, MPA | |
| View Slides in PDF | |
| 1:08 PM - 1:15 PM | Training Surgeons And Interventionalists In Vascular Access: What Are The Options |
| Presenter(s):Karl A. Illig, MD | |
| View Slides in PDF | |
| 1:16 PM - 1:23 PM | How Old Is Too Old: How Can I Stay Relevant In My Specialty |
| Presenter(s):John R. Ross, Sr., MD | |
| View Slides in PDF | |
| 1:24 PM - 1:31 PM | Development Of MIPS (Merit Based Incentive Payment System) Value Pathways For Dialysis Access |
| Presenter(s):Evan C. Lipsitz, MD, MBA | |
| View Slides in PDF | |
| 1:32 PM - 1:39 PM | Coding Integrity: Compliance 101 For Vascular Access Providers |
| Presenter(s):Terry Litchfield, MPA | |
| View Slides in PDF | |
| 1:40 PM - 1:50 PM | Panel Discussion |
| END OF SESSION 111 | |
| SESSION 112 SCHEDULE | |
|
Saturday
SESSION 112:
NOVEL TECHNOLOGIES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
|
|
| x | |
| 1:51 PM - 1:58 PM | Initial Clinical Experience With A Novel Ultrasound System: Feasibility Trial Update |
| Presenter(s):Alexander Yevzlin, MD | |
| View Slides in PDF | |
| 1:59 PM - 2:06 PM | Potential Use Of Infrared Hyperspectral Imaging To Predict Hemodialysis Fistula Maturation And Complications |
| Presenter(s):John E. Aruny, MD | |
| View Slides in PDF | |
| 2:07 PM - 2:14 PM | Natural Vascular Scaffolding: What Is It And How Can It Be Used In Hemodialysis Access |
| Presenter(s):Venita Chandra, MD | |
| View Slides in PDF | |
| 2:15 PM - 2:22 PM | Is There A Role For Intravascular Lithotripsy In Hemodialysis Access Surgery |
| Presenter(s):Surendra Shenoy, MD, PhD | |
| View Slides in PDF | |
| 2:23 PM - 2:30 PM | The Future Of AV Graft Technology: What Is In The Pipeline |
| Presenter(s):Buddy D. Ratner, PhD | |
| View Slides in PDF | |
| 2:31 PM - 2:38 PM | Novel Endovascular Venous Anastomotic Device For AV Graft Implantation: Results Of A Prospective Multicenter Trial |
| Presenter(s):Alexander Yevzlin, MD | |
| View Slides in PDF | |
| 2:39 PM - 2:49 PM | Panel Discussion |
| END OF SESSION 112 | |
| SESSION 113 SCHEDULE | |
|
Saturday
SESSION 113:
UPDATE ON CLINICAL CHALLENGES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
Moderators:Larry A. Scher, MD / Surendra Shenoy, MD, PhD
|
|
| x | |
| DEBATE: THORACIC OUTLET DECOMPRESSION AFTER HEMODIALYSIS ACCESS CREATION | |
| 2:50 PM - 2:57 PM | DEBATE: Transaxillary First Rib Resection For Thoracic Outlet Decompression For Subclavian Venous Stenosis After Ipsilateral Hemodialysis Access Creation |
| Presenter(s):Sungho Lim, MD | |
| View Slides in PDF | |
| 2:58 PM - 3:05 PM | DEBATE: Selective Use Of First Rib Resection Versus Medical Claviculectomy For Thoracic Outlet Decompression After Hemodialysis Access Creation |
| Presenter(s):Surendra Shenoy, MD, PhD | |
| View Slides in PDF | |
| 3:06 PM - 3:13 PM | Optimizing AV Fistula Maturation With The VasQ Device: Update On Clinical Trials |
| Presenter(s):Ellen D. Dillavou, MD | |
| View Slides in PDF | |
| 3:14 PM - 3:21 PM | Creating AV Access In Patients With Ipsilateral Central Venous Stenosis |
| Presenter(s):William Jennings, MD | |
| View Slides in PDF | |
| 3:22 PM - 3:29 PM | New Paradigms To Treat Cephalic Arch Stenosis: Go With The Flow |
| Presenter(s):Mark G. Davies, MD | |
| View Slides in PDF | |
| 3:30 PM - 3:37 PM | Optimizing Dialysis Access Strategies In The Geriatric And Bariatric Population |
| Presenter(s):Jason K. Wagner, MD | |
| View Slides in PDF | |
| 3:38 PM - 3:45 PM | Hemodialysis Access: Which Patients Fare Well, Which patients Fare Poorly |
| Presenter(s):Laura E. Niklason, MD, PhD | |
| View Slides in PDF | |
| 3:46 PM - 3:56 PM | Panel Discussion |
| 3:57 PM - 4:00 PM | Closing Remarks End of Program O |
| Presenter(s):Larry A. Scher, MD | |
| END OF SESSION 113 | |
| SESSION 114 SCHEDULE | |
|
Saturday
SESSION 114:
VASCULAR SONOGRAPHY IN ACUTE AND CHRONIC LIMB ISCHEMIA
Moderators:George L. Berdejo, BA, RVT, FSVU
|
|
| x | |
| 7:00 AM - 7:10 AM | Welcome And Opening Remarks: Navigating The Meeting And Optimizing Your Experience |
| Presenter(s):George L. Berdejo, BA, RVT, FSVU | |
| View Slides in PDF | |
| 7:10 AM - 7:20 AM | Still Important Role Of Physiologic Testing |
| Presenter(s):Anahita Dua, MD, MS, MBA | |
| View Slides in PDF | |
| 7:20 AM - 7:30 AM | Infrapopliteal And Pedal Artery Imaging |
| Presenter(s):Jill S. Sommerset, BS, RVT, FSVU | |
| View Slides in PDF | |
| 7:30 AM - 7:40 AM | Clinical Decision Making Based On The Results Of Noninvasive Testing |
| Presenter(s):David L. Dawson, MD | |
| View Slides in PDF | |
| 7:40 AM - 7:50 AM | Duplex Guided Interventions |
| Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM | |
| View Slides in PDF | |
| 7:50 AM - 8:00 AM | Post-Operative Surveillance: When, How Often |
| Presenter(s):R. Eugene Zierler, MD, RPVI | |
| View Slides in PDF | |
| 8:00 AM - 8:20 AM | Panel Discussion |
| END OF SESSION 114 | |
| SESSION 115 SCHEDULE | |
|
Saturday
SESSION 115:
WAVEFORMS – LESSONS LEARNED FROM CASES WITH UNIQUE WAVEFORMS WHICH LEAD TO FURTHER TESTING OR UNUSUAL PATHOLOGY
Moderators:George L. Berdejo, BA, RVT, FSVU
|
|
| x | |
| 8:20 AM - 8:30 AM | Global Cardiac Effects On The Peripheral Vascular Evaluation |
| Presenter(s):David M. Williams, MS, RDCS, RVT, FSVU | |
| CASE STUDY PRESENTATIONS | |
| 8:30 AM - 8:38 AM | Vein Imaging |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| View Slides in PDF | |
| 8:38 AM - 8:46 AM | Cerebrovascular |
| Presenter(s):Maya Hutchinson, MHS, ACS, RVT, RDMS, PS, RDCS (AE/PE) | |
| View Slides in PDF | |
| 8:46 AM - 8:54 AM | Abdominal |
| Presenter(s):Traci B. Fox, EdD, RDMS, RVT | |
| View Slides in PDF | |
| 8:54 AM - 9:02 AM | Hemodialysis Access |
| Presenter(s):Ann Marie Kupinski, PhD, RVT, FSVU | |
| View Slides in PDF | |
| 9:02 AM - 9:20 AM | Panel Discussion |
| 9:20 AM - 9:45 AM | Break - Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 115 | |
| SESSION 116 SCHEDULE | |
|
Saturday
SESSION 116:
LESSONS LEARNED IN THE VASCULAR LAB THROUGH THE QA ACCREDITATION PROCESS
Moderators:Ann Marie Kupinski, PhD, RVT, FSVU
|
|
| x | |
| 9:45 AM - 9:53 AM | Instantaneous Vascular Lab QA Reporting From The EVS Suite And OR |
| Presenter(s):David M. Williams, MS, RDCS, RVT, FSVU | |
| View Slides in PDF | |
| 9:53 AM - 10:01 AM | Reports: Improving The Interpretation |
| Presenter(s):David L. Dawson, MD | |
| View Slides in PDF | |
| 10:01 AM - 10:09 AM | Quality Improvement Metrics – What We Need To Look For |
| Presenter(s):Joseph P. Hughes, MBA, RVT, RVS, RPhS, NVS, FSVU | |
| View Slides in PDF | |
| 10:09 AM - 10:30 AM | Panel Discussion |
| END OF SESSION 116 | |
| SESSION 117 SCHEDULE | |
|
Saturday
SESSION 117:
BEYOND THE CORE CONCEPTS IN VASCULAR TESTING: ARE YOU MEETING THE STANDARD
Moderators:Natalie A. Marks, MD, RPVI, RVT, FSVM
|
|
| x | |
| (This session will venture into advanced vascular evaluation related to vascular testing as it related to pre-operative diagnosis and post-intervention follow-up and patient evaluation and will describe appropriate use, standard and non-standard image acquisition and other components that define the “complete” vascular examination.) | |
| 10:35 AM - 10:45 AM | Lower Extremity Imaging After Endovenous Procedures: When, What To Expect And How To Report Your Findings |
| Presenter(s):Neil M. Khilnani, MD | |
| View Slides in PDF | |
| 10:45 AM - 10:55 AM | Limited” Imaging Protocols In A Covid-19 World: How Safe Is This; Are They Still Necessary |
| Presenter(s):Anahita Dua, MD, MS, MBA | |
| View Slides in PDF | |
| 10:55 AM - 11:05 AM | Carotid Artery Imaging Pre And Post Stenting And/Or Endarterectomy: It’s More Than The Usual Protocol |
| Presenter(s):Maya Hutchinson, MHS, ACS, RVT, RDMS, PS, RDCS (AE/PE) | |
| View Slides in PDF | |
| 11:05 AM - 11:15 AM | Evaluation Of Fibromuscular Dysplasia |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| View Slides in PDF | |
| 11:15 AM - 11:35 AM | Panel Discussion |
| 11:35 AM - 11:50 AM | Lunch Break |
| END OF SESSION 117 | |
| SESSION 118 SCHEDULE | |
|
Saturday
SESSION 118:
TECHNICAL SKILLS LAB
Moderators:Fernando Amador, RVT / Richard Dubin, AAS-DMS, RVT, RDMS
|
|
| x | |
| 11:50 AM - 12:50 PM | Station 1: Pedal Artery Imaging |
| Presenter(s):Jill S. Sommerset, BS, RVT, FSVU | |
| 11:50 AM - 12:50 PM | Station 2: Carotid Artery Imaging |
| Presenter(s):William N. Del Valle, RVT | |
| 11:50 AM - 12:50 PM | Station 3: Transcranial Duplex |
| Presenter(s):Joseph P. Hughes, MBA, RVT, RVS, RPhS, NVS, FSVU | |
| 11:50 AM - 12:50 PM | Station 4: Pelvic Venous Reflux Testing |
| Presenter(s):Jan M. Sloves, RVT | |
| 11:50 AM - 12:50 PM | Station 5: Renal Artery Imaging |
| Presenter(s):Robert De Jong, RDMS, RVT, FSDMS | |
| 11:50 AM - 12:50 PM | Station 6: Physiologic Testing |
| Presenter(s):Kayla Wieseckel, MHSc, RVT, RVS, RPhS | |
| 11:50 AM - 12:50 PM | Station 7: Hemodialysis Access |
| Presenter(s):Ann Marie Kupinski, PhD, RVT, FSVU | |
| END OF SESSION 118 | |
| SESSION 119 SCHEDULE | |
| x | |
| 12:50 PM - 1:50 PM | Panel Discussion: Interpreting With The Masters |
| Panelist(s): David L. Dawson, MD / Anahita Dua, MD, MS, MBA / Ann Marie Kupinski, PhD, RVT, FSVU / R. Eugene Zierler, MD, RPVI | |
| View Slides in PDF | |
| END OF SESSION 119 | |
| SESSION 120 SCHEDULE | |
|
Saturday
SESSION 120:
VENOUS IMAGING: TESTING FOR LEG REFLUX AND PELVIC VEIN DISORDERS
Moderators:Nicos Labropoulos, BSc (Med), PhD, DIC, RVT
|
|
| x | |
| 1:50 PM - 1:58 PM | The Clinical Examination Matters And Guides The Ultrasound Examination |
| Presenter(s):Anahita Dua, MD, MS, MBA | |
| View Slides in PDF | |
| 1:58 PM - 2:06 PM | 5 Top Tips For Lower Extremity Vein Mapping |
| Presenter(s):Richard Dubin, AAS-DMS, RVT, RDMS | |
| View Slides in PDF | |
| 2:06 PM - 2:14 PM | 5 Top Tips For Pelvic Vein Imaging |
| Presenter(s):Jan M. Sloves, RVT | |
| View Slides in PDF | |
| 2:14 PM - 2:22 PM | The Role Of IVUS In Vein Procedures |
| Presenter(s):Steve Elias, MD | |
| View Slides in PDF | |
| 2:22 PM - 2:30 PM | Common And Uncommon Reflux Pathways |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| View Slides in PDF | |
| 2:30 PM - 2:38 PM | Panel Discussion |
| END OF SESSION 120 | |
| SESSION 121 SCHEDULE | |
|
Saturday
SESSION 121:
ERGONOMICS - AUDIT YOUR VASCULAR LAB: ARE YOU ERGONOMICALLY “SOUND”; ERGONOMICS “SOS” (SOUND OCCUPATIONAL STRATEGIES)
|
|
| x | |
| (This important session will discuss strategies designed to help you to Ergonomically Enhance the Experience for the Vascular Sonographer by 1) increasing awareness around health and safety in the workplace; 2) recognizing factors that influence the Vascular ultrasound professionals’ likelihood of developing work-related musculoskeletal disorders; and 3) reducing ergonomic injury and prevent long-term permanent bodily damage.) | |
| 2:38 PM - 2:46 PM | Managing Turbulent High Volumes And High Impact Examinations – Save Your Staff, Enhance Sonographer Satisfaction And Maximize Productivity And Maximize Careers: Advocating On Behalf Of Yourself And Your Staff – How And Why It’s Important |
| Presenter(s):Joseph P. Hughes, MBA, RVT, RVS, RPhS, NVS, FSVU | |
| View Slides in PDF | |
| 2:46 PM - 2:54 PM | Increase Your “Ergonomic Index” – Basic And Innovative Ways To Make Exams More Ergonomic – “Accessorizing” The Vascular Lab Suite |
| Presenter(s):Kayla Wieseckel, MHSc, RVT, RVS, RPhS | |
| View Slides in PDF | |
| 2:54 PM - 3:02 PM | How To Be Ergonomically Sound With Obese And Uncooperative Patients |
| Presenter(s):Robert De Jong, RDMS, RVT, FSDMS | |
| View Slides in PDF | |
| 3:02 PM - 3:15 PM | Break |
| END OF SESSION 121 | |
| SESSION 122 SCHEDULE | |
|
Saturday
SESSION 122:
PRACTICE ENHANCEMENTS AND PHILOSOPHICAL ISSUES
Moderators:George L. Berdejo, BA, RVT, FSVU
|
|
| x | |
| 3:15 PM - 3:25 PM | Critical Vascular Lab Findings: Which Are They And How Do You Manage This |
| Presenter(s):R. Eugene Zierler, MD, RPVI | |
| View Slides in PDF | |
| 3:25 PM - 3:33 PM | IAC Consensus Criteria 0 How Widespread Is Its Use In IAC Accredited Labs And How To Incorporate It Into Your Practice |
| Presenter(s):Aubrey J. Rybyinski, BS, RDMS, RVT, FSDMS | |
| View Slides in PDF | |
| 3:33 PM - 3:41 PM | CEA – When Duplex Is And Is Not Enough Or Redundant Testing/Imaging Prior To CEA: Is There Too Much Happening; When Is Duplex Enough And When Is More Imaging Necessary, If At All |
| Presenter(s):David L. Dawson, MD | |
| View Slides in PDF | |
| 3:41 PM - 3:49 PM | Patterns Of Infrapopliteal Arterial Occlusive Disease: Lessons Learned From A Survey Of A Small Community Hospital |
| Presenter(s):William N. Del Valle, RVT | |
| View Slides in PDF | |
| 3:49 PM - 3:57 PM | IAC Updates |
| Presenter(s):Aubrey J. Rybyinski, BS, RDMS, RVT, FSDMS | |
| View Slides in PDF | |
| 3:57 PM - 4:05 PM | Reimbursement Updates |
| Presenter(s):Joseph P. Hughes, MBA, RVT, RVS, RPhS, NVS, FSVU | |
| View Slides in PDF | |
| 4:05 PM - 4:20 PM | Panel Discussion (Combined Sessions 121 And 122) |
| END OF SESSION 122 | |
| SESSION 123 SCHEDULE | |
|
Saturday
SESSION 123:
ABDOMEN; CURVEBALLS AND CONTROVERSIES
Moderators:Richard C. Pennell, MD, FACS, RPVI
|
|
| x | |
| 4:20 PM - 4:30 PM | Renal Artery Evaluation: 5 Top Tips |
| Presenter(s):Robert De Jong, RDMS, RVT, FSDMS | |
| View Slides in PDF | |
| 4:30 PM - 4:40 PM | The Endograft Examination From A to Z |
| Presenter(s):Kayla Wieseckel, MHSc, RVT, RVS, RPhS | |
| View Slides in PDF | |
| 4:40 PM - 4:50 PM | Common And Not So Common Aortic Pathologies |
| Presenter(s):Richard C. Pennell, MD, FACS, RPVI | |
| View Slides in PDF | |
| 4:50 PM - 5:00 PM | Hemodialysis Access “Surveillance”: Flow Volume, Flow Velocity And How Often Is Appropriate |
| Presenter(s):Ann Marie Kupinski, PhD, RVT, FSVU | |
| View Slides in PDF | |
| 5:00 PM - 5:10 PM | Pre-Operative Dialysis Access Mapping Including Endo-AVF Creation: Tips And Tricks |
| Presenter(s):Richard Dubin, AAS-DMS, RVT, RDMS | |
| View Slides in PDF | |
| 5:10 PM - 5:30 PM | Panel Discussion End of Program P |
| END OF SESSION 123 | |